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external cues. In this work, we have examined the regulation and function of HS1, a poorly-understood
actin regulatory protein, in T cells. This protein, which becomes tyrosine phosphorylated upon T cell
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activation of the IL2 promoter. TCR engagement leads to phosphorylation of HS1 at Tyr 378 and Tyr 397,
creating binding sites for SH2 domain-containing proteins, including Vav1 and Itk. Phosphorylation at
these residues is required for Itk-dependent recruitment of HS1 to the IS, Vav1 IS localization, and
HS1-dependent actin reorganization and IL2 production. Therefore, in addition to directly interacting with
branched actin filaments, HS1 regulation of Vav1 localization provides another mechanism by which HS1
signals to the actin cytoskeleton. Analysis of Ca2+ responses in HS1-/- T cells reveals that the defect in
these cells lies at the level of release from intracellular stores. Phosphorylated HS1 interacts with PLCγ1,
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clearly important for signaling downstream of the TCR, HS1-/- mice exhibit normal T cell development and
normal peripheral populations. Surprisingly, HS1 is not required for T cell homing to lymphoid organs, for
TCR endocytosis or for CD8+ T cell effector function. However, T cells from HS1-/- mice produce reduced
amounts of Ifnγ, and are subsequently less likely to become Ifnγ-producing TH1 effector cells. These
data demonstrate that HS1 functions as a cytoskeletal adaptor protein and plays specific roles
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Abstract
ROLE AND REGULATION OF THE ACTIN-REGULATORY PROTEIN HS1 IN TCR
SIGNALING
Esteban Carrizosa
Advisor: Dr. Janis K. Burkhardt
Numerous aspects of T cell function, including TCR signaling, migration, and execution
of effector functions, depend on the actin cytoskeleton. Cytoskeletal rearrangements are
driven by the action of actin-regulatory proteins, which promote or antagonize the
assembly of actin filaments in response to external cues. In this work, we have examined
the regulation and function of HS1, a poorly-understood actin regulatory protein, in T
cells. This protein, which becomes tyrosine phosphorylated upon T cell activation, is
thought to function primarily by stabilizing existing branched actin filaments. Loss of
HS1 results in unstable actin responses upon TCR engagement and defective Ca2+
responses, leading to poor activation of the IL2 promoter. TCR engagement leads to
phosphorylation of HS1 at Tyr 378 and Tyr 397, creating binding sites for SH2 domaincontaining proteins, including Vav1 and Itk. Phosphorylation at these residues is
required for Itk-dependent recruitment of HS1 to the IS, Vav1 IS localization, and HS1dependent actin reorganization and IL2 production. Therefore, in addition to directly
interacting with branched actin filaments, HS1 regulation of Vav1 localization provides
another mechanism by which HS1 signals to the actin cytoskeleton. Analysis of Ca2+
responses in HS1-/- T cells reveals that the defect in these cells lies at the level of release
from intracellular stores. Phosphorylated HS1 interacts with PLCγ1, and mediates its
iv

association with the cytoskeleton and regulates microcluster dynamics. Although HS1 is
clearly important for signaling downstream of the TCR, HS1-/- mice exhibit normal T cell
development and normal peripheral populations. Surprisingly, HS1 is not required for T
cell homing to lymphoid organs, for TCR endocytosis or for CD8+ T cell effector
function. However, T cells from HS1-/- mice produce reduced amounts of Ifnγ, and are
subsequently less likely to become Ifnγ-producing TH1 effector cells. These data
demonstrate that HS1 functions as a cytoskeletal adaptor protein and plays specific roles
downstream of TCR engagement.
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Chapter 1: Introduction1
Regulated reorganization of the actin cytoskeleton is important for multiple
aspects of T cell function, including signaling and differentiation along discrete
developmental lineages, migration through tissues, and execution of effector functions.
Early studies testing the role of actin in T cell activation were based on the use of actindisrupting agents such as cytochalasin D (CytoD). These studies showed that actin is
required for adherence to target cells and cytotoxic activity (Henney and Bubbers, 1973),
as well as for signaling events associated with Ca2+ flux and downstream changes in gene
expression (Valitutti et al., 1995). However, these studies revealed a complex role for
actin. For example, in T cells stimulated with superantigen-pulsed antigen presenting
cells (APCs), CytoD-treatment results in diminished Ca2+ flux, but stimulation with antiCD3 antibodies results in a prolonged Ca2+ response (Valitutti et al., 1995). Similarly,
while one study showed that CytoD treatment impairs the activation of the IL2 promoter
(Holsinger et al., 1998), another found that at low doses of CytoD, Ca2+ signaling is
prolonged and IL2 production increases (Rivas et al., 2004). These findings and more
recent data described below suggest that actin filaments play a dual role, enhancing T cell
activation by promoting conjugate formation and the assembly of signaling complexes,

1

This chapter is a modified version of a review article titled “The Actin Cytoskeleton in T Cell
Activation.” It was published in the 2008 issue of Annual Review of Immunology, Volume 26, pages 233259, with the following author list: Janis K. Burkhardt, Esteban Carrizosa, and Meredith H. Shaffer.
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but also down-regulating activation, perhaps by facilitating molecular movements that
culminate in the internalization of the TCR.

Interaction with APCs and immunological synapse formation
Upon interaction with an APC bearing appropriate MHC-peptide complexes, the
T cell extends large pseudopodia and lamellipodia toward the APC, a process resulting
from the recruitment and localized activation of actin polymerizing and actin binding
proteins. This process results in the formation of a flattened, F-actin rich interface with
the APC. In parallel with these shape changes, the MTOC and associated secretory
organelles reorient within the T cell cytoplasm, and come to lie just beneath the plasma
membrane, near the center of the APC contact site. This reorientation of T cell
cytoskeletal elements was observed by several investigators in the early 1980s, and was
recognized as a hallmark of productive T cell activation and a prerequisite for directed
cytolysis and T cell help (Kupfer et al., 1985; Kupfer et al., 1994; Ryser et al., 1982).
Actin responses at the T cell-APC contact site are important for organization of
signaling molecules at this site, to form the immunological synapse (IS) (Campi et al.,
2005; Sims et al., 2007; Tskvitaria-Fuller et al., 2003; Wulfing et al., 2000). Protein
segregation within the IS was initially described as forming a “supramolecular activation
cluster (SMAC)” comprised of a central region (c-SMAC) containing TCR and
associated signaling proteins within a peripheral ring (p-SMAC) containing LFA-1 and
associated adhesion molecules (Monks et al., 1998). Recent studies have shown,
however, that IS architecture and dynamics vary greatly depending on several variables,
2

including the nature of the T cell and the APC, agonist strength, costimulatory
interactions, and the tissue context in which the interaction is taking place (Friedl et al.,
2005; Jacobelli et al., 2004). Our understanding of IS function has evolved considerably
over the past decade. Once thought to facilitate TCR signaling by bringing interacting
molecules together, the c-SMAC was subsequently shown to be a site where signaling is
terminated by internalization of TCR signaling complexes (Cemerski et al., 2007;
Mossman et al., 2005; Varma et al., 2006). The role for the c-SMAC in downregulating
T cell signaling is supported by studies in which signaling is enhanced under conditions
in which c-SMAC formation is blocked and inhibited under conditions in which c-SMAC
formation is induced (Cemerski et al., 2007; Lee et al., 2003; Mossman et al., 2005). An
interesting study combining empirical analysis with mathematical modeling has shown
that both ideas are probably correct, and that parameters such as peptide-MHC half life
determine the balance between these two interrelated facets of IS function (Cemerski et
al., 2007). A more recent study supports and refines this idea, suggesting that c-SMAC
formation serves to regulate signal strength (Cemerski et al., 2008). Enforced c-SMAC
formation reduces proliferative responses for strong agonists, but enhances responses for
weak agonists. Moreover, stimulation with low doses of antigenic peptide results in
detectable signaling in the c-SMAC, whereas with high peptide doses, signaling is
detectable only in the p-SMAC.
Video analysis of molecular movements during IS formation show that the TCR
and associated signaling molecules form microclusters around the periphery of the cellcell contact site, and converge to form the c-SMAC (Bunnell et al., 2002; Campi et al.,
3

2005; Varma et al., 2006; Yokosuka et al., 2005). Sustained signaling occurs in the
peripheral clusters, while central clusters are destined for degradation, at least in the
context of a strong signal. Microcluster formation and centripetal movement are actindependent processes, controlled in part by Cdc42 (Campi et al., 2005; Tskvitaria-Fuller et
al., 2003; Varma et al., 2006). Once formed, however, these signaling complexes are
highly stable and are largely unaffected by actin-depolymerizing agents. It will be
interesting to learn how specific actin regulatory molecules work to orchestrate
microcluster formation and movement, especially as this relates to parameters such as
peptide-MHC half life and T cell subset.

CONTROL OF ACTIN DYNAMICS AT THE IMMUNOLOGICAL
SYNAPSE
Engagement of the TCR activates multiple actin regulatory proteins that work in concert
to drive actin polymerization at the IS (Figure 1.1). The best understood of these
molecules function downstream of Vav1 and other GEFs, which activate the Rho
GTPases Rac1 and Cdc42 at sites of TCR engagement.

4

Figure 1.1: TCR signaling pathways leading to actin polymerization
Encounter of an APC induces a signaling cascade comprised of tyrosine
kinases (dark green), adaptor proteins (yellow), and immediate upstream actin
regulatory proteins (dark blue), that transduce signals to several nucleation
promoting factors (red) that direct the polymerization of branched actin
filaments at sites of TCR engagement. Engagement of costimulatory
molecules leads to activation of proteins that sever actin filaments (peach),
creating new barbed ends as substrates for filament growth. Question marks
indicate the unknown mechanisms by which actin remodeling leads to IL2
promoter activation and other changes in gene expression.

5

Arp2/3 complex-dependent actin regulatory proteins
The initiation of actin filament formation is a kinetically unfavorable process,
requiring the action of nucleation-promoting factors (NPFs) to generate a “seed” from
which a filament can elongate. Many of the best-understood NPFs work in concert with
the 7-subunit Arp2/3 complex to form new actin branches on the sides of existing actin
filaments (Goley and Welch, 2006) (Figure 1.2). This complex, which is composed of
two actin-related proteins, Arp2 and Arp3, and five other proteins, ARPC1-5, binds to the
side of an existing actin filament, where Arp2 and Arp3 mimic two actin monomers as
part of the core nucleus. NPFs such as WASp and WAVE2 then bind to Arp2/3 complex
and present an actin monomer, allowing elongation to take place. Using an RNAi-based
strategy, the Billadeau group showed that suppression of either Arp2 or Arp3 in Jurkat T
cells results in degradation of other complex components (Gomez et al., 2007). Arp2/3
complex-deficient cells do not polymerize branched actin at the IS, and they fail to form
lamellipodia in spreading assays using anti-TCR coated coverslips. Interestingly, these
cells generate highly dynamic F-actin-rich filopodia in response to either APCs or antiTCR coated surfaces, a finding that points toward additional, Arp2/3 complexindependent actin regulatory pathways. Nonetheless, this study demonstrates that Arp2/3
complex and its upstream activators are central effectors of actin polymerization at the IS.

6

Figure 1.2: Model for branched actin polymerization by Arp2/3 complex.
Model for branched actin polymerization by Arp2/3 complex.
Arp2/3 complex complex nucleates a new actin filament at a 70º angle from
the side of an existing filament. NPFs function by binding to and inducing a
conformational change in Arp2/3 complex and presenting actin monomers to
form the new filament (Goley and Welch, 2006).

7

WASp
The best-characterized activator of Arp2/3 complex is WASp, named for its
causative role in Wiskott-Aldrich syndrome (WAS), a severe X-linked immune
deficiency disorder (Derry et al., 1994; Orange et al., 2004). The characteristic
symptoms are thrombocytopenia, eczema, and recurrent infections. Patients are also
prone to malignancy and autoimmune disease. Recent studies have shown that WASp is
required for the function and, in certain contexts, the development of regulatory T cells
(Adriani et al., 2007; Humblet-Baron et al., 2007; Maillard et al., 2007; Marangoni et al.,
2007).
The domain structure of WASp is shown in Figure 1.3. The N-terminal WASphomology region (WH1) binds constitutively to WASp interacting protein (WIP).
Disruption of this interaction results in degradation of WASp (de la Fuente et al., 2007;
Volkman et al., 2002). Most mutations associated with WAS are found in this region and
interfere with WIP binding (Notarangelo and Ochs, 2003). WIP is almost certainly an
important actin regulatory protein in its own right, but WIP function per se has not been
tested, presumably because of the challenges associated with constructing WIP-deficient
cells that express normal levels of WASp. However, evidence that WIP and WASp play
non-redundant roles comes from analysis of WIP/WASp double-knockout mice: T cells
lacking both proteins migrate less well than T cells from either of the single knockouts
(Gallego et al., 2006). WASp recruitment and activation at the IS are relatively well
understood.
8

Figure 1.3: Domain structures of selected Arp2/3 complex regulators.
The domain structure of key Arp2/3 activating molecules is shown, with related
regions colored similarly. Important binding partners are listed below the domains to
which they bind. Known tyrosine (Y) and serine (S) phosphorylation sites are
indicated, a predicted threonine phosphorylation site is indicated in italics (T), and
total amino acid numbers are shown at the top right of each.
Abbreviations: NTA – N-terminal acidic region; HTH – Helix-turn-helix;
PRD – Proline rich domain; SH3 – Src homology 3; WH1 – Wasp homology 1; GBD
– GTPase binding domain; VCA – verprolin, cofilin homology, acidic region; WHD –
WAVE homology domain; WH2 – WASP homology 2

9

Recruitment occurs through an interaction between the WASp proline-rich domain (PRD)
and the SH3 domains of the adaptors Nck and PST-PIP (Badour et al., 2003; Zeng et al.,
2003). Localization to the IS facilitates WASp contact with Cdc42-GTP, which binds to
the GTPase-binding domain (GBD) (Zeng et al., 2003), leading to a conformational
change in WASp. In resting cells, WASp exists in a closed, inactive state in which the
GBD contacts the verprolin, cofilin, acidic (VCA) region. Cdc42 binding releases the
VCA domain, allowing the VCA to interact with Arp2/3 complex (Kim et al., 2000).
Phosphorylation of WASp at tyrosine 291 by the Src family kinase Fyn, and subsequent
binding of the SH2-SH3 domain module of Src kinases to WASp, works in a synergistic
manner with Cdc42 binding to induce optimal WASp activity (Badour et al., 2004a;
Torres and Rosen, 2003, 2006). Binding of Nck or the SH3 domain of HS1
(hematopoietic cell-specific lyn substrate 1) or cortactin may also activate WASp or NWASp (discussed below) (Kowalski et al., 2005; Rohatgi et al., 1999). Analysis of
WASp localization in T cells spreading on anti-CD3-coated coverslips reveals that
WASp is initially recruited to signaling microclusters. It then translocates to the cell
periphery, presumably to aid in actin polymerization in lamellipodial protrusions (BardaSaad et al., 2005).
WASp-deficient T cells from both mice and humans exhibit consistent defects in
signaling pathways leading to IL2 production, but the literature is divided about the
importance of WASp for controlling actin polymerization at the IS. Although there are
numerous reports that T cells from WAS patients exhibit defective actin responses
10

(reviewed in (Notarangelo and Ochs, 2003)), Jurkat cells depleted of WASp using RNAi
polymerize actin normally (Nolz et al., 2006). Moreover, T cells from two different
WASp knockout mice behave differently with respect to their ability to polymerize actin
in response to TCR engagement (Badour et al., 2004a; Cannon and Burkhardt, 2004;
Krawczyk et al., 2002). A possible explanation for these discrepancies is that other
proteins (including the close homologue N-WASp, as well as less closely related proteins
such as WAVE2 and HS1) have partially overlapping functions. Indeed, loss of both
WASp and N-WASp impairs thymocyte function and development much more severely
than loss of either protein alone (Cotta-de-Almeida et al., 2007). Recent work from the
Dustin lab supports the idea that WASp-dependent actin polymerization is indispensable
for T cell activation (Sims et al., 2007). This study shows that naïve T cells contacting
APCs or lipid bilayers containing MHC-peptide complexes and ICAM-1 form a shortlived IS, then migrate some distance before generating a second, more stable contact.
Intriguingly, although WASp-/- T cells form an initial contact in this assay, they continue
to migrate and fail to re-form and maintain a long-lived IS.

WAVE2
Another important activator of Arp2/3 complex is the WAVE/SCAR family
member WAVE2, an NPF that functions as an effector for Rac1. RNAi-mediated
suppression of WAVE2 in Jurkat T cells results in loss of actin polymerization at the IS
(Nolz et al., 2006; Zipfel et al., 2006). In addition, WAVE2 suppression perturbs
conjugate formation, suggesting a role in integrin function. WAVE2 resembles WASp in
11

that it binds Arp2/3 complex via a C-terminal VCA domain (Figure 1.3), but WAVE2
lacks a GBD and does not bind Rac1 directly (Miki et al., 1998). WAVE2 exists as part
of a constitutive complex containing Abi1/2, Sra1/PIR121, Hspc300, IRSp53 and HEM-1
(Billadeau et al., 2007). WAVE complex components stabilize one another against
degradation, and suppression of Abi1/2 or HEM-1 also results in actin defects (Innocenti
et al., 2004; Miki et al., 2000; Nolz et al., 2006; Zipfel et al., 2006). WAVE complex
components also function in WAVE2 targeting and activation. IRSp53 acts as an adaptor
between Rac1 and WAVE2, and this interaction leads to the recruitment of WAVE2 to
the membrane (Miki et al., 2000). Abi1/2 can mediate an interaction between Abl kinase
and WAVE2, resulting in phosphorylation at Tyr 150, which increases the actin
polymerization activity of WAVE2 (Leng et al., 2005).
WAVE2-deficient mice have not been generated, due to embryonic lethality
(Billadeau et al., 2007). However, a mouse strain with a nonsense mutation in Hem-1
resulting in termination at residue 445 was generated using random mutagenesis (Park et
al., 2008). These mice exhibit lymphopenia, neutrophilia, anemia, and pathology
throughout a variety of tissues. Thymocyte cellularity is severely reduced, and
development is abnormal. Actin responses in neutrophils, macrophages, and T cells from
these mice are severely impaired. As expected, this mutation in Hem-1 results in loss of
other components of the WAVE complex. Although the mutation responsible may leave
a fragment of Hem-1 intact, this study makes it clear that the WAVE complex is integral
to leukocyte development and function. It is possible that the function of Hem-1 is
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attributable to its role in other complexes (Weiner et al., 2006); however, Hem-1 appears
to associate exclusively with the WAVE2 complex in T cells (Nolz et al., 2006).

HS1 and cortactin
A third activator of Arp2/3 complex, and the focus of this dissertation, is HS1.
HS1 is a hematopoietic-lineage restricted (Kitamura et al., 1989) homolog of the actin
binding protein cortactin (product of the EMS1 gene). Cortactin is the better studied of
the two proteins, and both are discussed below. The domain structures of HS1 and
cortactin are shown in Figure 1.3, and a sequence comparison with key features indicated
is shown in Figure 1.4.
Like WASp and WAVE, HS1 and cortactin contain an acidic region (NTA) that
binds Arp2/3 complex, and both can modestly activate Arp2/3-dependent actin
polymerization (Uruno et al., 2001; Uruno et al., 2003b; Weaver et al., 2001). However,
HS1 and cortactin also bind to F-actin directly. HS1 binds through its helix-turn-helix
(HTH) repeats and coiled-coil (CC) domain (Hao et al., 2005). Cortactin exists as at least
two major isoforms, containing either 5.5 or 6.5 HTH repeats; the fourth full repeat is
required for F-actin binding (Katsube et al., 2004; Uruno et al., 2001; Weed et al., 2000).
Because of their ability to directly bind F-actin, it is thought that HS1 and cortactin
function primarily to stabilize existing branched actin filaments by bridging Arp2/3
complex with F-actin (Uruno et al., 2001; Uruno et al., 2003b; Weaver et al., 2001)
(Figure 1.5). In keeping with this idea, we have found that HS1-suppressed T cells
exhibit unstable actin responses ((Gomez et al., 2006) and Chapter 2). HS1 and cortactin
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each contain a proline rich region (PRR) and an SH3 domain at the C-terminus (see
below).
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Figure 1.4: Sequence alignments of HS1 and cortactin.
Sequence alignments of human HS1 (hHS1), mouse HS1 (mHS1), human cortactin
(hCTTN), and mouse cortactin (mCTTN), generated using the multiple sequence
alignment function of MacVector, are shown. The cortactin isoforms shown contain
6.5 helix-turn-helix repeats. Sequence identities are shaded in dark gray and sequence
similarities are shaded in light gray. Critical residues for Arp2/3 binding, DDW, are
boxed in green. The glutamic acid-proline (EP) repeat region in human HS1 is boxed
in orange. The tryptophan residue responsible for SH3 domain specificity is boxed in
blue. Tyrosine phosphorylation sites that have been empirically identified for the
protein of either species are boxed in red and noted above or below the alignment. A
poly-proline region that may be involved in intramolecular SH3 domain binding is
boxed in gray. A potential MAP kinase recognition site is boxed in light blue. Major
domains for HS1 are noted below the alignment. Residue numbering above sequences
refers to human cortactin.
Genbank accession numbers of sequences used: hHS1 – AAH16758.1, mHS1
– NP_032251.1, hCTTN – NP_005222, mCTTN – NP_031829.2
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Figure 1.5: Model for HS1 interaction with Arp2/3 complex.
HS1, through its NTA region, interacts with Arp2/3 complex and crosslinks new
actin filaments by binding via the HTH repeats and CC region. Model proposed
by (Hao et al., 2005).
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Interestingly, the repeat region has been used to trace the evolutionary origin of these
molecules, as it is a unique feature (van Rossum et al., 2005). Cortactin homologs are
found in metazoans, but not in unicellular organisms or in plants. In contrast, HS1
expression is limited to vertebrates, and is thought to have originated from a gene
duplication event.
Both HS1 and cortactin are inducibly tyrosine phosphorylated. Cortactin was
initially identified as a Src kinase substrate in transformed cells overexpressing activated
Src (Kanner et al., 1990; Wu et al., 1991). At least three Src target sites have been
identified: Tyr 421, Tyr 466, Tyr 482 (these numbers refer to murine cortactin, and
correspond to Tyr 421, Tyr 470, and Tyr 486 in the human protein). Loss of Csk, a
negative regulator of Src kinases, leads to increased tyrosine phosphorylation of
cortactin, further implicating Src in cortactin phosphorylation (Thomas et al., 1995).
Src-dependent cortactin tyrosine phosphorylation is physiologically important.
Phosphorylation regulates the role of cortactin in cell migration, although the effect may
vary depending on the molecular and cellular context. Mutation of the three
phosphorylated tyrosines substantially impairs migration in a wound healing assay
(Huang et al., 1998). One study suggests that tyrosine phosphorylation impairs the ability
of cortactin to activate Arp2/3 complex (Martinez-Quiles et al., 2004), but another study
demonstrates that, in the presence of Nck, Src phosphorylation potentiates Arp2/3
complex activation (Tehrani et al., 2007). It is thought that tyrosine phosphorylation of
cortactin imparts a conformational change, highlighted by increased susceptibility to
cleavage by calpain (Huang et al., 1997b; Perrin et al., 2006).
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Early studies showed that HS1 undergoes tyrosine phosphorylation in response to
B cell receptor (BCR) (Hata et al., 1994; Yamanashi et al., 1993), T cell receptor (TCR)
(Takemoto et al., 1995), Fcε Receptor I (FcεRI) (Fukamachi et al., 1994), FcγRIIIA
(Zeng et al., 1995), and IL-5 receptor (Sato et al., 1994) stimulation. In vitro
phosphorylation experiments have identified Tyr 378 and Tyr 397 (these numbers refer to
human HS1, and are equivalent to Tyr 388 and Tyr 405, respectively, in the mouse
homolog) as targets of Syk family kinases (Brunati et al., 1995; Gomez et al., 2006), and
studies in B cells (Yamanashi et al., 1997), T cells (Gomez et al., 2006), NK cells (Butler
et al., 2008), and platelets (Brunati et al., 2005) have confirmed that these sites are
phosphorylated, most likely by Syk family kinases, in intact cells. Phosphorylation at
Tyr 378 and Tyr 397 creates a binding site for SH2 domains ((Gomez et al., 2006),
Chapters 2 and 3). This allows HS1 to act as a cytoskeletal adaptor protein, linking
signaling machinery to the actin cytoskeleton. HS1 can also be phosphorylated at Tyr
222 by Src family kinases in vitro and in intact platelets (Brunati et al., 1999; Brunati et
al., 1995); whether this occurs in T cells is not known. Phosphorylation at this site is
contingent on phosphorylation at Tyr 378 and Tyr 397 to create a docking site for Src
family kinases (Ruzzene et al., 1996). The functional relevance of phosphorylation at
this site has not been explored; however, it lies within the CC domain, and may regulate
F-actin binding.
Phosphorylation at Tyr 378 and Tyr 397 is a crucial event for HS1 function. The
WEHI-231 mutant line M1 is resistant to BCR-induced activation-induced cell death
(AICD), due to low expression of HS1 (Fukuda et al., 1995). While forced expression of
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wild-type HS1 can rescue the AICD response in one of this line, expression of a Tyr to
Phe mutant at both of these sites fails to rescue the AICD response (Yamanashi et al.,
1997). Our own studies have confirmed that phosphorylation at these sites in T cells is
physiologically important ((Gomez et al., 2006) and Chapter 2).
There is also evidence that HS1 can also be tyrosine phosphorylated at other sites.
The c-Abl tyrosine kinase can phosphorylate HS1 in vitro, and is required for efficient
HS1 phosphorylation in Jurkat cells (Huang et al., 2008). Although the target site is not
known, Tyr 421 in cortactin is an Abl target (Boyle et al., 2007), and the HS1 homolog,
Tyr 360, is a consensus site for Abl-mediated phosphorylation. Phosphorylation at Tyr
198 has been identified in a proteomic screen in Jurkat cells stimulated with anti-CD3
and anti-CD4 (Salomon et al., 2003), although the physiological relevance of
phosphorylation at this site has not been determined. Interestingly, this tyrosine is
conserved in HS1 and cortactin, and lies within the half HTH repeat in HS1 (Figure 1.3
and Figure 1.4), suggesting that it may regulate F-actin binding.
Although most work on HS1 phosphorylation has focused on antigen receptor
signaling, ligation of other cell-surface molecules may induce HS1 phosphorylation or
enhance antigen receptor-induced phosphorylation. Ligation of the costimulatory
receptors CD2 and CD28 alone or in conjunction with the TCR does not affect total HS1
tyrosine phosphorylation (Hutchcroft et al., 1998). In contrast, a recent study from
Cooper and colleagues has shown that, in human NK cells plated on integrin ligands,
HS1 undergoes tyrosine phosphorylation, an event that is required for adhesion (Butler et
al., 2008).
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Interestingly, WASp, WAVE2 and HS1 are highly modular in structure and can
interact with multiple signaling molecules at the IS. This structure undoubtedly
facilitates coordination of actin polymerization. Cortactin can cooperate with various
combinations of WIP, WASp, and Nck1 to activate Arp2/3 complex (Tehrani et al.,
2007), and we have explored the possibility that HS1 participates in similar interactions
((Gomez et al., 2006) and Chapter 2). In addition to the actin-regulatory domains
described above, HS1 and cortactin contain a proline-rich region and an SH3 domain at
the C terminus. The SH3 domain of cortactin has been shown to enhance N-WASpdependent actin polymerization, at least in vitro (Martinez-Quiles et al., 2004).
It is also likely that HS1, as well as WASP and WAVE2, facilitate T cell
activation by coordinating other signaling molecules independently of their role in actin
polymerization. For example, the SH3 domain of the Src family kinase Lck (leukocytespecific protein tyrosine kinase) binds to the proline-rich region of HS1 constitutively
(Takemoto et al., 1995), and the SH2 domain of Lck interacts with HS1, probably
through Tyr 378 and Tyr 397 (Gomez et al., 2006). This interaction may permit
phosphorylation at Tyr 222 by Src family kinases in vitro and in intact platelets (Brunati
et al., 2005; Brunati et al., 1999; Ruzzene et al., 1996). However, the functional
significance of this interaction is unknown.
Although the function of the HS1 SH3 domain has not been elucidated, the SH3
domain of cortactin interacts with dynamin family members and is important for
endocytosis (McNiven et al., 2000; Sauvonnet et al., 2005). The SH3 domain of cortactin
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also interacts with WIP and WASp or N-WASP and can potentiate actin polymerization
through that pathway (Kinley et al., 2003; Martinez-Quiles et al., 2004).
In addition to activation by tyrosine phosphorylation, HS1 and cortactin may be
regulated by serine/threonine phosphorylation. Phosphorylation of cortactin at Ser 405
and Ser 418 promotes actin polymerization (Martinez-Quiles et al., 2004). This may
occur by relieving an intramolecular interaction between the SH3 domain and the prolinerich region. HS1 also undergoes serine/threonine phosphorylation, although the sites are
unknown (Ruzzene et al., 2000). Although HS1 lacks homologs to cortactin Ser 405 and
Ser 418, HS1 does have a potential MAP kinase recognition site at Thr 352 (Figure 1.4)
(Takemoto et al., 1995). HS1 becomes a substrate of caspase 3 upon induction of
apoptosis (Chen et al., 2001), and serine/threonine phosphorylation by CK2 renders HS1
resistant to caspase 3-mediated cleavage (Ruzzene et al., 2002). Although the
physiological relevance of this phenomenon is unclear, it suggests that phosphorylation
induces a conformational change, as described above for cortactin.
No crystal structures for HS1 or cortactin have been published, presumably
because conformational flexibility of the HTH repeat region makes the protein difficult to
crystallize (Pant et al., 2006). However, low-resolution studies have been conducted on
the cortactin. Electron microscopy experiments have suggested that cortactin exists as a
relatively long, unstructured molecule, with a length of approximately 220-290 Å
(Weaver et al., 2002). In contrast, a more recent study using a combination of small
angle X-ray scattering, circular dichroism, and chemical crosslinking suggested an
ordered, globular structure with a length of approximately 110 Å (Cowieson et al., 2008).
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In this model, cortactin folds in such a way that the SH3 domain is close to the HTH
repeats; the authors do not exclude an interaction with the PRR. The differences between
these two structures may reflect a conformational change that cortactin may undergo,
from a closed, globular state to a more open, unstructured conformation.
However, the differences between the two structures may also be partially attributable to
the differences in the methodologies between the two studies. To date, no such structural
studies on HS1 have been published, but its structure is likely to bear some resemblance
to that of cortactin. Differences between the conformations of the molecules, in
particular from the differences in the HTH repeat region, may reflect the differences in
the signaling machinery between hematopoietic and non-hematopoeitic cells.

HS1 knockout mice
Mice lacking HS1 have been described (Taniuchi et al., 1995). These mice
develop normally, and no overt pathology has been detected. A limited analysis of B cell
and T cell development revealed normal progression through developmental stages, and
peripheral lymphoid populations appeared to be normal. However, responses to antigen
receptor ligation, for both B cells and T cells, were blunted: proliferative responses were
reduced, peritoneal B cells were abnormally resistant to activation-induced cell death
(AICD) resulting from multivalent BCR crosslinking, and thymocytes exhibited a defect
in negative selection in an H-Y transgenic model system. The phenotype of T cells from
these mice is further explored in Chapter 4.
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HS1 and cortactin in disease
Both HS1 and cortactin have been linked to disease. A variant of HS1 that lacks
the third HTH repeat, due to an exon-skipping mutation, was found in a SLE (systemic
lupus erythematosus) patient, as well as in the patient’s father and a sister, who also
displayed anti-nuclear antibodies (Sawabe et al., 2003); henceforth, this variant is
referred to as HS1HTH2.5. Moreover, an allelic variant with eight glutamic acid-proline
repeats (referred to as HS1EP8) instead of the more common six (HS1EP6) within the
proline-rich region (Figure 1.4), is significantly more common in SLE patients than in the
healthy population (Otsuka et al., 2004). 18.4% of SLE patients examined in this study
were homozygous for HS1EP8, whereas 9.8% of healthy individuals had this genotype. In
these studies, expression of HS1HTH2.5 or HS1EP8 promoted AICD more strongly than did
HS1EP6 in the WEHI231 cell death assay described above. The reason for this has not
been explored.
Numerous studies have linked cortactin expression to malignancy. Cortactin
overexpression has been associated with higher metastatic potential and poor prognoses
in many cancers, including breast, colorectal, and gastric cancers (Weaver, 2008). The
role of cortactin in cancer most likely stems from its effects on cell migration. It is a
component of invadopodia, actin-rich membrane protrusions that allow migrating cells to
invade tissues by degrading extracellular matrix (Bowden et al., 1999). Additionally, a
switch in expression from HS1 to cortactin has been found in certain B lymphoid tumor
lines (Miglarese et al., 1994). The reason for this switch is unclear; however, cortactin is
a more potent activator of Arp2/3 complex than HS1, and thus may be a more potent
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promoter of tumor metastasis. However, HS1 has also been linked to malignancy
(Scielzo et al., 2005). Constitutive phosphorylation of HS1 in chronic lymphocytic
leukemia is associated with a significantly shorter survival time.
Cortactin has also been shown to play a role in bacterial invasion at the level of
pathogen uptake and trafficking. Several studies have demonstrated that cortactin is
involved in cell invasion by intracellular bacteria, including Shigella flexneri, a causative
agent of dysentery (Bougneres et al., 2004; Dehio et al., 1995; Dumenil et al., 1998);
Staphylococcus aureus (Agerer et al., 2005); Neisseria meningitidis, which can cause
life-threatening meningitis (Hoffmann et al., 2001); and food-borne pathogens
Salmonella typhimurium and Listeria monocytogenes (Barroso et al., 2006; Unsworth et
al., 2004; Veiga and Cossart, 2005) (reviewed in (Selbach and Backert, 2005)). Although
no such role has been demonstrated for HS1, HIV depends on intact T cell cytoskeletal
dynamics for proper assembly (Jolly et al., 2007). It would be interesting to determine
whether HS1 deficiency imparts increased resistance to pathogen invasion.
The various disease associations of both HS1 and cortactin highlight the
importance of understanding the basic biology of these proteins and the broader
immunological and cell biological processes in which they are involved.

INTERPLAY BETWEEN T CELL SIGNALING AND ACTIN
DYNAMICS
TCR signaling to and through the actin cytoskeleton
TCR engagement induces a tyrosine phosphorylation cascade that facilitates the assembly
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of the signaling machinery into multimolecular signaling complexes (Smith-Garvin et al.,
2009). One of the earliest events after TCR engagement is the activation of the Src
family kinase Lck, which phosphorylates ITAMs (immunotyrosine-based activation
motifs) within the TCR complex. This creates a docking site for the Syk family kinase
ZAP-70 (ζ-chain associated protein kinase-70 kDa). ZAP-70, in turn, phosphorylates the
adapter proteins LAT (linker for activation of T cells) and Slp-76 (SH2-domain
containing leukocyte protein of 76 kDa). Slp-76 and LAT nucleate the assembly of large
multimolecular complexes, often referred to as signalosomes. Although the specific
composition is likely to vary between individual complexes, signaling proteins that
participate include PLCγ1 (phospholipase C γ1), the Rho GEF (guanine nucleotide
exchange factor) Vav-1, and the Tec family kinase Itk (IL2-inducible T cell kinase)
(Figure 1.6). Other adaptors, including Nck (non-catalytic region of tyrosine kinase),
Grb2, and GADS are also involved.
These proteins stabilize one another at sites of TCR engagement, and loss of any
of these molecules results in disruption of actin polymerization at the IS (Bubeck
Wardenburg et al., 1998; Bunnell et al., 2001; Fischer et al., 1998). Interaction with
complex components promotes the activation of Vav1 by phosphorylation and
phosphoinositide-dependent engagement of its PH domain (Bustelo, 2002). Vav1 then
generates localized pools of active Cdc42 and Rac1, promoting actin polymerization by
WASp and WAVE2, respectively (Dombroski et al., 2005; Labno et al., 2003). As
discussed above, other events also contribute to WASp and WAVE2 activation; however,
Vav1 function is clearly critical (Fischer et al., 1998; Holsinger et al., 1998).
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Importantly, Vav1 binds to multiple actin regulatory molecules, suggesting that its central
role in controlling actin dynamics involves adaptor functions as well as GEF activity.
Itk plays a key role in T cell activation, regulating both cytoskeletal
rearrangements and Ca2+ flux. The domain structure of Itk is shown in Figure 1.6. Itk
contains a pleckstrin homology domain that mediates inducible binding to PtIns(3,4,5)P3
generated by PI3K (phosphoinositide 3-kinase) upon T cell activation, a proline-rich
region, an SH3 domain, an SH2 domain, and the kinase region. The proline rich region,
SH3 domain, and SH2 domain are involved in intermolecular interactions with other
signalosome components (Bunnell et al., 2000).
Although it lacks domains that interact directly with the actin cytoskeleton, Itk is
required for actin polymerization at the IS. T cells from Itk-/- mice or Jurkat cells
depleted of Itk by RNAi exhibit severe defects in actin polymerization at the IS
(Dombroski et al., 2005; Grasis et al., 2003; Labno et al., 2003). Interestingly, control of
actin dynamics is an adaptor function of Itk, since an intact SH2 domain, but not kinase
activity, is required. Itk regulates cytoskeletal dynamics in part by recruiting Vav1 to the
IS. The link between Itk and the actin cytoskeleton is further explored in Chapter 3.
Interactions between signalosome components, as well as interactions between the
SH3 domain and proline rich region of Itk (in cis or in trans) are important for regulating
its kinase activity. Phosphorylation of Itk at Tyr 180 and Tyr 511 induces conformational
changes that result in full activation of kinase activity (Joseph et al., 2007; Wilcox and
Berg, 2003). Binding of Slp-76 to the SH2 and SH3 domain of Itk promotes kinase
activity by preserving the open, active conformation (Bogin et al., 2007). Upon
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activation, Itk phosphorylates PLCγ1 at activating tyrosines (Bogin et al., 2007), leading
to Ca2+ and DAG signaling, discussed below.

Costimulation-dependent actin regulatory pathways
Costimulatory signaling also controls actin responses at the IS (Tskvitaria-Fuller
et al., 2003). A major consequence of costimulation via CD28 is the activation of PI3K.
Through the production of PtIns(3,4,5)P3, PI3K can influence the localization and
activation of PH-domain containing signaling molecules including Vav1 and Itk, leading
to enhanced and/or sustained activation of the pathways described above (Finkelstein and
Schwartzberg, 2004; Han et al., 1998; Michel et al., 2000). CD28 can also signal through
a PI3K-Ras pathway to dephosphorylate and activate cofilin, an actin filament severing
protein (Wabnitz et al., 2006). Though less well studied, costimulatory signaling via
other molecules such as CD2, CD82, CD46 and ICOS also affects TCR-induced actin
responses (Delaguillaumie et al., 2002; Nukada et al., 2006; Wabnitz et al., 2007; Zaffran
et al., 2001). Thus, one way that costimulation promotes full T cell activation is by
augmenting actin-dependent signaling events at the IS.

Pathways leading to Ca2+ signaling in T cells
A common consequence of disruption of actin dynamics in T cells is perturbation
in Ca2+ signaling events. Ca2+ signaling pathways downstream of TCR engagement are
therefore summarized here, starting from phosphorylation and activation of PLCγ1.
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Figure 1.6: Domain structures of signaling molecules of interest.
The domain structure of key signaling molecules is shown, with related regions
colored similarly. Important binding partners and targets of catalytic activity are listed
below the relevant domains. Key tyrosine phosphorylation sites (Y) are indicated, and
total amino acid numbers are shown at the top right of each.
Abbreviations: CH - calponin homology; Ac – acidic; DH – Dbl homology;
PH – Pleckstrin homology; sPH – split PH; SH2 – Src homology 2; TH – Tec
homology
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PLCγ1 is a key signaling protein responsible for translating the tyrosine
phosphorylation cascade and signalosomes assembly events into Ca2+ flux responses that
lead to transcription factor activation. TCR engagement leads to rapid (within one
minute) tyrosine phosphorylation of PLCγ1. Although it contains numerous tyrosine
phosphorylation sites, Tyr 775 and Tyr 783 are considered most important:
phosphorylation at both sites is required for full activation (Serrano et al., 2005) (by
convention, PLCγ1 residues are numbered according to their position within the bovine
protein).
PLCγ1 is a large (145 kDa) protein composed of a pleckstrin homology (PH)
domain followed by an EF hand at the amino terminus (Figure 1.6). The catalytic region
is divided into the X and Y fragments, which are situated N-terminal and C-terminal,
respectively, to a segment containing two SH2 domains and one SH3 domain. A C2
domain is located at the C-terminus of the molecule.
The split nature of the catalytic region and presence of multiple Src homology
domains underscore the importance of regulation by protein conformation and intra- and
intermolecular interactions. Recruitment of PLCγ1 to the membrane and to signaling
microclusters requires its N-terminal SH2 domain, which interacts with phosphorylated
Tyr 132 of LAT (Braiman et al., 2006; Stoica et al., 1998; Zhang et al., 2000).
Paradoxically, this domain appears not to be necessary for tyrosine phosphorylation of
PLCγ1 (Braiman et al., 2006) or downstream transcription factor activation by PLCγ1
(Irvin et al., 2000), although these requirements may vary depending on the experimental
system. In contrast, the C-terminal SH2 domain is required for enzymatic activity, but
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not for recruitment to microclusters or for phosphorylation at Tyr 783 (Braiman et al.,
2006; Poulin et al., 2005). In keeping with this, phosphorylation at Tyr 783 is
insufficient to activate lipase activity; additional events are required (Sekiya et al., 2004).
Phosphorylation at Tyr 783 can activate PLCγ1 by creating a binding site for the Cterminal SH2 domain. This intramolecular interaction induces a conformational change
that causes the X and Y domains to assemble into a fully functional catalytic region
(Poulin et al., 2005). Intermolecular interactions can also activate PLCγ1, most likely by
inducing conformational changes: binding of SHIP1 to the SH3 domain results in
increased Ins(1,4,5)P3 production in transfected COS7 cells (Song et al., 2005).
Several studies have demonstrated that PLCγ1 interacts with components of the
actin cytoskeleton. In rat embryo fibroblasts, immunofluorescence microscopy studies
have shown an SH3 domain-dependent localization of PLCγ1 to the actin cytoskeleton
(Bar-Sagi et al., 1993). Several studies have biochemical approaches to show that PLCγ1
or PLCγ2 inducibly interact with F-actin in a manner dependent on either SH2 domain
(Dearden-Badet and Mouchiroud, 2005; Nojiri and Hoek, 2000; Pei et al., 1996).
Although the physiological relevance of this cytoskeletal interaction is unclear, poisoning
of actin dynamics with CytoD could impair PLCγ1 activity (Suzuki and Takahashi,
2001). No such studies have been conducted in T cells; however, pharmacological
disruption of actin dynamics or loss of actin regulatory proteins in T cells commonly
disrupts Ca2+ signaling, as discussed above. We have shown that the C-terminal SH2
domain of PLCγ1 interacts with HS1 ((Gomez et al., 2006) and Chapter 2). This may
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serve to regulate PLCγ1 localization and/or function by linking it to the actin
cytoskeleton. This idea is explored in chapter 3.
Upon activation, PLCγ1 hydrolyzes the membrane lipid PtIns(4,5)P2
(phosphatidylinositol 4,5 bisphosphate) to generate Ins(1,4,5)P3 (inositol 1,4,5
trisphosphate) and DAG (diacylglycerol). Ins(1,4,5)P3 binds to Ins(1,4,5)P3 receptors on
the ER (endoplasmic reticulum), inducing the release of Ca2+ (calcium ions) from ER
stores (Majerus et al., 1986; Rhee, 2001; Singer et al., 1997). Depletion of ER Ca2+
stores induces a conformational change in the Ca2+ sensor STIM1 (stromal interacting
molecule 1) that allows it to interact with and activate CRAC (Ca2+ release-activated
Ca2+) channels (Luik et al., 2006; Park et al., 2009; Wu et al., 2006). Although
electrophysiological experiments had permitted functional characterization of the CRAC
channel, its molecular identity was not known until three groups independently identified
Orai1 as a critical component of CRAC channels (Feske et al., 2006; Prakriya et al.,
2006; Vig et al., 2006; Zhang et al., 2006).
Activation of CRAC channels causes the influx of Ca2+ from the extracellular
milieu (Oh-hora and Rao, 2008). The increase in intracellular Ca2+ is detected by the
calcium binding protein calmodulin. Ca2+ binding causes calmodulin to interact with and
activate the phosphatase calcineurin, which dephosphorylates cytosolic NF-AT (nuclear
factor of activated T cells) family transcription factors. This reveals the nuclear
localization sequence of NF-AT, allowing it to translocate to the nucleus to drive gene
expression.
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While significant progress has been made in understanding the upstream events
linking TCR engagement to actin remodeling, our understanding of how actin contributes
to downstream signaling events is largely restricted to activation of the IL2 promoter.
Disruption of the actin network perturbs the activation of each of the three key elements
within the IL2 promoter (NF-AT, NFκB, and AP-1). Virtually every condition that
affects actin dynamics affects Ca2+ signaling pathways leading to NF-AT activation.
Treatment of T cells with CytoD affects Ca2+ flux and NF-AT activation, though as noted
above, the effects vary depending on the time of treatment and dose of inhibitor
(Holsinger et al., 1998; Rivas et al., 2004; Valitutti et al., 1995). Diminished Ca2+ influx
and inefficient NF-AT activation have also been observed in T cells deficient for Vav1,
WASp, WAVE2 and HS1 (Cannon and Burkhardt, 2004; Cianferoni et al., 2005; Fischer
et al., 1998; Gomez et al., 2006; Holsinger et al., 1998; Nolz et al., 2006; Zhang et al.,
1999). However, the requirement is not simply for actin per se, because individual actin
regulatory proteins facilitate Ca2+ signaling in distinct ways. For example, WAVE2
deficient T cells exhibit defects in coupling store release to CRAC channel activation
(Nolz et al., 2006), while HS1-deficient T cells exhibit a defect at the level of release
from stores, as shown in Chapter 3. T cells deficient for Vav1 and WASp also fail to
activate AP1, likely stemming from upstream defects in ERK activation (Cianferoni et
al., 2005; Costello et al., 1999). Activation of NFκB is defective in T cells lacking Vav1
or HS1 (Costello et al., 1999; Gomez et al., 2006). The molecular basis for this defect
has not been established, but it may reflect defects in PKCθ signaling.
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Additional analysis of signaling events in T cells lacking actin regulatory proteins
will be required to fill in the “black box” linking actin polymerization and changes in T
cell gene expression. It is unlikely that these events represent simple, linear pathways.
There is growing evidence that actin networks facilitate formation of or stabilize proteinprotein interactions to promote sustained signaling (Campi et al., 2005; Gomez et al.,
2006). In addition, actin promotes the internalization of TCR signaling complexes and
costimulatory molecules, an event that is thought in some cases downregulate signaling,
and in others, to sustain it (Badour et al., 2007; McGavin et al., 2001).
This dissertation describes an analysis of the regulation of HS1 and its role in T
cell receptor signaling. As shown in Chapter 2, I have found that HS1-/- T cells exhibit
profound defects in actin polymerization at the IS in response to TCR engagement, and
that these cells exhibit dampened signaling Ca2+ signaling, resulting in a defect in IL2
production. Tyr 378 and Tyr 397 were identified as key phosphorylation sites, and HS1
function in T cells depends on the integrity of phosphorylation at these sites. In Chapter
3, I describe an interaction between HS1 and Itk that is required for recruitment of HS1 to
the IS. In addition, I explore the role of HS1 in Ca2+ signaling, finding that HS1 is
important for proper recruitment of PLCγ1 to the actin cytoskeleton and to signaling
microclusters. Chapter 4 describes a characterization of T cells from the HS1-/- mouse.
Thymocyte and peripheral populations develop normally; however, HS1-/- T cells exhibit
defects in TH1 skewing, likely a result of defects in IFNγ production. This may reflect a
defect in Ca2+ signaling. Finally, in Chapter 5, I discuss the implications of these
findings and propose future avenues for research.
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Chapter 2: HS1 functions as an essential actin-regulatory
adapter protein at the Immune Synapse2
Summary
HS1, the leukocyte-specific homologue of cortactin, regulates F-actin in vitro and is
phosphorylated in response to TCR ligation, but its role in lymphocyte activation has not
been addressed. We demonstrate that HS1-deficient T cells fail to accumulate F-actin at the
immune synapse (IS), and upon TCR ligation form actin-rich structures that are disordered
and unstable. Early TCR activation events are intact in these cells, but Ca2+ influx and IL2
gene transcription are defective. Importantly, HS1 tyrosine phosphorylation is required for
its targeting to the IS, and for its function in regulating actin dynamics and IL2 promoter
activity. Phosphorylation also links HS1 to multiple signaling proteins, including Lck,
PLCγ1, and Vav1, and is essential for the stable recruitment of Vav1 to the IS. Taken
together, our studies show that HS1 is indispensable for signaling events leading to actin
assembly and IL2 production during T cell activation.

Introduction

2

This chapter is a modified version of a manuscript titled, “HS1 functions as an essential
actin-regulatory adapter protein at the immune synapse.” It was published in the June
2006 Issue of Immunity (volume 24, page 741) with the following author list: Timothy
S. Gomez, Sean D. McCarney, Esteban Carrizosa, Christine M. Labno, Erin O.
Comiskey, Jeffrey C. Nolz, Peimin Zhu, Bruce D. Freedman, Marcus R. Clark, Daniel D.
Billadeau, and Janis K. Burkhardt
36

In response to interaction with APCs, T cells undergo dramatic shape changes to
form a flattened contact site enriched in F-actin and signaling molecules, termed the
immune synapse (IS) (Bromley et al., 2001; Kupfer and Kupfer, 2003). Actin
polymerization at the IS stabilizes conjugate formation and facilitates T cell activation
(Fuller et al., 2003). Several proteins have been implicated in regulating actin dynamics
at the IS, including the proximal tyrosine kinases Lck and ZAP-70 and the adaptors LAT
and SLP-76 (Bubeck Wardenburg et al., 1998; Bunnell et al., 2001; Morgan et al., 2001;
Zeng et al., 2003). In addition, the Rho family guanine nucleotide exchange factor Vav1
regulates actin responses through the small GTPases Cdc42 and Rac1 (Turner and
Billadeau, 2002; Zeng et al., 2003). Finally, we recently showed that the Tec kinase Itk
and the large GTPase Dynamin 2 collaborate with Vav1 to control actin responses at the
IS (Dombroski et al., 2005; Gomez et al., 2005; Labno et al., 2003). While much has
been learned about upstream signaling pathways, the immediate effectors controlling
actin dynamics are still poorly understood. The two Rho family proteins regulated by
Vav1, Rac1 and Cdc42, both play pivotal roles. Rac1 activates the WAVE2 complex,
which we recently showed is required for actin-dependent signaling at the IS (Nolz et al.,
2006), while Cdc42 regulates Wiskott-Aldrich Syndrome protein (WASp) (Cannon et al.,
2001). Although WASp activation is required for T cell activation (Badour et al., 2004b),
recent experiments indicate that WASp-deficient T cells can retain the ability to
polymerize actin at the IS (Cannon and Burkhardt, 2004). Thus, other mechanisms must
contribute to the regulation of actin dynamics at the IS.
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Hematopoietic lineage cell-specific protein 1 (HS1, HCLS1, LckBP1) is a major
substrate for tyrosine phosphorylation during T and B cell activation (Ruzzene et al.,
1996; Takemoto et al., 1996; Yamanashi et al., 1993). HS1, which is expressed only in
hematopoietic cells, is related to cortactin (EMS1), a widely expressed oncogene that was
recently identified as an actin regulatory protein (Daly, 2004). Similarly to cortactin,
HS1 contains an Arp2/3 complex binding domain, a region of 37 amino acid tandem
repeats and a coil-coiled region that bind F-actin (Hao et al., 2005), a proline rich domain
that binds to Lck (Takemoto et al., 1996), and a C terminal SH3 domain. In vitro studies
show that HS1 and cortactin can activate Arp2/3-dependent actin polymerization and
prolong the half-life of branched actin structures (Uruno et al., 2003a; Weaver et al.,
2002; Weaver et al., 2001). HS1-/- mice display defects in antigen-induced clonal
expansion and lymphocyte deletion (Taniuchi et al., 1995), but the role of HS1 in T cell
signaling has not been tested. Here we demonstrate that HS1 is required for sustained
actin responses at the IS and Ca2+ signaling events leading to IL2 gene expression.

Results
HS1 regulates the accumulation of F-actin at the immune synapse
We began our analysis by examining HS1 distribution in T cells responding to
APCs. HS1 co-localized with F-actin at the IS in conjugates formed with Jurkat T cells,
primary human CD4+ T cells, and murine DO11.10 TCR Tg T cells (Figure 2.1A).
Recruitment of HS1 to the cell-cell contact site was antigen-dependent, as was the
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accumulation of F-actin (data not shown and Figure 2.1E). Thus, T cell activation
induces recruitment of HS1 to the IS, where it co-localizes closely with F-actin.
To test HS1 function, we suppressed HS1 expression in Jurkat T cells using
shRNA-mediated gene silencing. Two different HS1 targeting vectors (shHS1b and
shHS1f), but not empty vector or a scrambled version of shHS1b (shHS1mut), suppressed
HS1 protein to 10% of control or less (Figure 2.1B). All studies were performed using
both shHS1b and shHS1f, with similar results. HS1-suppressed T cells formed
conjugates efficiently with SEE-pulsed B cells (Figure 2.1C). To assess actin responses,
conjugates were fixed at 15 minutes and analyzed by microscopy. As expected, control
transfectants showed accumulation of HS1 and F-actin at the IS (Figure 2.1D). HS1suppressed cells no longer stained for HS1, verifying that HS1 was efficiently depleted.
Although these cells flattened relatively normally against the APCs, F-actin labeling at
the IS was absent or greatly reduced. Time-course analysis revealed that HS1-suppressed
cells initially polymerized actin efficiently (Figure 2.1E), but failed to maintain F-actin at
the IS, such that by 5 minutes, the response was reduced to background levels (defined by
control cells without SEE).
To validate these findings, we analyzed primary lymph node T cells from HS1-/mice responding to P815 cells decorated with anti-TCR antibodies. Wild type T cells
formed a well-defined F-actin-rich IS in this assay (Figure 2.1F). In contrast, although T
cells from HS1-/- mice formed conjugates with P815 cells efficiently, they failed to
exhibit clear F-actin polymerization at the IS. After 30 minutes, the frequency of HS1-/T cells showing F-actin labeling at the IS was at baseline levels (Figure 2.1G).
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Moreover, this defect was not restored by the addition of costimulatory antibody. Thus,
we conclude that HS1 is required for the stable accumulation of F-actin at the IS.
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Figure 2.1: HS1 regulates the accumulation of F-actin at the IS
A, Conjugates were formed between Jurkat T cells and SEE-pulsed NALM6 B cells,
primary human CD4+ T cells and sAg-pulsed Raji B cells, or 2° DO11.10 Tg T cells
and ova-pulsed A20 B cells. Conjugates were labeled with anti-HS1 and phalloidin to
label F-actin. B cells were labeled with CMAC (blue and not shown). B, Short
hairpin RNA (shRNA) suppression time-course for HS1. Jurkat cells were transiently
transfected with RNA targeting vectors (shHS1b or shHS1f), a mutated form of
shHS1b (shHS1mut), or vector control. Lysates were prepared at the indicated times
post-transfection and immunoblotted for HS1 and ZAP70. C, To assess conjugation
efficiency, Jurkat cells were transfected with shHS1b or shHS1mut control vectors
containing a separate GFP cassette. T cells were incubated with SEE-pulsed, PKH26stained EBV-B cells and the % transfected T cells in conjugates was determined by
flow cytometry. D, To assess actin responses at the IS, Jurkat cells transfected as in C
(GFP) were incubated with SEE-pulsed NALM6 B cells (blue). Fixed conjugates with
labeled with phalloidin to visualize F-actin and anti-HS1. E, Conjugates formed as in
D were fixed at the indicated times following initial contact and labeled with
phalloidin. Conjugates containing GFP+ T cells were scored for F-actin at the IS. F,
WT and HS1-/- T cells (∗) were conjugated to P815 cells bearing anti-CD3 antibodies
and stained with phalloidin (red). G, Conjugates were formed between HS1+/+ or HS1/-

T cells and P815 cells bound with the indicated stimulating antibodies and scored for

F-actin at the IS. Data are from one representative experiment. Bars in C and E
represent mean ±StDev from three experiments.
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HS1-deficient cells fail to stabilize actin following TCR engagement
In non-hematopoietic cells, the HS1 homologue cortactin is thought to stabilize Factin (Daly, 2004). We confirmed that neither Jurkat cells nor primary mouse T cells
expressed detectable levels of cortactin mRNA (Figure 2.2), and we observed no
compensatory upregulation of cortactin in HS1-/- T cells or HS1-suppressed Jurkat cells.
To ask if HS1 functions by stabilizing F-actin, we analyzed the spreading of Jurkat cells
stably expressing GFP-actin on anti-TCR-coated coverslips (Bunnell et al., 2001).
Control cells spread in a highly ordered fashion, forming a round lamellipodial structure
with uniform width (Figure 2.3A and Supplemental Movies 2.1-2.3). Spreading was
typically maximal by 2 minutes, with retraction after about 5 minutes. DIC images (not
shown) showed ruffling at the cell periphery and radial retrograde flow within the
lamellar region; this process is also evident in the GFP-actin videos (Supplemental
Movies 2.4-2.7). In contrast, HS1-suppressed cells spread erratically. These cells
continuously sent out actin-rich protrusions, but these were asymmetric and quickly
retracted, and they frequently failed to maintain contact with the coverslip (Figure 2.3B).
Quantitation of the coverslip contact area vs. time revealed that HS1-suppressed cells
spread poorly and failed to undergo the sharp increase in contact area observed in control
cells during the first 90 seconds (Figure 2.3C). To measure the irregular shape of HS1suppressed cells, the variance in radial length was calculated. Control cells became
round (low variance) by 120 seconds, while HS1-suppressed cells were irregularly
shaped at all times (Figure 2.3D). These data show that TCR-stimulated actin
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polymerization, ruffling and lamellipodial protrusion can occur in the absence of HS1,
but HS1 is required for organizing and maintaining these structures.
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Figure 2.2: RT-PCR analysis of HS1 and cortactin expression.

RT-PCR analysis of HS1 and cortactin expression. Total RNA was extracted from
secondary LN T cells from wild type or HS1-/- mice, or from total mouse thymus (A).
Alternatively, RNA was extracted from Jurkat T cells transfected for 72 hours with
empty suppression vector or shHS1b, or from MCF7 breast cancer cells (B). RT-PCR
analysis was conducted for mouse (A) and human (B) HS1, cortactin and actin.
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Figure 2.3: HS1-deficient cells exhibit abnormal actin dynamics in response to TCR
engagement
Jurkat cells stably expressing GFP-actin were transfected with empty vector (A) or
shHS1b (B). Actin dynamics were monitored by video confocal microscopy as the
cells spread on anti-TCR-coated coverslips. Selected time-lapse image projections
acquired at the indicated times after contact with the coverslip are shown. C, The
contact area of each cell at each time point was determined, and the average calculated
for each cell population at each 5s timepoint (17 cells for each condition). The
difference in area was statistically significant (p=0.0002 at 135s). D, Irregularity of cell
shape was assessed by measuring the radial variance of the cell outline for each cell at
each time point, and calculating the average values for each time point. C and D, black
circles, control transfectants; red triangles, HS1-suppressed cells.
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Tyrosine phosphorylation of HS1 is required for actin remodeling
As reported previously (Hutchcroft et al., 1998; Takemoto et al., 1996;
Yamanashi et al., 1993), TCR and CD28 ligation induced transient tyrosine
phosphorylation of HS1 (Figure 2.4A). Stimulation with APCs had a similar effect,
although phosphorylation was more sustained (Figure 3B). Phosphorylation requires
both Lck and ZAP-70, since cells lacking these kinases failed to phosphorylate HS1
(Figure 2.4A).
To map the sites of HS1 phosphorylation, we conducted phosphopeptide mapping
by mass spectrometry. We first tested recombinant HS1, which is phosphorylated in
vitro by Syk at Y378 and Y397 (Brunati et al., 1999). HS1 yields a tryptic peptide of
4610 Da, which is shifted by the 80 Da mass of a single phosphate after phosphorylation
by Syk (Figure 2.4C). This peptide includes both Y378 and Y360, but other peptides
containing Y360 showed no evidence of phosphorylation (data not shown), indicating
that phosphorylation occurs at Y378. This peptide, and another that includes Y397 (not
shown) were confirmed as the major peptides phosphorylated by Syk in vitro. The
phospho-peptide containing Y378 was also evident in HS1 immunoprecipitated from
pervanadate-treated T cells, though it could not be identified with confidence in lysates
from CD3-stimulated cells. A phosphopeptide containing only Y397 was clearly visible
in material isolated from both pervanadate-treated and anti-CD3-activated cells. In vitro
phosphorylation of HS1 at Y222 has been documented (Brunati et al., 1999; Ruzzene et
al., 1996; Takemoto et al., 1996), and there is a report of Y198 phosphorylation in T cells
(Salomon et al., 2003), however we did not detect phosphorylation at these sites. Thus,
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we conclude that Y378 and Y397 are the principal sites for HS1 tyrosine phosphorylation
in response to TCR stimulation. Consistent
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Figure 2.4: HS1 is phosphorylated at tyrosines 378 and 397 in stimulated T cells
A, Jurkat T cells or the Jurkat-derived cell lines JCaM1 (Lck-deficient) and P116
(ZAP-70-deficient) were stimulated with anti-TCR/anti-CD28. HS1
immunoprecipitates were immunoblotted for phospho-tyrosine. B, Jurkat T cells were
unstimulated (time 0) or stimulated using fixed Raji B cells pulsed with SEE, and HS1
immunoprecipitates were immunoblotted for phospho-tyrosine. In A and B, rabbit
IgG (NRS) was used as an immunoprecipitation control. C, Recombinant HS1 (rHS1,
a and b) was incubated +/- Syk kinase. Alternatively, endogenous HS1 was
immunoprecipitated from unstimulated (c and f), pervanadate-treated (d and g), or
anti-CD3 stimulated (e and h) Jurkat cells. Following proteolysis, peptides were
analyzed by Mass Spectroscopy. Top panel, tryptic peptides containing pY378
(asterisks), detected by MALDI-TOFF. Bottom panel, Glu-C peptides containing
pY397 (asterisks) detected by v-MALDI ion trap. D, Jurkat T cells were transfected
with FLAG-tagged WT HS1 or the Y378F, Y397F, and 2YF mutants. Cells were
pervanadate-treated, the FLAG-tagged proteins immunoprecipitated, and
immunoblotted with anti-phosphotyrosine.
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with this, mutation of either individual residue (Y378F or Y397F) permitted tyrosine
phosphorylation of the protein, whereas mutation of both sites (2YF) abrogated
phosphorylation (Figure 2.4D).
To test the function of HS1 phosphorylation, T cells were transfected with YFPtagged HS1 or HS1-2YF, and targeting to the IS was assessed. As shown in Figure 2.5A
and B, YFP-HS1 colocalized with F-actin at the IS, but the 2YF mutant remained
diffusely distributed. To express the HS1 mutant in cells lacking endogenous protein, we
used a "suppression-re-expression" vector that encodes the HS1 shRNA targeting
sequence together with shRNA-resistant wild type HS1 or HS1-2YF cDNA. This vector
allows re-expression at near-endogenous levels (Figure 2.5C, right). Wild type HS1
restored actin polymerization at the IS, but the 2YF mutant did not (Figure 2.5C),
indicating that phosphorylation of HS1 at Y378/Y397 is required for actin regulation at
the IS.
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Figure 2.5: Phosphorylation at Y378/Y397 is required for HS1 localization and
actin accumulation at the IS
A, Jurkat cells were transfected with YFP or YFP-tagged HS1 (WT or 2YF) and conjugated to
SEE-pulsed Raji B cells (blue), and fixed conjugates were labeled with phalloidin. B, Conjugates
formed as in A were scored for YFP-HS1 localization to the IS. C, Jurkat T cells transfected with
the indicated constructs to allow suppression and re-expression of HS1 in the same cell. After
48h, cells were conjugated to SEE-pulsed NALM6 B cells, labeled with phalloidin, and
conjugates containing GFP+ T cells were scored for actin polarization. Immunoblot analysis
shows HS1 suppression and re-expression. ZAP-70 serves as a loading control.
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Tyrosine phosphorylation of HS1 mediates binding to key signaling molecules
SH2 domains from several proteins known to participate in T cell actin-regulatory
pathways could bind phospho-HS1 in GST-pulldown assays (Figure 2.6A). In addition to
Lck and Fyn, which are known to bind HS1 (Takemoto et al., 1996), both SH2 domains
from the p85 subunit of PI3K, the second SH2 domain of PLCγ1 and the SH2 domains
from all three Vav isoforms also interacted with phospho-HS1. To confirm these
interactions in vivo, coimmunoprecipitation analysis was performed. Both PLCγ1 and
Vav1 co-immunoprecipitated with HS1, with kinetics that mirrored HS1 tyrosine
phosphorylation (Figure 2.6B). In contrast, Lck bound constitutively to HS1, with
enhanced binding upon activation. This is consistent with previous work showing that
HS1 binds both the SH3 and SH2 domains of Lck (Takemoto et al., 1996).

HS1 and Vav1 interact specifically and directly
Given the role of Vav1 in controlling actin responses, we focused on this
interaction. As shown in Figure 2.6C, the GST-Vav1-SH2 fusion protein did not interact
with overexpressed HS1-2YF from lysates of pervanadate-treated Jurkat cells; it bound
weakly to the Y397F, and more strongly to Y378F HS1. An inactivating mutant of the
GST-Vav1-SH2 (R696A) failed to bind HS1, confirming the specificity of binding. We
conclude that the Vav1 SH2 domain can bind to both Y378 and Y397, but binds
preferentially to Y397. To ask if HS1 binds Vav1 directly phosphorylated GST fusion
peptides (p-GST) encompassing HS1 amino acids 361-436 were used in an in vitro
pulldown of MBP-Vav1-SH2. The Vav1-SH2 bound directly to the WT, Y378F and
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Y397F p-GST peptides, but not to the 2YF mutant (Figure 2.6D), mirroring the results
from pervanadate-treated cells (Figure 2.6C). Direct interaction was also verified in a
far-western blot (data not shown). These data show that the Vav1 SH2 domain binds
directly to tyrosine phosphorylated HS1.

HS1 is required for maintaining Vav1 at the IS
Since Y378 and Y397 are required for HS1 targeting to the IS and for binding to
Vav1, we reasoned that Vav1 might recruit HS1 to the IS. However, we found that HS1
recruitment was normal in T cells suppressed for Vav1 expression (Figure 2.6E). The
converse experiment revealed a requirement for HS1 in localizing Vav1 to the IS (Figure
2.6F); HS1-suppressed cells initially recruit Vav1 to the IS, but Vav1 recruitment is
abnormally short-lived. The kinetics of Vav1 loss closely resembles the kinetics of Factin loss (Figure 2.1E). Importantly, this effect is specific to Vav1; WASp and WIP
were recruited normally in HS1-suppressed cells (Figure 2.6G). These data show that
one important function of HS1 is to stabilize Vav1 at the IS. As discussed below, this is
likely to involve both direct and indirect interactions. Given the other actin-regulatory
functions of HS1, it seems likely that HS1 and Vav1 function together to coordinate actin
dynamics at the IS.
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Figure 2.6: HS1 interacts with T cell signaling intermediates and functions to
maintain Vav1 at the IS
A, Lysates from pervanadate-treated Jurkat cells were incubated with GSH-agarose-bound GST fusion
proteins of various SH2 domains, and bound HS1 was detected by immunoblotting. Loading of fusion
proteins was visualized with Coomassie. B, HS1 was immunoprecipitated from Jurkat cells following
TCR/CD28 ligation, and interacting proteins were detected by immunoblotting. Rabbit IgG (NRS) was
used as an immunoprecipitation control. C, Jurkat T cells were transfected with the indicated versions
of FLAG-tagged HS1 and treated with pervanadate as in Figure 3D. Lysates were incubated with GSHagarose-bound GST-Vav1-SH2 and the bound HS1 proteins were detected by immunoblotting with
anti-FLAG. Loading of fusion proteins was visualized with Coomassie. D, GST fusion peptides
encompassing AA361-436 of HS1 were created in a phosphorylated form (p-GST) as described in
Experimental Procedures. HS1 p-GST fusion proteins corresponding to WT, Y378F, Y397F and 2YF
were bound to GSH-agarose and tested for their ability to bind MBP-Vav1-SH2 in vitro.
Phosphorylation of the p-GST fusions was visualized using anti-pTyr and bound MBP-Vav1 SH2 was
detected with anti-MBP. ‘Input’ indicates the total amount of MBP-Vav-SH2 and Vav-SH2 R696A
used per tube. In C and D, Vav1-SH2 domain containing an inactivating mutation (R696A) serves as
control. E, Jurkat T cells were transfected with control or shVav1-GFP vectors, incubated for 15 min
with NALM6 B cells +/- SEE, fixed, and labeled with anti-HS1. The frequency of conjugates
containing GFP+ T cells exhibiting HS1 localization to the IS was scored. F, Jurkat cells were
transfected with control or shHS1b-GFP vectors, fixed at the indicated times, and labeled with antiVav1. Conjugates containing GFP+ T cells were scored for Vav1 localization to the IS. G, Jurkat T
cells were treated as in F, but labeled with anti-WASp or anti-WIP. Conjugates containing GFP+ T
cells were scored for WASp or WIP localization to the IS. Data represent mean ±StDev from three
experiments. Data in E and F are from one representative experiment.

56

HS1-mediated actin stabilization is required for sustained TCR signaling
Since T cells from HS1-/- mice have proliferative defects (Taniuchi et al., 1995),
we asked if they exhibit defects in IL2 production. T cells from wild type and HS1-/mice were cultured for 24 hours in the presence of SEB and wild type T-depleted
splenocytes, and IL2 levels were measured. HS1-/- T cells produced significantly reduced
levels of IL2 at all doses of SEB (Figure 2.7A). Analysis of IL2 reporter activity showed
that HS1 suppression strongly inhibited activation of the IL2 promoter, demonstrating
that IL2 defects occur at the transcriptional level (Figure 2.7B).
The defects in HS1-/- T cells are not attributable to alterations in basal TCR
expression levels, or in activation-induced downregulation of CD3 or upregulation of the
activation markers CD25 and CD69 (Figure 2.7C). However, single cell analysis using
ratiometric imaging showed a significant decrease in TCR-crosslinking-induced Ca2+
influx in HS1-suppressed cells and T cells from HS1-/- mice (Figure 2.8 A,B). Because
Ca2+ signaling is required for NF-AT translocation, we assessed NF-AT-reporter
activation. As shown in Figure 2.8C, NF-AT activity was significantly reduced in HS1suppressed cells. Parallel analysis of NFκB also showed defects in this pathway (Figure
2.8D). Taken together, these results show that HS1 is dispensable for early TCR
signaling events, but required for sustained signaling events leading to gene activation.
In the course of asking if HS1’s role in controlling gene activation requires
tyrosine phosphorylation of Y378/397, we found that IL2 reporter activity is exquisitely
sensitive to the expression level of HS1. Overexpression of FLAG-tagged (or untagged)
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HS1 inhibited IL2 promoter activity in a dose-dependent fashion (Figure 2.8E and data
not shown). Similar effects have been observed with other adapters, presumably because
superstoichiometric expression leads to disruption of signaling complexes. In keeping
with the idea that HS1 function involves tightly controlled protein levels, high-level
overexpression of HS1 led to diminished levels of endogenous protein (Figure 2.8E, top).
Although this overexpression effect made it impossible for us to conduct transcriptional
analysis based upon re-expression of HS1 mutants in shRNA-suppressed cells, we found
that the 2YF mutant lacks the inhibitory effects of the wild type molecule on IL2
promoter activity (Figure 2.8F). Thus, phosphorylation of HS1 is also important for
activation of IL2 promoter activity.
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Figure 2.7: HS1 is required for IL-2 production
A, T cells isolated from wt or HS1-/- mice were cultured for 24 h in the presence of WT Tdepleted splenocytes and the indicated doses of SEB. Total IL-2 levels were measured by
ELISA. Data are mean +/- StDev from replicate wells of one representative experiment. B,
Jurkat T cells were co-transfected with IL2p-luc reporter and either vector control, shHS1b, or
shHS1f plasmid. Cells were un-stimulated or stimulated with SEE-pulsed NALM6 B cells for
5h, and luciferase activity was measured hourly. Data represent mean ±StDev from triplicate
samples. C, T cells isolated from WT and HS1-/- mice were unstimulated (shaded profiles) or
stimulated for 24h with anti-CD3 and wt T-depleted splenocytes (open profiles). CD4+ T
cells were analyzed for surface expression of CD3, CD25 and CD69 by flow cytometry.
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Figure 2.8: HS1 is required for sustained TCR-mediated signaling events leading to
gene activation
A, Jurkat cells were transfected with control or shHS1 vectors. After 72h, TCRinduced Ca2+ signaling was examined using Fura-2 imaging. In Ca2+-free bath,
increases in Fura-2 ratio reflect Ca2+ release from intracellular stores. Extracellular
Ca2+ entry via activated CRAC channels was then assessed by addition of extracellular
Ca2+. Each trace represents the average response of at least 100 cells. B, CD4+ LN T
cells from WT or HS1-/- mice were loaded with Fura-2, incubated with biotinylated
anti-CD3 and activated by crosslinking with streptavidin. Analysis was as in A.
Jurkat T cells were co-transfected with an NF-AT-luc (C) or NFkB-luc (D) reporter
construct along with vector control, shHS1b, or shHS1f. Cells were un-stimulated or
stimulated with SEE-pulsed NALM6 B cells and luciferase activity was measured.
Jurkat cells were transfected with IL-2p-luc along with (E) vector control (40 µg) or
an increasing concentration of FLAG-HS1 expression vector (10µg, 20µg, 40µg) or
with (F) vector control, FLAG-HS1, or FLAG-HS1 2YF. Cells were un-stimulated or
stimulated and luciferase activity was measured. The accompanying immunoblots
show endogenous HS1 and FLAG-HS1 expression in whole cell lysates from each cell
population. All bars represent mean ±StDev from triplicate samples.
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HS1 is recruited to the periphery of spreading T cells
To more closely examine the localization of HS1 upon after TCR engagement, we
generated a Jurkat cell clone stably expressing a variant of HS1 tagged at the N-terminus
with the bright YFP variant Venus (Nagai et al., 2002). These cells expressed
approximately a 1:1 ratio of tagged:endogenous HS1 (not shown). Cells spreading on
anti-CD3-coated coverslips were observed by confocal microscopy over 3 minutes. HS1
was initially observed in discrete puncta and was enriched at the periphery throughout, in
a pattern much like that observed for GFP-actin (Figure 2.9 and Supplementary Movies
2.8 and 2.9). These data suggest that HS1 is primarily localized to F-actin rich
lamellipodia.

HS1 binding to F-actin is important for actin polymerization at the IS
A variant of HS1 lacking the third HTH repeat has been isolated from a patient with SLE
(Sawabe et al., 2003). Since the HTH repeat region is involved in binding to F-actin
(Hao et al., 2005), we reasoned that this disease-associated variant would provide an
interesting opportunity to examine the role of actin binding in HS1 function. Hao et al.
have reported that F-actin binding in vitro does not explicitly require the HTH repeat
region and is instead more dependent on the CC domain, although F-actin binding in cells
appears to be more complicated (Hao et al., 2005). To test the effect of loss of one HTH
repeat on F-actin binding, recombinant GST-HS1EP6 or GST-HS1HTH2.5 was incubated
with increasing concentrations of F-actin and ultracentrifuged to separate F-actin-bound
(pellet, P) from unbound (supernatant, s) protein. As shown in Figures 2.9A and 2.9B,
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HS1EP6 bound F-actin at all doses tested. In contrast, HS1HTH2.5 bound less efficiently at
all doses, and was fully unbound at the lowest dose of F-actin. We then asked if this
defect in actin binding influences the ability of HS1 to promote Arp2/3 complexdependent actin polymerization. Recombinant HS1 was incubated with Arp2/3 complex,
and polymerization was initiated by the addition of actin. WASp VCA fragment was
included as a positive control. HS1EP6 promoted actin polymerization more efficiently
than HS1HTH2.5 (Figure 2.9C).
HS1 deficiency or mutation of Tyr 378 and Tyr 397 result in a failure to stabilize
F-actin at the IS (Figure 2.1 and Figure 2.5, respectively). To determine if IS-associated
F-actin structures depend on HS1, we expressed HS1EP6 or HS1HTH2.5 in T cells from
HS1-/- mice, conjugated these cells to P815 cells bearing anti-CD3, and assessed actin
responses. HS1EP6 expression was able to rescue actin responses to WT levels, but
HS1HTH2.5 expression resulted only in a partial rescue of F-actin responses (Figures 2.11D
and Figures 2.11E). These experiments need to be repeated to validate these results.

Discussion
In this study, we show that HS1 is required for the stabilization of F-actin filaments
following TCR engagement, for maximal Ca2+ influx, and for NF-AT and NFkB-mediated
gene transcription. In addition, we find that tyrosine phosphorylation is necessary for HS1
recruitment to the IS, and regulates its interaction with Lck, PLCγ1, and Vav1. These
findings identify HS1 as an actin-regulatory adapter protein essential for T cell activation.
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Figure 2.9: HS1 is recruited to the actin-rich periphery upon TCR engagement.
Top, Jurkat cells stably expressing Venus-HS1 were plated on anti-CD3-coated
coverslips and imaged by confocal microscopy over the indicated time course after
contact with the coverslip (seconds). Bottom, The 20 second time point is expanded,
and HS1-rich clusters are marked with red arrows. This time-lapse sequence
corresponds to supplemental movie 2.8
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Figure 2.10: HS1-F-actin binding is important for actin responses.
A, GST-HS1EP6 or GST-HS1HTH2.5 was incubated with the indicated concentrations of
F-actin and fractionated by ultracentrifugation. F-actin bound (pellet, P) and unbound
(supernatant, S) fractions were analyzed by immunoblotting for GST. B, Quantitation
of the blot shown in A. Data are expressed as the ratio of HS1 in the supernatant to
HS1 in the pellet. C, GST-HS1EP6 or GST-HS1HTH2.5 was incubated with Arp2/3 and
G-actin containing 20% pyrene-labeled monomers. Polymerization was measured
over the indicated time course. WASp VCA fragment was included as a positive
control. D, WT or HS1-/- T cells (red) were transduced with the indicated constructs
and conjugated to P815 cells (blue) and stained as in Figure 2.1F. E, Conjugates in D
were analyzed for the conjugates of cells with F-actin at the IS.
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HS1-deficient T cells show unique defects in actin polymerization at the IS; actin-rich
structures are formed initially, but are unstable and erratic. This phenotype is distinct
from that of cells lacking WASp or WAVE2, both of which also bind Arp2/3 complex.
Cells lacking WASp spread essentially normally, while cells lacking WAVE2 fail to
spread altogether (Nolz et al., 2006). The phenotype of HS1-deficient T cells resembles
that of cortactin-deficient fibroblasts, which display disorganized lamellipodial formation
(Bryce et al., 2005; Kempiak et al., 2005). These phenotypes are consistent with the idea
that by binding F-actin as well as Arp2/3 complex, these proteins inhibit debranching and
stabilize cortical actin (Uruno et al., 2003b). An unresolved question is whether HS1 also
acts via direct interactions with WASp and WIP, as reported for cortactin (Kempiak et
al., 2005; Kinley et al., 2003; Tehrani et al., 2007; Uruno et al., 2003a; Weaver et al.,
2002; Weaver et al., 2001). Though we can readily detect binding of HS1 to the
WIP/WASp complex in vitro, we have so far failed to verify interaction by coimmunoprecipitation from T cell lysates. This may reflect weak interactions that are
disrupted upon T cell lysis. Nonetheless, we show that HS1 is not required for
recruitment of WASp or WIP to the IS. Indeed, their continued presence likely
contributes to the residual actin dynamics in HS1-deficient cells.
We mapped the major sites of HS1 tyrosine phosphorylation in activated T cells
to amino acids 378 and 397, and our data suggest that ZAP-70 is responsible for
phosphorylating these sites. Y378 and Y397 are critical for several aspects of HS1
function. Mutation of these residues leads to defective HS1 targeting to the IS, abrogates
binding to Vav1, and perturbs actin responses. Finally, these residues are required for
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overexpression-induced inhibition of IL2 promoter activation. Phosphorylationdependent membrane targeting may be a general feature of HS1 function; in B cells,
tyrosine phosphorylation of HS1 mediates its recruitment to lipid rafts (Hao et al., 2004).
Although we have failed to detect HS1 in lipid raft fractions from T cell (not shown), we
have found that the Tec family kinase Itk binds to these tyrosines, and mediates HS1
recruitment to the IS. These studies are described in Chapter 3. While it is possible that
the functional defects observed in T cells expressing HS1 2YF are solely attributable to
the aberrant localization of this mutant, it seems more likely that phosphorylation
regulates multiple aspects of HS1 function. In addition to mediating binding to other
signaling molecules (discussed below), phosphorylation may induce conformational
changes that influence HS1 function, as already shown for cortactin (Huang et al., 1997a;
Martinez-Quiles et al., 2004).
One clear role of HS1 phosphorylation is to mediate binding to SH2-domaincontaining proteins, including Lck, Vav1, and PLCγ1. The functional significance of
Vav1 binding is underscored by the finding that HS1-suppressed T cells progressively
lose Vav1 from the IS. Interestingly, the loss of Vav1 from the IS in HS1-suppressed
cells parallels the loss of F-actin at this site. This, and finding that the kinetics Vav1/Factin loss differ from those of HS1 phosphorylation, suggest that HS1 stabilizes Vav1 at
the IS via a complex mechanism. Since Vav1 recruitment to the IS dependents on
interactions with SLP-76 and Itk (Dombroski et al., 2005; Zeng et al., 2003), we propose
that SLP-76, Itk and HS1 coordinately recruit Vav1 to the IS at early time points. Once
this complex is localized to the IS, Vav1 initiates actin polymerization through activation
70

of Cdc42 and Rac. HS1 participates in forming and/or stabilizing F-actin at later times,
and this feeds back to stabilize Vav1 interactions with the SLP-76 complex. Stabilization
could occur through direct interactions or via the F-actin scaffold. The fact that HS1
binds directly to Vav1 suggests that these important actin regulatory proteins function
coordinately. It will be interesting to ask if this interaction modifies the activity of either
protein.
Phosphorylation also mediates HS1 interaction with PLCγ1, and studies further
probing this interaction are described in Chapter 3. Regulated interactions with PLCγ1
and the p85a subunit of PI-3K may also play a role in HS1-mediated actin regulation via
effects on inositol phospholipids.
High-resolution live-cell microscopy has shown that signaling molecules coalesce
within signaling microclusters at sites of TCR engagement (Bunnell et al., 2002;
Yokosuka et al., 2005). We have found that HS1 is transiently recruited to puncta
reminiscent of these microclusters, but primarily redistributes to the actin-rich periphery,
where active signaling predominates. Phosphorylation likely occurs at both sites. These
data support the idea that HS1 primarily functions to link active signaling complexes to
the actin cytoskeleton, although further investigation is necessary. In Chapter 3, this
concept is explored further.
We showed here, using a disease-associated variant of HS1, that efficient F-actin
binding is important for HS1-mediated Arp2/3 complex-dependent actin polymerization
and for actin responses at the IS. From the data presented here, it is not possible to judge
whether the observed partial defect in actin polymerization in vitro represents a true
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defect in Arp2/3 complex activation, or whether it is due to premature disassembly of
polymerized actin throughout the course of the assay. It will be interesting to examine
the effect of this actin binding mutation on signaling to the IL2 promoter.
Initial analysis of HS1-/- mice demonstrated defects in T cell proliferation and
negative selection (Taniuchi et al., 1995) but did not address the molecular basis of these
defects. We show that HS1-/- T cells have defective actin and Ca2+ responses, as well as
defective IL2 production associated with defects in activation of NF-AT and NFkB
transcriptional elements. It remains to be determined how alterations in HS1 function
result in the observed changes in IL2 promoter activation. Perturbations in signaling
through Vav1 and/or PLCγ1 may be involved, since both proteins are required for
activation of NF-AT and NFkB (Cao et al., 2002; Costello et al., 1999; Dolmetsch et al.,
1998; Irvin et al., 2000). The role of HS1 in regulating Ca2+ signaling is further explored
in Chapter 3.
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Chapter 3: Recruitment of HS1 to the immunological synapse
by Itk regulates actin responses and PLCγ1 microcluster
dynamics3
Summary
Productive T cell activation requires efficient reorganization of the actin
cytoskeleton. We showed previously that the actin regulatory protein hematopoietic
lineage cell-specific protein 1 (HS1) is required for the stabilization of F-actin and Vav1
at the immunological synapse (IS) and for efficient calcium responses. The Tec family
kinase Itk regulates similar aspects of T cell activation, suggesting that these proteins act
in the same pathway. Using video microscopy, we show that T cells lacking Itk or HS1
exhibited similar defects in actin responses, extending unstable lamellipodial protrusions
upon TCR stimulation. HS1 and Itk could be co-immunoprecipitated from T cell lysates,
and GST-pulldown studies showed that Itk’s SH2 domain binds directly to two
phosphotyrosines in HS1. In the absence of Itk, or in T cells overexpressing an Itk SH2domain mutant, HS1 failed to localize to the IS, indicating that Itk serves to recruit HS1
to sites of TCR engagement. Since Itk is required for PLCγ1 phosphorylation and
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This chapter is a modified form of paper entitled, “Hematopoietic lineage cell-specific
protein 1 is recruited to the immunological synapse by IL-2-inducible T cell kinase and
regulates phospholipase Cγ1 microcluster dynamics during T cell spreading,” published
in the December 1 issue of the Journal of Immunology, Volume 183, pages 7352-7361,
with the following author list: Esteban Carrizosa, Timothy S. Gomez, Christine M.
Labno, Deborah A. Klos Dehring, Xiaohong Liu, Bruce D. Freedman, Daniel D.
Billadeau, and Janis K. Burkhardt. Copyright 2009. The American Association of
Immunologists, Inc.
73

calcium store release, we examined the calcium signaling pathway in HS1-/- T cells in
greater detail. In response to TCR engagement, T cells lacking HS1 exhibited abnormal
calcium store release but normal TCR-dependent PLCγ1 phosphorylation. However,
these cells exhibited defective cytoskeletal association of PLCγ1 and altered formation of
PLCγ1 microclusters. We conclude that Itk-dependent recruitment of HS1 mediates actin
stabilization at the IS, and directs the spatial organization of PLCγ1 signaling complexes.

Introduction
Effective T cell activation requires reorganization of the actin cytoskeleton. The
interaction between a T cell and an antigen presenting cell (APC) bearing cognate antigen
results in the activation of multiple actin regulatory proteins, which promote the
polymerization of actin filaments at the immunological synapse (IS) (Burkhardt et al.,
2008). T cells lacking these molecules or treated with pharmacological agents that
disrupt actin dynamics exhibit functional defects in their responses to antigen.
Commonly, diminished calcium (Ca2+) mobilization responses are observed, resulting in
poor IL2 production and proliferation. Although the molecular mechanisms by which
actin dynamics influence T cell signaling are poorly understood, visualization of highorder signaling complexes using live-cell imaging has begun to yield some insights.
Proper actin dynamics are required for the formation of signaling microclusters at the cell
periphery and for their movement toward the center, while the maintenance of centralized
microclusters is largely independent of the actin cytoskeleton (Campi et al., 2005; Varma
et al., 2006). Peripheral and central microclusters also appear to be functionally distinct
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with respect to their role in signaling. Though details differ depending on experimental
conditions (Cemerski et al., 2008), newly formed, peripheral, microclusters are thought to
be the predominant sites for early phosphorylation events, while central microclusters are
usually associated with signal down-regulation (Seminario and Bunnell, 2008). Thus,
actin dynamics are required to assemble active signaling complexes, and to drive the
mechanism that ultimately extinguishes signaling.
HS1 is an actin regulatory protein expressed throughout the hematopoeitic system
(Kitamura et al., 1989). Like its more widely expressed homologue, cortactin, HS1 binds
to the Arp2/3 complex and actin filaments, and is thought to stabilize branched actin
filaments (Uruno et al., 2003b; Weaver et al., 2001). We have shown that T cells lacking
HS1 can generate actin-rich lamellipodial protrusions in response to T cell receptor
(TCR) engagement, but these protrusions are disordered and rapidly collapse (Gomez et
al., 2006). Consistent with this observation, accumulation of F-actin at the IS is
abnormally short-lived. HS1-deficient T cells also exhibit defects in Ca2+ signaling
leading to diminished IL2 production. The regulation of HS1 activity is not fully
understood. TCR engagement leads to rapid phosphorylation of HS1 at tyrosines 378 and
397. This is required for recruitment of HS1 to the IS, and for its binding to numerous
key signaling proteins, including the Rac-1/Cdc42 guanine nucleotide exchange factor
Vav1. While T cells lacking HS1 exhibit defects in the maintenance of Vav1 at the IS,
Vav1 is dispensable for recruitment of HS1 to the IS (Gomez et al., 2006). How HS1 is
recruited to the IS is unknown.

75

TCR ligation-induced activation of actin-regulatory proteins, including HS1,
depends on signaling through tyrosine kinases and adapter proteins (Reviewed in
(Burkhardt et al., 2008)). Although these molecules do not directly influence the actin
cytoskeleton, cells lacking them exhibit severe defects in actin dynamics. We and others
have shown that T cells lacking the Tec family kinase Itk fail to polymerize actin
properly in response to TCR ligation (Dombroski et al., 2005; Grasis et al., 2003; Labno
et al., 2003), and fail to recruit Vav1 to the IS (Dombroski et al., 2005). Interestingly, the
actin-regulatory role of Itk is independent of kinase activity, and depends instead on
adapter functions carried out by its SH2 domain (Dombroski et al., 2005; Grasis et al.,
2003).
To begin to understand how the interactions between actin regulatory proteins and
upstream regulators lead to productive T cell activation, we examined the possibility of
an interaction between HS1 and Itk. Using live cell imaging, we now show that cells
lacking Itk exhibit similar defects in actin dynamics to those lacking HS1. The SH2
domain of Itk binds to phosphotyrosines in HS1, and this interaction is required for the
recruitment of HS1 to the IS. Recruitment of HS1 to the IS then promotes productive
Ca2+ signaling by modulating the formation of PLCγ1 microclusters. Taken together,
these studies show that Itk-HS1 interactions play an important role in controlling actindriven dynamics of TCR signaling microclusters leading to productive T cell activation.

Results
Itk-deficient T cells show unstable lamellipodial protrusions
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Previous studies have shown that Itk is required for proper actin responses in a
manner dependent on its SH2 domain, but not its kinase activity (Dombroski et al., 2005;
Grasis et al., 2003; Labno et al., 2003). To better understand how Itk regulates T cell
actin responses, we generated Itk-deficient T cells using RNA interference (RNAi),
(Figure 3.1E), and visualized actin dynamics in these cells during spreading on coverslips
coated with anti-CD3. As previously shown (Bunnell et al., 2001), control Jurkat T cells
expressing GFP-actin extended stable actin-rich lamellipodia and exhibited retrograde
actin flow from the periphery of the cell toward the center (Figure 3.1A and Supp. Videos
3.1 and 3.2). Itk-deficient T cells also extended actin-rich lamellipodia, but these
structures were disordered and retracted frequently (Figure 3.1B and Supp. Videos 3.3
and 3.4). The overall spreading area of Itk-suppressed cells was less than that of wildtype cells (Figure 3.1C). Furthermore, whereas control cells maintained a regular, round
profile, Itk-suppressed cells were irregularly shaped. This difference is illustrated by an
increased radial variance in the Itk-suppressed cells relative to controls (Figure 3.1D).
The phenotype of Itk-deficient T cells in this assay is strikingly similar to that of T cells
lacking HS1, an actin-binding protein that is thought to stabilize branched actin filaments
generated in response to TCR engagement. Like Itk-suppressed cells, HS1-suppressed
cells exhibit diminished spreading and irregular and unstable lamellipodial protrusions
(Chapter 2, (Gomez et al., 2006), and Supp. Videos 3.5 and 3.6).
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Figure 3.1: Itk-deficient T cells exhibit unstable lamellipodial protrusions.
A, Jurkat T cells stably expressing GFP-actin were transfected with empty
suppression vector. After 72 hours, cells were plated on coverslips coated with
anti-CD3 and imaged by confocal microscopy for the indicated times (seconds).
Selected images from one time-lapse series are shown; these correspond to
Supplemental video 1. B, Jurkat cells stably expressing GFP-actin were
transfected with Itk suppression vector and analyzed as in A. Selected images
from one time-lapse series are shown; these correspond to Supplemental video 3.
C, The contact area of each cell at each time point was determined and the average
was calculated for each cell population at each 5 s time point (control=46 cells,
shItk=49 cells). D, Irregularity of cell shape was assessed by measuring the radial
variance for each cell at each time point and calculating the average values. E,
Western blot analysis showing suppression of Itk or HS1 in GFP-actin Jurkat cells
transfected with the indicated suppression vectors.
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The SH2 domain of Itk mediates binding to HS1
To test the possibility that HS1 is an effector for Itk in the T cell actin regulatory
pathway, we assessed interaction between these two proteins by co-immunoprecipitation.
As shown in Figure 3.2, Itk was found in association with HS1 in both activated and
resting mouse CD4+ T cell blasts. Similar results were obtained using Jurkat T cells;
moreover, HS1 was present in Itk immunoprecipitated (data not shown).
To map the site(s) of interaction between the two proteins, we used a GST
pulldown approach. Domain maps of HS1 and Itk are shown in Figure 3.3A. Itk has
SH3 and SH2 domains that could bind to proline-rich sequences or phosphotyrosines in
HS1, respectively. Conversely, the SH3 domain of HS1 could bind to the proline-rich
region of Itk. To test the role of the Itk SH3 and SH2 domains, we generated a panel of
GST-fusion constructs encoding the wild-type SH3-SH2 domain fragment of Itk, or with
inactivating point mutations in the SH3 domain, the SH2 domain or both. These
fragments were used to probe Jurkat T cell lysates for binding of HS1. As shown in
Figure 3.3B, HS1 bound to the wild-type Itk fragment in an activation-dependent manner.
This binding was unaffected by mutation of the Itk SH3 domain, but was abolished upon
mutation of the SH2 domain, consistent with binding mediated by SH2 domainphosphotyrosine interactions. In some experiments, we detected modest HS1 binding to
the wild-type construct in the absence of pervanadate treatment (data not shown).
However, this was also abolished upon mutation of the SH2 domain, suggesting that this
interaction is attributable to basal tyrosine phosphorylation of HS1. To ask if the SH3
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Figure 3.2: HS1 and Itk interact in T cells
HS1 and Itk interact in T cells. CD4+ T cell blasts were stimulated with anti-CD3
for the indicated times (minutes), treated with pervanadate (PV), or left untreated.
HS1 was immunoprecipitated from lysates, and immunoprecipitates were
analyzed by western blotting for HS1, phosphorylated HS1 (by blotting for total
phosphotyrosine, pTyr), or Itk. Control immunoprecipitation was performed
using pre-immune rabbit serum.
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Figure 3.3: The SH2 domain of Itk binds directly to phosphorylated HS1.
A, Domain maps of HS1 and Itk. B, A panel of recombinant GST fusion proteins
comprised of the wild-type SH3-SH2 fragment of Itk and inactivating point mutants in
either domain were coupled to glutathione resin and incubated with lysates from
Jurkat cells that had been treated with pervanadate (PV) or left untreated. The
pulldown reactions were washed and analyzed by western blotting for HS1 (top) or
Coomassie staining to monitor the GST-Itk proteins (bottom). C, The wild-type GSTHS1-SH3 domain or an inactivating point mutant were coupled to glutathione resin
and incubated with lysates from Jurkat cells that had been treated with pervanadate
(PV) or left untreated. The pulldown reactions were washed and analyzed by western
blotting for Itk or Dynamin 2. D, Jurkat cells were transfected with expression vectors
encoding wild-type FLAG-tagged HS1 or the indicated point mutants. These cells
were treated with pervanadate, lysed, and probed with GST-Itk SH2 domain. Left,
bound proteins were analyzed by western blotting for FLAG or Coomassie staining to
monitor the GST-Itk proteins. Right, FLAG immunoprecipitates were probed for
phosphotyrosine and FLAG to monitor phosphorylation status of HS1 mutants. E,
Purified recombinant GST-Itk SH2 domain was incubated with recombinant HS1
phosphopeptide fused to myelin basic protein (MBP). Left, bound proteins were
analyzed by western blotting and Coomassie staining. Right, purified MBP fusion
peptides were analyzed by western blotting for phosphotyrosine and MBP.
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domain of HS1 provides an additional means of interaction with Itk, we conducted
reciprocal pulldown experiments using the HS1 SH3 domain. However, Itk binding to
the HS1 SH3 domain could not be detected, even under conditions where interactions
with other binding partners could be verified (Figure 3.3C). We conclude that HS1
binding to Itk depends predominantly on interactions between the SH2 domain of Itk and
tyrosine phosphorylation sites in HS1.
Phosphorylation at Y378 and Y397 of HS1 mediates binding to many SH2
domains (Chapter 2 and (Gomez et al., 2006)), making these sites the likely points of
interaction between HS1 and Itk. To test this hypothesis, we transfected Jurkat cells with
vectors expressing wild-type FLAG-tagged HS1, or HS1 point mutants at one or both
tyrosines. Transfected T cells were treated with pervanadate and lysates were probed for
binding of FLAG-HS1 to the SH2 domain of Itk. As shown in Figure 3.3D, wild-type
HS1 bound efficiently. Mutation of either tyrosine substantially reduced binding, and
mutation of both sites abolished the interaction altogether. This shows that both tyrosines
378 and 397 contribute to the interaction with Itk.
To determine if HS1 and Itk interact directly, we asked whether the recombinant
GST-Itk SH2 domain could bind to phosphorylated recombinant HS1 fusion protein in
the absence of other components of the T cell signaling machinery. As Figure 3.3E
shows, HS1 and Itk interacted directly, and efficient binding required both Y378 and
Y397. We conclude that HS1 and Itk interact in T cells and that this interaction involves
direct binding between the SH2 domain of Itk and tyrosines 378 and 397 of HS1. Since
we have shown previously that these sites on HS1 are phosphorylated transiently upon
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TCR engagement ((Gomez et al., 2006) and Chapter 2), direct interaction between HS1
and Itk is predicted to be transient, and the observed constitutive association between
these proteins (Figure 3.2) is likely to involve additional interactions with mutual binding
partners.

Itk is required for HS1 recruitment to the IS
We have shown previously that phosphorylation of HS1 at Y378 and Y397 is
required for its recruitment to the IS (Chapter 2 and (Gomez et al., 2006)). Since these
sites mediate direct binding to the SH2 domain of Itk, we asked if Itk is required for
recruitment of HS1 to the IS. As shown in Figure 3.4A, control Jurkat cells conjugated to
superantigen-pulsed B cells recruited HS1 to the IS, but this recruitment was impaired in
cells transfected with an Itk suppression vector. In contrast, T cells lacking HS1 showed
no defect in recruitment of Itk to the IS (Figure 3.4B), indicating that the requirement for
recruitment is unidirectional. To quantitate the requirement for Itk in recruiting HS1 to
the IS, conjugates were prepared using control and Itk-suppressed Jurkat cells, and the
frequency of conjugates showing a bright band of HS1 at the IS was scored. As shown in
Figure 3.4C, Itk suppression diminished HS1 recruitment to frequencies similar to those
observed in the absence of superantigen. Using a similar approach, we asked what
portions of Itk are required to mediate HS1 recruitment. Jurkat T cells were transfected
with wild-type Itk, the kinase-dead (K390R) mutant, or the SH2 domain (R265A) mutant,
and HS1 recruitment to the IS was assessed. As shown in Figure 3.4D, overexpression of
wild-type or kinase dead Itk had no effect on HS1 localization, but overexpression of the
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Itk SH2 domain mutant efficiently inhibited HS1 recruitment to the IS. The requirements
for HS1 recruitment with respect to Itk parallel those for actin recruitment (Dombroski et
al., 2005). We conclude that Itk, through its SH2 domain, recruits HS1 to the IS to
promote TCR-induced actin responses.

HS1 is required for efficient Ca2+ store release
In addition to its role in regulating actin responses, Itk is a key signaling
intermediate in TCR signaling-induced Ca2+ responses (Liu et al., 1998; Schaeffer et al.,
1999). Itk is required for phosphorylation of PLCγ1, leading to Ins(1,4,5)P3 production
and release of Ca2+ from intracellular stores. HS1 is also required for normal T cell Ca2+
responses (Gomez et al., 2006), but the level at which HS1 functions in this pathway has
not been addressed. To test this, HS1-/- T cells were stimulated with anti-CD3 in the
absence of extracellular Ca2+ to visualize ER store release, and then exposed to
extracellular Ca2+ to permit Ca2+ influx via CRAC channels. HS1-/- T cells showed a
significant blunting of Ca2+ responses (Figure 3.5A). Expansion of the Y-axis to better
show the response in the absence of extracellular Ca2+ (Figure 3.5A, right panel) reveals
that HS1-deficient T cells fail to show significant release of Ca2+ from ER stores. To
confirm this finding, T cells were treated with the SERCA pump inhibitor thapsigargin to
pharmacologically induce store depletion, and Ca2+ responses were assessed. As shown
in Figure 3.5B, treatment with thapsigargin rescued the Ca2+ defect in HS1-deficient T
cells, indicating that HS1, like Itk, is required for Ca2+ store release.
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Figure 3.4: The SH2 domain of Itk is required for recruitment of HS1 to the IS.
A, Jurkat cells transfected with Itk suppression or control vectors were conjugated
to CMAC-stained, SEE-loaded Raji B cells (blue) for 15 minutes. Conjugates
were fixed and stained for HS1 (red) or F-actin (green). B, CD4+ T cells from
HS1+/- or HS1-/- AND TCR transgenic mice were conjugated to CMAC-stained,
MCC peptide-loaded CH27 B cells for 3 minutes and stained for Itk (red). C, Itksuppressed or control Jurkat T cells conjugated to Raji B cells were scored for
recruitment of HS1 to the cell-cell contact site. D, Jurkat cells were transfected
with expression vectors for wild-type, SH2 domain mutant (SH2m), or kinasedead (KD) Itk. Conjugates were prepared and analyzed as in C. Data in C and D
represent averages of at least 50 conjugates from one representative experiment.
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Figure 3.5: HS1 is required for release of Ca2+ from intracellular stores.
HS1 is required for release of Ca2+ from intracellular stores. A, CD4+ T cells from
HS1+/+ or HS1-/- mice were loaded with the Fura-2AM and plated on poly-L-lysinecoated coverslips. Immediately before TCR stimulation, the cells were superfused
with Ca2+-free bath solution. At the indicated time, cells were stimulated by the
addition of anti-CD3 (500.A2) and analyzed by fluorescence microscopy to visualize
a rise in cytoplasmic Ca2+ indicative of release from ER stores. Extracellular Ca2+
was then added to visualize Ca2+ influx. Right, an expansion of the Y-axis to
visualize release from ER stores. B, Cells prepared as in A were treated with 1 µM
thapsigargin (Tg) and imaged as in A.
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Previous studies have demonstrated that at least one Itk binding partner, SLP-76, can
activate Itk kinase activity toward PLCγ1 (Bogin et al., 2007). To ask if HS1 plays a
similar role, T cells from wild-type and HS1-/- mice were stimulated with anti-CD3 for
various times and the phosphorylation of PLCγ1 was analyzed by western blotting using
site-specific antibodies. As shown in Figure 3.6A, phosphorylation of PLCγ1 at tyrosine
783 proceeded normally in the absence of HS1. Phosphorylation at tyrosine 775 was also
intact (data not shown). Thus, we conclude that HS1 is not required for phosphorylationdependent activation of PLCγ1. PLCγ1 activation is characterized not only by
phosphorylation, but also by localization to the IS, in association with other components
of the LAT signalosome (Braiman et al., 2006). We therefore analyzed PLCγ1
localization in wild-type and HS1-/- AND TCR transgenic T cells conjugated to MCCpulsed CH27 B cells. As shown Figure 3.6B, PLCγ1 localized efficiently to the IS at
early time points in both control and HS1-deficient T cells. Time course analysis showed
that wild-type cells were able to maintain PLCγ1 at the IS for 20 minutes, whereas HS1-/cells showed significant loss of IS-associated PLCγ1 by 10 minutes. This mirrors the
defects we have previously observed for F-actin and Vav1 (Gomez et al., 2006).
Nonetheless, given the rapid kinetics of Ca2+ store release relative to the defects we
observed in PLCγ1 localization, the Ca2+ signaling defects we observe in HS1-deficient T
cells cannot be explained by a gross failure to recruit PLCγ1 to the IS.
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Figure 3.6: HS1 is dispensable for PLCγ1 phosphorylation and early recruitment to
the IS.
A, T cells from HS1+/+ or HS1-/- mice were stimulated as indicated and lysates were
analyzed by western blotting for PLCγ1 phosphorylated at Y783, total PLCγ1, and
HS1. B, CD4+ T cells from HS1+/- or HS1-/- AND TCR transgenic mice were
conjugated to CMAC-stained, MCC peptide-loaded CH27 B cells (blue) and stained
for PLCγ1 (red). C, The fraction of conjugates with PLCγ1 at the indicated times was
determined.
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The finding that sustained PLCγ1 localization to the IS depends on HS1 led us to
examine earlier actin-driven aspects of PLCγ1 signaling in greater detail. To ask if HS1
functions to modulate PLCγ1 association with the cytoskeleton, we prepared insoluble
actin-rich fractions from wild-type or HS1-/- T cells, and assessed the association of total
and phospho-PLCγ1 with these fractions by western blotting. In wild-type T cells, a
fraction of PLCγ1 became associated with the cytoskeleton within 1 minute of TCR
engagement (Figure 3.7A). PLCγ1 continued to accumulate in the cytoskeletal fraction
over the next five minutes (Figure 3.7B). Importantly, this pool was enriched in
phospho-PLCγ1 such that the vast majority of phospho-PLCγ1 was cytoskeletally
associated (Figures 3.7A and 3.7C). In contrast, little or no activation-induced
cytoskeletal association of PLCγ1 was observed in lysates from HS1-/- T cells. Although
the experiment shown in Figure 7A shows increased phospho-PLCγ1 in the cytoskeletal
fraction at 3 minutes in HS1-/- T cells, this result was not reproducible. The significance
of the insoluble pool of PLCγ1 remains to be defined; however, given that the
phosphorylated pool of the molecule is thought to represent the active pool, it seems
likely that cytoskeletal association is intimately linked with PLCγ1 function.
Nonetheless, these results support the idea that HS1 affects PLCγ1 organization during
early phases of TCR signaling.
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Figure 3.7: HS1 is required for PLCγ1 cytoskeletal association
A, T cells from HS1+/+ or HS1-/- mice were stimulated as indicated, lysed in
cytoskeletal stabilizing lysis buffer, and separated into cytosol-enriched supernatant
and F-actin rich pellet fractions. Fractions were analyzed by western blotting as
indicated. pPLCγ1 was detected using an antibody specific for PLCγ1 phosphorylated
at Y783. B, The amount of PLCγ1 in the pellet fractions at each time point was
quantified and normalized to the amount of PLCγ1 in the pellet in unstimulated cells.
Data represent averages from four independent experiments +/- SEM. *, p<0.05. C,
The amount of PLCγ1 phosphorylated at Y783 in the pellet fractions at each time
point was quantified and normalized to the amount of PLCγ1 phosphorylated at Y783.
94 averages from four independent
.the pellet in unstimulated cells. Data represent
experiments +/- SEM. *, p<0.05; **, p<0.01.

To observe directly the effects of HS1 on PLCγ1 dynamics, we analyzed the
formation of signaling microclusters in Jurkat cells expressing PLCγ1-eYFP during
spreading on anti-CD3 coated coverslips. In control cells, as reported previously
(Braiman et al., 2006), PLCγ1 assembled into microclusters at the T cell-coverslip
interface. As spreading progressed, new microclusters were formed within actin-rich
lamellipodial protrusions, near the edge of the spreading cell (Figure 3.8A). HS1suppressed cells also formed microclusters, but these clusters were often disorganized
and formed large aggregates (Figure 3.8B). The formation of microclusters at the cell
periphery was also impaired, presumably because HS1-deficient cells do not spread
normally. To assess this phenotype, individual microclusters were identified in video
sequences, and pseudocolored in order of appearance. As shown in Figure 3.8C, in
control cells, microclusters were formed at distinct sites in a concentric fashion, with
newer microclusters in the periphery. In contrast, HS1-deficient T cells exhibited
formation of new microclusters that overlapped with older ones, resulting in aggregates
of mixed age (Figure 3.8D). We assessed the size of these mixed aggregates in each cell
at 90 seconds after contact with the coverslip. As shown in Figure 3.8E, suppression of
HS1 resulted in a two-fold increase in average microcluster size. This increase in
average size was attributable to an abnormally disparate size distribution. As shown in
Figure 3.8F, the vast majority of microclusters in control cells were less than 0.5 µm in
diameter. HS1-deficient cells also showed numerous small microclusters, but nearly half
of the microclusters in these cells exceeded 0.5 µm, with some as large as 6 µm. Since
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peripheral microclusters are key sites for early TCR signaling events (Campi et al., 2005;
Varma et al., 2006; Yokosuka et al., 2005), the defect in Ca2+ responses in HS1-deficient
T cells may reflect a role for HS1 in controlling PLCγ1 signaling at the level of
microcluster dynamics.
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Figure 3.8: HS1 regulates PLC1 microcluster dynamics

A, Jurkat cells stably expressing PLCγ1-eYFP were transfected with empty vector,
plated on coverslips coated with anti-CD3, and imaged by confocal microscopy.
Selected images from one time-lapse series are shown; these correspond to
Supplemental video 7. B, Jurkat cells stably expressing PLCγ1-eYFP were transfected
with HS1 suppression vector and analyzed as in A. Selected images from one timelapse series are shown; these correspond to Supplemental video 9. C and D, PLCγ1
microclusters in empty vector (C) or HS1-suppressed (D) T cells were identified and
color coded by order of appearance, with newer microclusters colored orange and red,
and older microclusters colored blue and green. Left hand panels show cells from the
sequences shown shown in A and B. Right hand panels show additional examples. E,
The area of individual microclusters was determined at 90 seconds after the initiation
of contact with the coverslip. At least 20 cells were analyzed per condition, yielding
approximately 400 microclusters each. Data represent mean +/- SEM. **, p<0.0001.
F, The areas of individual microclusters from E were grouped into the indicated bins.
The percent of total microclusters falling into each size category is shown.
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Discussion
Regulation of actin dynamics in T cells involves coordination of multiple actin
regulatory proteins by upstream kinases including Lck, ZAP70, and c-Abl (Huang et al.,
2008; Lowin-Kropf et al., 1998; Morgan et al., 2001). Itk has also been demonstrated to
play a role in regulating T cell actin responses, but this function is independent of its
kinase activity and instead requires its SH2 domain (Dombroski et al., 2005; Donnadieu
et al., 2001; Grasis et al., 2003; Labno et al., 2003). We show here that one role of the
SH2 domain of Itk is to recruit HS1 to the IS. Video analysis shows that T cells lacking
Itk or HS1 have similar defects in actin reorganization downstream of TCR engagement.
In contrast to T cells lacking WAVE2 or Arp2/3 complex components, which fail to
extend actin-rich lamellipodial protrusions (Gomez et al., 2007; Nolz et al., 2006), T cells
deficient for HS1 or Itk can extend these structures, but they are unstable and retract
frequently. This phenotype is consistent with in vitro studies showing that HS1 functions
to stabilize existing branched actin filaments (Uruno et al., 2003b; Weaver et al., 2001).
In addition to stabilizing actin filaments directly, HS1, like Itk, has been implicated in
regulating the localization of Vav1 at the IS (Gomez et al., 2006). Localization of Vav1
to the IS requires an intact Itk SH2 domain (Dombroski et al., 2005). Since Vav1 binds
directly to HS1, this suggests that HS1 links Vav1 to Itk during T cell activation. It is
important to point out, however, that these proteins also interact with other signalosome
components including LAT, SLP-76, and PLCγ1, such that loss of any one of these
molecules disrupts interactions among the others and perturbs T cell actin responses
(Bunnell et al., 2006). Finally, there is evidence that the actin scaffolds generated by
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these signaling molecules function to stabilize newly formed signaling complexes (Campi
et al., 2005), thereby generating a positive feedback loop to facilitate T cell activation.
We have mapped binding of the Itk SH2 domain to phosphotyrosines 378 and 397
of HS1. These residues are phosphorylated upon TCR engagement in a ZAP70dependent manner and are required for recruitment of HS1 to the IS and for its functions
in actin remodeling and signaling to the Il2 promoter (Gomez et al., 2006). Interestingly,
these two tyrosines also serve as docking sites for Vav1 binding. It is unclear whether
one molecule of HS1 can bind simultaneously to Itk and Vav1. This need not be the
case, since multiple molecules of HS1 would be present in any given actin-associated
signaling complex. Although our in vitro data clearly indicate that HS1 and Itk associate
via activation-dependent phosphotyrosine-based interactions, these two molecules can be
co-immunoprecipitated constitutively from T cell lysates. This constitutive interaction
does not appear to involve the SH3 domain of either molecule. This interaction can be
explained, in part, by basal tyrosine phosphorylation of HS1, but it probably also involves
mutual interactions of these proteins with other T cell signaling molecules. Similar
conclusions have been reached for other signalosome proteins, e.g. Itk and SLP-76
(Jordan et al., 2008).
In addition to their similarities with respect to actin dynamics, T cells lacking Itk
or HS1 both have defects in Ca2+ store release (Gomez et al., 2006; Liu et al., 1998;
Schaeffer et al., 1999). In the case of Itk-deficient T cells, the defects in Ca2+ store
release are well-studied and stem from the requirement for Itk-dependent phosphorylation
of PLCγ1. Since HS1 binds to Itk, we considered the possibility that HS1 binding
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promotes Itk kinase activity, as has been documented for Slp76 and Itk (Bogin et al.,
2007). However, HS1 appears to be dispensable for Itk kinase activity, since HS1deficient cells show normal kinetics and magnitude of PLCγ1 phosphorylation. Based on
these findings, we conclude that HS1 and Itk function to promote Ca2+ store release
through distinct mechanisms. While Itk phosphorylates PLCγ1 (Bogin et al., 2007), HS1
appears to regulate PLCγ1 function by linking it to the actin cytoskeleton. Interestingly,
since Itk functions upstream of HS1 in the actin-regulatory pathway, this suggests that Itk
may promote PLCγ1 activation in two ways: via its kinase activity and through SH2
domain-mediated adaptor functions. Further analysis will be required to test this idea and
to address the interdependence of these two mechanisms.
Consistent with this dual mode of PLCγ1 activation, Braiman et al. (Braiman et
al., 2006) have shown that proper PLCγ1 function involves a complex interplay between
phosphorylation and association with other signalosome components in signaling
microclusters. There is evidence in other cell types that PLCγ1 associates with the actin
cytoskeleton, and this association can modulate PLCγ1 activity (Bar-Sagi et al., 1993;
Nojiri and Hoek, 2000; Pei et al., 1996; Suzuki and Takahashi, 2001). We now show that
T cell activation induces partitioning of PLCγ1 into an F-actin rich fraction, and that the
phosphorylated pool of PLCγ1 is enriched in this fraction. HS1-/- T cells show impaired
cytoskeletal association of PLCγ1. Moreover, whereas control T cells spreading on antiCD3-coated surfaces show processive assembly of PLCγ1 microclusters near the
periphery, HS1-deficient cells show disorganized microcluster assembly, with newlyformed microclusters overlapping with older ones. The simplest explanation for these
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observations is that formation of new, active PLCγ1 microclusters is linked to formation
of branched actin filaments at the periphery of spreading T cells. Thus, in HS1-deficient
cells, defects in stabilization of lamellipodial protrusions result in perturbation of
processive microcluster assembly.
It seems likely that the defects we observe in PLCγ1 dynamics underlie the
defects in Ca2+ store release, and it will be interesting to explore the molecular
mechanisms through which this occurs. Recent studies have led to a paradigm in which
microcluster dynamics are mechanistically linked to signal generation and extinction.
According to this model, early TCR signaling events mostly take place in newly-formed
peripheral microclusters. Depending on the quality of the antigen, signaling can continue
in centralized signaling complexes, but centralized complexes are ultimately subject to
signal extinction via internalization and degradation (Balagopalan et al., 2007; Barr et al.,
2006; Cemerski et al., 2008; Lee et al., 2003). Thus, the defects we observe in PLCγ1
microcluster dynamics might result in aberrant signaling due to premature mixing with
proteins responsible for signal extinction. Alternatively, efficient TCR signaling may
require the forces associated with myosin-based microcluster centralization (Ilani et al.,
2009; Varma, 2008). If so, the spreading defects in HS1-deficient T cells may result in
reduced PLCγ1 signaling as a result of diminished tension. Finally, the observed defects
in Ca2+ store release may arise as a result of altered cell geometry. In a well-spread T
cell, much of the endoplasmic reticulum is localized within a short distance of the cell
surface, whereas in a poorly-spread T cell, the bulk of the endoplasmic reticulum is
situated much further away. Since PLCγ1-induced IP3 production is very short-lived,
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typically peaking within a minute of TCR engagement (Olenchock et al., 2006), and
activation of IP3 receptors is highly cooperative (Meyer et al., 1988), T cell spreading
could serve to promote Ca2+ store release by bringing ER-associated IP3 receptors into
proximity with sites of IP3 production. Additional investigation will be required to test
these possibilities and to explore in more general terms the importance of actin
polymerization and cell spreading for T cell signaling.
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Chapter 4: Analysis of T cells from HS1-/- mice

Introduction
Mice with germline deletion of HS1 were described by the Watanabe lab in 1995
(Taniuchi et al., 1995). This report showed that HS1-/- mice have normal cellularity in all
lymphoid organs. A limited analysis of T cell development and peripheral T cell
populations revealed no defects, although negative selection was shown to be impaired.
However, these studies were limited in scope. Thymocyte and peripheral T cell
population analysis was limited to CD4 and CD8 staining. Activation and memory
markers were not examined, nor were regulatory T cells. Functionally, T cells exhibited
a mild defect in proliferative responses to anti-CD3, but effector T cell function was not
tested. These studies were conducted prior to the appreciation of HS1 as an actin
regulatory protein. Moreover, our understanding of T cell biology has advanced
considerably since these studies were published. In light of our data demonstrating that
HS1 is important for T cell activation (Chapter 2), I have conducted an more extended
analysis of the T cell compartment of HS1-/- mice, focusing primarily on responses to
TCR engagement.
I have conducted a more in-depth analysis of thymocyte development and
peripheral T cell populations, and have confirmed that HS1 is not required for thymocyte
development. Peripheral T cell populations also appear normal in HS1-/- mice. I have
also tested responses to TCR engagement in several assays. Although CTL function
appears normal, loss of HS1 results in reduced IFNγ production and a decrease in the
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development of TH1 cells accompanied by an increase in IL4-producing TH2 cells in
vitro. Several reports have described a role for cortactin, the non-hematopoietic homolog
of HS1, in migration (Bryce et al., 2005; Huang et al., 1998; Kowalski et al., 2005; van
Rossum et al., 2006). Surprisingly, HS1 deficient T cells appear to home normally to
lymphoid organs. These data support a role for HS1 in specific TCR signaling pathways.

Results
Analysis of thymocyte development in HS1-/- mice
HS1-deficient mice exhibit normal CD4 and CD8 single- and double-positive
thymocyte populations and cell numbers (Taniuchi et al., 1995). To verify and extend
these observations, I analyzed thymocytes from wild-type and HS1-/- mice by flow
cytometry. There was no difference in the number of thymocytes isolated from either
WT or HS1-/- mice. Thymocytes were stained for CD4, CD8, CD44, and CD25 to
analyze early development through the double-negative stages. HS1-/- mice had normal
percentages of single positive and double positive thymocytes (Figure 4.1a). As shown
in Figure 4.1b, the percentages of cells in the DN1 (CD4- CD8- CD44+ CD25-), DN2
(CD4- CD8- CD44+ CD25+), DN3 (CD4- CD8- CD44- CD25+), and DN4 (CD4- CD8CD44- CD25-) stages were comparable between WT and HS1-/- samples. To examine
NKT cell development, thymocytes were stained for CD3, CD4, CD8, and NK1.1.
Comparable percentages of NKT cells were detected in WT and HS1-/- thymi (NK1.1+
CD4+ CD3+) (Figure 4.1c). To examine the efficiency of signaling throughout thymocyte
development, surface levels CD5 and CD69, both of which are upregulated in response to
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TCR engagement, were examined and found to be comparable between WT and HS1-/mice (Figure 4.1d and 4.1e). In addition, CD3 levels were comparable between WT and
HS1-/- thymocytes (Figure 4.1f). Taken together, these data show that HS1 is dispensable
for thymocyte development.
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Figure 4.1: HS1 is not required for thymocyte development.
Single-cell suspensions from WT or HS1-/- mice were stained for CD4 and CD8 and
the indicated cell surface markers. A, CD4 and CD8 expression on thymocytes. B,
Thymocytes stained for CD44 and CD25 were gated on CD4- CD8- double-negative
cells to analyze early development. C, Thymocytes stained for CD3 and NK1.1 were
gated on CD4+ cells to analyze NKT cell development. D, CD5 expression was
analyzed at DN, DP, CD8SP and CD4SP stages. E, CD3 expression was analyzed at
DN, DP, CD8SP and CD4SP stages. F, CD69 expression was analyzed at DN, DP,
CD8SP and CD4SP stages.
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Normal peripheral T cell populations in HS1 knockout mice
To characterize the peripheral T cell compartment in HS1-/- mice, I began by
conducting flow cytometry analysis. Single cell suspensions were prepared from spleens
and lymph nodes of WT and HS1-/- mice, and stained for CD4, CD8, CD25, CD69,
CD44, and CD62L. CD4+ T cells and CD8+ T cells were present at similar ratios in both
WT and HS1-/- mice (Figure 4.2a), as reported previously (Taniuchi et al., 1995).
Staining of CD44 and CD62L to distinguish naïve (CD44lo CD62Lhi) and memory
(CD44hi CD62Llo) T cells revealed no difference between WT and HS1-/- mice (Figure
4.2b). Similarly, there was no difference in the fraction of freshly isolated T cells
expressing the activation markers CD25 or CD69 (Figure 4.2c). To determine if HS1 is
required for regulatory T cell development, lymph node and spleen cells were stained
with anti-CD4 and anti-CD25, then fixed, permeabilized, and stained with anti-FoxP3.
Regulatory T cells (CD4+ CD25+ FoxP3+) were present at equal ratios in WT and HS1-/mice (Figure 4.3).
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Figure 4.2: Normal peripheral T cell populations in HS1-/- mice.
Single cell suspensions from spleens and lymph nodes were stained for CD4
and CD8 and the indicated markers. The percentage of cells in each gate is
shown. A, CD4 and CD8 expression. B, Cells gated on CD4+ (top) or CD8+
(bottom) were analyzed for CD44 and CD62L expression. C, Cells gated on
CD4+ (top) or CD8+ (bottom) were analyzed for CD25 (left) and CD69 (right)
expression.
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Figure 4.3: HS1 is not required for regulatory T cell development.
Single cell suspensions from mesenteric lymph nodes, peripheral lymph nodes,
spleens, and thymi from WT (top) or HS1-/- (bottom) mice were surfacestained for CD4, CD8, and CD25, then fixed, permeabilized, and stained for
FoxP3. Treg were identified as CD25+ FoxP3+ cells within the CD4+ gate.
The percentage of cells in each gate is shown. Results are representative of
two independent experiments.
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HS1 in TH1/TH2 skewing
CD4+ T cells respond to immunological challenge by differentiating into various
effector subsets that secrete different sets of cytokines; each of these subsets is best suited
to respond to a different type of infection (Schoenborn and Wilson, 2007). TH1 cells
secrete IFNγ and IL2, leading to the development of a cell-mediated immune response,
which is required for the elimination intracellular pathogens such as viruses. TH2 cells
secrete IL4, IL5, and IL13, and promote the development of a humoral immune response,
which promotes the clearance of intestinal helminths.
Signaling through both cytokine receptors and through the TCR influences the
decision to differentiate to the TH1 or TH2 lineage. IL12 and IFNγ can lead to TH1
differentiation, whereas IL4 promotes TH2 differentiation. The strength of signal
received through the TCR also influences the differentiation process: strong signals that
promote robust, long-lived Ca2+ responses promote differentiation to the TH1 lineage,
whereas weaker signals, such as those provided by partial agonists, tend to skew T cells
to the TH2 lineage (Constant et al., 1995; Pfeiffer et al., 1995). In light of our data
showing defective Ca2+ responses in HS1-deficient cells (Chapter 2 and Chapter 3), we
hypothesized that HS1-deficient T cells would be less likely to become TH1 cells and
more likely to become TH2 cells following TCR engagement. However, in Chapter 3, I
describe a direct interaction between HS1 and Itk, which suggests an alternate possibility.
Itk-/- T cells exhibit significant defects in vitro and in vivo (Fowell et al., 1999; Miller et
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al., 2004; Schaeffer et al., 2001). Together, these results suggest that HS1 deficiency
may result in decreased TH2 skewing downstream of TCR engagement.
To examine the role of HS1 in helper T cell differentiation and discriminate
between the scenarios described above, CD4+ T cells from WT or HS1-/- mice were
stimulated in vitro on plates coated with anti-CD3 and anti-CD28 for three days, then
allowed to proliferate for four days. Cells were then restimulated with PMA and
ionomycin for four hours. Brefeldin A was added for the last two hours of culture to
prevent cytokine secretion. Cells were then stained with anti-IFNγ and anti-IL4, and
analyzed by flow cytometry. As shown in Figure 4.4a, HS1-deficient cultures had a
higher frequency of IL4-producing cells compared to WT and a lower frequency of IFNγproducing cells. Although the fraction of cells that skewed to each population varied
between experiments, HS1-deficient cells consistently exhibited significantly more TH2
skewing than did WT cells. These results support the first scenario described above, in
which HS1, by promoting a strong Ca2+ response, promotes differentiation to IFNγ
producing TH1 cells.
IFNγ signaling plays a key role in the TH1 differentiation program by inducing
production of the TH1-associated transcription factor Tbet (Lighvani et al., 2001; Mullen
et al., 2001; Szabo et al., 2002). Since NF-AT is involved in activation of the IFNg
promoter (Lee et al., 2004; Schoenborn and Wilson, 2007; Sica et al., 1997; Sweetser et
al., 1998), and HS1 deficiency results in reduced NF-AT activation (Chapter 2), I
examined IFNγ production by ex vivo CD4+ T cells from WT or HS1-/- mice. Cells were
stimulated on plates coated with high (1 µg/ml) and low (0.1 µg/ml) doses of anti-CD3
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and 1 µg/ml anti-CD28 for three days, after which supernatants were harvested and
analyzed by ELISA for IFNγ production (Figure 4.4b). At both high and low doses of
anti-CD3, HS1-/- CD4+ T cells produced less IFNγ than WT CD4+ T cells.
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Figure 4.4: HS1-deficient T cells have defects in TH1 skewing and IFNγ production.
A, CD4+ T cells from WT or HS1-/- mice were stimulated on plates coated with the
indicated concentration of anti-CD3 and 1 µg/ml anti-CD28 for three days. Cells were
then transferred to fresh plates and allowed to rest for four days. Cells were
restimulated with PMA and ionomycin in the presence of brefeldin-A, fixed, and
stained for IFN-γ and IL-4, and analyzed by flow cytometry. (Left), Representative
flow cytometry plots. The percentage of cells in each gate is shown. (Right),
Quantitation of triplicate samples showing the percent of cells that expressed either
IFN-γ or IL4. Error bars indicate +/- 1 standard deviation. Results are representative
of two independent experiments. B, CD4+ T cells from WT or HS1-/- mice were
stimulated for three days with plate-bound anti-CD3 and anti-CD28, and supernatants
were assayed for IFN-γ by ELISA.
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Role of HS1 in cytotoxic T lymphocyte function
Cytotoxic T lymphocytes (CTL) mediate adaptive immunity against intracellular
pathogens such as viruses and tumors by lysing infected or malignant cells bearing the
appropriate cognate antigen. These cells are also a major source of IFNγ.
To determine whether HS1 is required for CTL function, CTL were generated in
vitro by stimulating CD8+ T cells isolated by negative selection from lymph nodes from
WT or HS1-/- mice (C57Bl/6, H-2b) on plates coated with anti-CD3 and anti-CD28, in the
presence of IL2. After three days of stimulation, these cells were transferred to uncoated
plates, and cultured in the presence of exogenous IL2 for 2-3 days. WT and HS1-/- CTL
were then assayed in vitro for cytotoxicity against allogeneic (H-2d) 51Cr-labeled P815
target cells. Target cell lysis was equivalent between WT and HS1-/- cells (Figure 4.5a),
indicating that HS1 is not required for CTL function.
CD8+ T cells produce substantial amounts of IFNγ upon TCR engagement (Szabo
et al., 2002). To determine if HS1 is required for IFNγ production by CD8+ T cells, WT
or HS1-/- CD8+ T cells were stimulated using plate-bound anti-CD3 and anti-CD28 for
three days. As shown in Figure 4.5b, WT and HS1-/- CD8+ T cells produced equivalent
amounts of IFNγ. Thus, HS1 is not required for efficient IFNγ production by CD8+ T
cells.
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Figure 4.5: HS1 is not required for CTL-mediated killing or IFNγ production.
A, CTL generated in vitro from wild-type or HS1-/- C57Bl/6 mice were incubated
with 51Cr-labeled P815 mouse mastocytoma cells at the indicated effector:target
cell ratios. Supernatants were harvested after 5 hours, transferred to a Luma plate,
allowed to evaporate overnight, and measured using a TopCount scintillation
counter. Results are representative of two independent experiments. B, CD8+ T
cells from WT or HS1-/- mice were stimulated for three days with plate-bound antiCD3 and anti-CD28. Supernatants were then assayed by ELISA for IFNγ content.
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Activation-induced cell death
Strong signaling through B cell or T cell antigen receptors induced by
restimulation shortly after the initial activation of naïve lymphocytes leads to apoptosis
through a process termed activation-induced cell death. This process is important for the
control of chronically activated T cells, and for downregulation of the immune response
(Brenner et al., 2008).
B cells in the peritoneal cavity of HS1-deficient mice are resistant to apoptosis
induced by strong crosslinking of the B cell receptor (Taniuchi et al., 1995).
Furthermore, two WEHI-231 B cell lines have been isolated that are strongly resistant to
AICD. These cells express low levels of HS1, and reexpression of HS1 rescues the death
response in one of these lines (Fukuda et al., 1995). Based on these findings, I asked if
HS1-/- T cell blasts restimulated in vitro were sensitive to AICD.
CD4+ T cells from the lymph nodes of WT or HS1-/- mice were stimulated on
plate-bound anti-CD3 and anti-CD28 for 3 days, followed by an expansion phase of three
days in fresh culture plates in the presence of exogenous IL2. T cells were then
harvested, and restimulated on plates coated with varying concentrations of anti-CD3 or
left unstimulated. After eight hours, cells were harvested, stained with Annexin-V to
detect cells undergoing apoptosis and 7-AAD to detect dead cells, and analyzed by flow
cytometry. As shown in Figure 4.6, WT and HS1-/- T cells were equally sensitive to
AICD at all doses tested. These data demonstrate that HS1 is not required for AICD in
mature T cells.
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Figure 4.6: HS1 is not required for AICD in T cells.
WT or HS1-/- CD4+ T cell blasts were stimulated on plates coated with the indicated
concentrations of anti-CD3 for eight hours, the harvested, and stained with anti-CD4, 7AAD, and Annexin-V. A, Representative flow cytometry plots. B, The percent specific
cell death was calculated as1−

% Livetreated
×100 . Results are representative of two
% Liveuntreated

independent experiments.
€
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TCR Internalization
After stimulation, TCRs are internalized via clathrin-coated pits (Dietrich et al.,
1994; Schneider et al., 1999) and degraded via a lysosomal pathway (Valitutti et al.,
1997). TCR internalization, an actin dependent process (McGavin et al., 2001) is a
critical for the regulation of T cell responses (Ferber et al., 1994; Geisler, 2004;
Naramura et al., 2002; Schonrich et al., 1991; Viola and Lanzavecchia, 1996; Zanders et
al., 1983). The HS1 homolog cortactin, in conjunction with CD2AP and dynamin family
members, is a critical component of the clathrin-dependent endocytic pathway (Cao et al.,
2003; Lynch et al., 2003). T cells deficient for CD2AP have severe defects in TCR
endocytosis after antigen encounter, and as such are hyperresponsive (Lee et al., 2003).
Based on these observations, I asked whether HS1 is required for TCR
endocytosis. AND TCR transgenic CD4+ T cells derived from WT or HS1-/- mice were
stimulated in vitro with CH27 B cells loaded with varying concentrations of MCC88-103
for 10 minutes to 3 hours. Conjugates were then harvested, stained with anti-Vα11, the α
chain of the AND TCR, and analyzed by flow cytometry. As shown in Figure 4.7, T
cells lacking HS1 were able to downregulate surface TCR at rates equivalent to WT T
cells, and responded equally well to high and low doses of peptide. These data suggest
that HS1 does not play a role in downregulation of surface TCR upon stimulation.
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Figure 4.7: HS1 is not required for TCR internalization.
T cells from WT or HS1-/- AND TCR transgenic mice were stimulated with CD27
B cells loaded with 0.3 or 10 µM MCC88-103 peptide for ten minutes to three hours,
as indicated. Cells were stained for CD4 and Vα11, and analyzed by flow
cytometry. (A), Representative flow cytometry plots. (B), TCR internalization
was calculated as the percent MFI remaining, compared to unstimulated cells.
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Normal homing of HS1-/- T cells to lymphoid organs
Several studies have identified a role for cortactin, the non-hematopoietic
homolog of HS1, in cell migration (Lai et al., 2009; Patel et al., 1998). Actin regulatory
proteins such as WASp and WIP, which constitutively interact, play important roles in
lymphocyte migration (Gallego et al., 2006; Haddad et al., 2001). Therefore, we asked if
HS1 is required for T cell homing to lymphoid organs. Single-cell suspensions from
lymph nodes and spleens from WT or HS1-/- mice were labeled with either CFSE or
TRITC, and injected at a 1:1 ratio into WT C57BL/6 recipients. Injected cells were
allowed to migrate overnight, after which recipients were euthanized. Liver, lungs,
blood, spleen, and peripheral and mesenteric lymph nodes were analyzed by flow
cytometry for the presence of labeled injected T cells. As shown in Figure 4.8, WT and
HS1-/- cells were able to home equally well to all tissues examined, suggesting that HS1
is dispensable for T cell homing to lymphoid organs in the absence of an inflammatory
response.
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Figure 4.8: HS1 is not required for naïve T cell migration to lymphoid organs.
Single cell suspensions from spleens and lymph nodes of WT or HS1-/- mice were
stained with CFSE (WT) or TRITC (HS1-/-) and mixed at a 1:1 ratio. 2x107 cells were
injected into each WT recipient. A small sample of input cells was saved as a control
for variation in WT:HS1-/- ratios. After twenty-four hours, recipients were sacrificed,
and tissues were harvested, stained for CD4 and CD8, and analyzed by flow
cytometry. (A), Representative flow cytometry plots. (B), Homing index was
calculated according to the following equation:
representative of two independent experiments.
€
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Discussion
Although HS1 seems to be important for efficient TCR signaling in mature T
cells, the TCR signaling pathways that promote thymocyte maturation seem to be
independent of HS1. Alternatively, thymocyte signaling might be impaired only to the
extent that negative selection is reduced, as described in (Taniuchi et al., 1995). It may
be that positive selection is also impaired in the absence of HS1, such that the TCR
repertoire is skewed towards a more auto-reactive set. However, we have not observed,
and have not seen any reports detailing, a tendency towards autoimmune disease in HS1-/mice. If selection is altered in HS1-/- thymocytes, it may be that additional contributing
factors are necessary to initiate an autoimmune response. To that end, it might be
interesting to breed HS1-/- mice to a model of autoimmunity (e.g., SLE1/2/3) to examine
changes in the kinetics of development or magnitude of autoimmune disease.
Peripheral T cell populations also appear normal in HS1-/- mice, in
agreement with the finding that HS1 is dispensable for T cell development. Although
regulatory T cell development appears normal, these cells may exhibit reduced function.
WASp is not strictly required Treg development, several studies have now established
that Treg from WASp-/- mice and from WAS patients are functionally impaired, leading
to an increased risk of autoimmune disease (Adriani et al., 2007; Humblet-Baron et al.,
2007; Maillard et al., 2007; Marangoni et al., 2007). This may be independent of the
actin-regulatory function of these proteins, because WT Treg do not efficiently
polymerize actin at the IS.
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Negative selection in HS1-/- mice was originally studied in the HY TCR
transgenic system, in which T cells specific for the male antigen are deleted in male mice.
Expression of TCRα occurs abnormally early in this model system, leading to aberrant
thymocyte development and selection. Expression of the HY TCR α chain during the DP
stage promotes a development and selection pattern that more closely reflects that seen in
WT C57BL/6 mice (Baldwin et al., 2005). Thus, the negative selection phenotype in
HS1-/- mice may have been overstated. To address this issue, negative selection could be
studied in a superantigen model system, in which the presence of endogenous
superantigens leads to the deletion of thymocytes expressing specific Vβ chains (Jordan
et al., 2008). Thymocyte CD5 levels correlate directly with TCR signal strength (Azzam
et al., 1998). That I did not observe alterations in CD5 levels at any stage of development
suggests that HS1 does not affect thymocyte signal strength.
Of all the phenotypes examined, the most striking is a significant decrease in the
development of IFNγ-producing cells after in vitro stimulation. The reason for a defect in
TH1 differentiation in vitro in HS1-/- T cells is not clear. Several possibilities exist. HS1deficient T cells exhibit a defect in Ca2+ signaling (Chapters 2 and 3). As discussed
above, reduced Ca2+ signaling is associated with TH2 responses. Stimulation of naïve T
cells leads to the Ca2+-dependent activation of the NF-AT transcription factor, which is
partly responsible, in concert with NFκB and AP1, for the activation of the IL2 and IFNg
promoters (Schoenborn and Wilson, 2007). The Ca2+ signaling defect leading to reduced
NF-AT activation in HS1-/- T cells (Chapter 2) may lead to reduced production of IFNγ;
this, in turn, may reduce the efficiency with which HS1-/- T cells differentiate to TH1
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cells. Differentiated TH1 cells, due to their higher usage of the Ca2+ signaling pathway
(Sloan-Lancaster et al., 1997), may also be more dependent on HS1 for TH1 recall
responses. That is to say, HS1-deficient T cells may be able to differentiate to the TH1
lineage normally, but may fail to produce IFNγ normally upon restimulation. However,
this scenario is less likely because to measure detect intracellular cytokines, cells were
restimulated with PMA and ionomycin, which stimulate components downstream in the
signaling cascade compared to where HS1 is thought to act.
HS1 is required for efficient IFNγ production by freshly isolated CD4+ T cells
(Figure 4.4). Recent mathematical modeling studies have suggested that IFNγ is key to
the initiation of TH1 differentiation by inducing expression of the TH1-associated
transcription factor Tbet (Schulz et al., 2009). Thus, without additional signals from
other cells (e.g., cytokine signals derived from APCs or other bystander cells), inefficient
IFNγ production by HS1-/- T cells in response to TCR and CD28 ligation may lead to
inefficient differentiation to the TH1 lineage. HS1 is required for full activation of the
NF-AT and NF-κB transcription factors downstream of TCR engagement (Chapter 2 and
(Gomez et al., 2006)), both of which are involved in transcription of the IFNg gene
(Schoenborn and Wilson, 2007; Sica et al., 1997). It would therefore be important
directly characterize the activation of the IFNg promoter with respect to these as well as
other key transcription factors in HS1-/- cells.
Other actin regulatory proteins have been shown to influence helper T cell
skewing and cytokine production. CD4+ T cells from Wiskott-Aldrich syndrome patients
exhibit severe defects in TH1 cytokine production in response to TCR stimulation, even
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after culture in a TH1 skewing environment (Trifari et al., 2006). These cells, as well as
CD4+ T cells from WASp-/- mice (Cannon and Burkhardt, 2004) exhibit defects in NFAT nuclear translocation and maintenance. This stands in contrast to T cells lacking
Vav1, which preferentially produce TH1-associated cytokines at the expense of TH2
cytokines (Tanaka et al., 2005). Disruption of the WAVE2 complex through loss of
Hem1 leads to normal IFNγ production, but substantially increased production of IL17
These varied effects underscore the complexity of the signaling pathways leading to
cytokine production and differentiation.
Ultimately, it will be important to test how well HS1-/- mice respond to immune
challenge using a variety of models. The original report describing the HS1-/- mice
demonstrated normal antibody responses to the T-dependent antigen NP-chicken
gammaglobulin, but slightly reduced responses to the T-independent antigen TNP-Ficoll
(Taniuchi et al., 1995). These experiments suggest that B cell function in vivo is not
grossly impaired. HS1-/- CD4+ T cells produce less IFNγ upon initial stimulation, and are
less likely to become IFNγ-producing TH1 effector cells, compared to WT CD4+ T cells.
Therefore, it will be interesting to test how well these mice respond to pathogens, such as
L. major, that require a robust TH1 response for clearance. The reduction in TH1 cells
accompanies an increase in the frequency of IL4-producing TH2 cells. This may result in
improved clearance of TH2 pathogens, but may also increase susceptibility to TH2mediated disease, such as allergy, asthma, and colitis. Therefore, testing reactions to
these conditions would also help determine if HS1 is a factor in these diseases. A role for
HS1 has not been described in other leukocytes. However, studies in progress in our lab
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suggest that antigen presentation by dendritic cells requires HS1. Thus, any in vivo
studies would require careful design and interpretation. These may involve use of
adoptive transfer experiments to generate and study mice that lack HS1 in specific cell
types.
The data presented here suggest that HS1 is dispensable for CTL killing. In
contrast, the Cooper lab has reported that human NK cell lines lacking HS1 fail to kill
target cells, likely due to defects in NK-target cell conjugate formation (Butler et al.,
2008). Although it is possible that the discrepancy between my data and those of the
Cooper lab are attributable to the species difference, it is more likely that they are due to
differences between the way T cells and NK cells employ the actin regulatory machinery.
Indeed, the Wülfing group has shown that mild disruption of actin dynamics using low
doses of jasplakinolide impairs the ability of NK cells, but not CTL, to kill target cells
(Wulfing et al., 2003). The reason for this apparent difference in sensitivity to actin
disruption between CTL and NK cells is unclear. The signals downstream of the TCR
may be more robust (i.e., less sensitive to mild perturbations) compared to those
downstream of NK cell activating receptors. These studies were conducted using highdose peptide for P14 TCR transgenic CTL or high dose anti-CD3 for polyclonal CTL.
Perhaps studies using lower dose or weaker agonists might uncover a situation in which
CTL are sensitive to mild disruptions of actin dynamics or loss of HS1.
My data suggest that HS1 is not required for T cell AICD. This stands in contrast
to the finding that HS1-deficient WEHI-231 cells (Fukuda et al., 1995) and peritoneal B
cells (Taniuchi et al., 1995) are resistant to AICD. The reason for the apparent difference
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between B and T cell requirements for HS1 in AICD is not known; however, in addition
to differences in the signaling pathways between the two cell types, it is possible that the
different experimental approaches contribute. The B cell experiments described by
(Taniuchi et al., 1995) were conducted in vivo, whereas my studies were conducted by in
vitro stimulation of CD4+ T cell blasts. Alternatively, HS1 may play a role in AICD only
at certain developmental stages. WEHI-231 cells are an immature B cell line,
representing a stage at which B cells undergo negative selection—strong signaling
through the B cell receptor induces apoptosis to eliminate autoreactive B cells. Similar to
this, HS1-/- mice exhibit a defect in negative selection of thymocytes in the HY TCR
transgenic system (Taniuchi et al., 1995). Together with data presented here, this
suggests that the role of HS1 in AICD is limited to its role in facilitating antigen receptor
signaling in developing lymphocytes.
Several studies have demonstrated that cortactin interacts with
components of the endocytic machinery, including Dynamin 2 and CD2AP, and have
shown a requirement for these interactions in endocytosis (Cao et al., 2003; Lynch et al.,
2003; McNiven et al., 2000; Sauvonnet et al., 2005). Moreover, preliminary data from
our laboratory have demonstrated a role for HS1 in receptor-mediated endocytosis in
dendritic cells (not shown). It was therefore surprising to find that T cells lacking HS1
downregulate surface TCR normally. These experiments were conducted on T cells
homozygous for the AND transgene. Therefore, it is possible that developmental
abnormalities resulting from premature TCR expression in developing thymocytes
compensate for the lack of HS1 in these cells. These studies should be repeated on T
136

cells hemizygous for the AND transgene, or on polyclonal T cells to rule out the
possibility that these data are artifactual.
Jurkat cells depleted of Dynamin 2 by RNAi internalize surface TCR normally
after antibody stimulation, in spite of a severe defect in antigen receptor-induced actin
polymerization at the IS. The authors suggest that a more physiological stimulus (i.e.,
peptide/MHC) might reveal a role for Dynamin 2 in TCR internalization (Gomez et al.,
2005). Together with my results, these data suggest that the endocytic machinery
responsible for downregulating surface TCR upon antigen encounter differs from the
cortactin/dynamin system found in other cell types.
Data presented here demonstrate that HS1 is not required for homing to lymphoid
organs (Figure 4.7). This is somewhat surprising, considering abundant data in nonhematopoietic cell types demonstrating that cortactin is important for regulating cell
migration (Huang et al., 2008; Lai et al., 2009; Patel et al., 1998; van Rossum et al.,
2006). Moreover, in NK cells, HS1 is required for efficient chemotaxis to SDF-1α, a
CXCR4 ligand, and for LFA1-mediated adhesion (Butler et al., 2008). More work is
necessary to determine whether HS1 is important for chemokine receptor or integrin
function in T cells.
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Chapter 5: Discussion

Summary
Regulation of cytoskeletal dynamics is a key component of T cell activation.
Early experiments showed that disruption of actin filaments using pharmacological
agents can severely impair several aspects of T cell function. This includes interaction
with APCs, early signaling events, cytokine production, and killing of target cells by
CTL. Mutation in actin regulatory proteins can result in disease, as highlighted by the
severe the immunodeficiency Wiskott-Aldrich syndrome. More recently, investigators
have begun to tease apart the role and regulation of the actin cytoskeleton in lymphocytes
by examining the contributions of individual actin regulatory proteins.
We have examined the role and regulation of HS1 in T cell activation, under the
hypothesis that efficient signal transduction downstream of the TCR would depend on
HS1. HS1 is a hematopoietic lineage-restricted protein that undergoes tyrosine
phosphorylation upon immunoreceptor ligation. It has been shown to regulate the actin
cytoskeleton through Arp2/3 complex. Our data show that HS1 is important for the
stabilization of F-actin-rich structures, and that it acts as an adaptor protein that can
interact with multiple signaling molecules upon T cell activation. HS1 interacts directly
with Vav1 and stabilizes it at the IS. HS1 recruitment to the IS depends on Itk, with
which it also interacts directly. We show that HS1-deficient T cells have defects in IL2
production stemming from inefficient Ca2+ responses. This is likely to be due to
regulation of PLCγ1 cytoskeletal association and microcluster dynamics by HS1.
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We have also examined the role of HS1 on other aspects of T cell function using
HS1-/- mice. Thymocyte development proceeds normally, and peripheral T cell
populations are grossly normal based on their expression of characteristic cell-surface
markers. HS1-/- CD8+ T cell function appears to be normal, but HS1-/- CD4+ T cells
exhibit defects in IFNγ production upon initial TCR stimulation, and are subsequently
less likely to become IFNγ-producing TH1 effector cells. Here, I discuss the overall
significance of these data and potential new avenues for research.

Why does T cell development proceed normally in the absence of HS1?
The loss of HS1 in mice does not result in any detectable perturbations in T cell
development or in peripheral populations (Chapter 4). Moreover, HS1-/- mice do not
develop any detectable autoimmune disease that would suggest significant defects in
negative selection. Developing thymocytes pass through several developmental
checkpoints that require TCR signaling, yet HS1 is seemingly dispensable for these
processes. Another actin regulatory protein that is essential for T cell activation, WASp,
also appears to be dispensable for thymocyte development (Snapper et al., 1998). It is
not known why these proteins, which are essential for efficient signaling in peripheral T
cells, are seemingly dispensable for thymocyte development. It may be that the signaling
pathways in mature T cells in which these proteins participate are different in developing
thymocytes.
In addition to differences in signaling pathways between mature and developing T
cells, compensatory mechanisms may be at play: one actin regulatory protein may offset
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the loss of another. It is possible that thymocytes express low levels of cortactin, which
might compensate for loss of HS1. However, we have not detected cortactin mRNA in
WT or HS1-/- T cells or in mouse thymus (Chapter 2 and (Gomez et al., 2006)).
Compensation between homologous proteins has been demonstrated for WASp.
Although mice lacking either WASp or N-WASp exhibit normal thymocyte
development, loss of both proteins results in severe defects in thymocyte development
and function (Cotta-de-Almeida et al., 2007). Compensation may also exist between
non-homologous proteins. It is possible that the activity of WASp masks a role for HS1
in thymocyte development, and vice-versa. To resolve these issues, it would be
necessary to generate HS1-/- x WASp-/- mice. It seems likely that such a model would
reveal cooperativity or compensation between the two proteins.
In chapter 3, I discuss a direct biochemical and functional interaction between
HS1 and Itk in the pathway leading to actin polymerization. This leads one to ask if
HS1-deficient T cells or mice resemble Itk-deficient T cells or mice in other respects. Itk
deficiency results in the abnormal development of memory-like CD8+ T cells in the
periphery and deficient CD8+ T cell responses (Atherly et al., 2006a; Atherly et al.,
2006b; Broussard et al., 2006; Hu et al., 2007). HS1 deficiency does not result in the
development of these abnormal cells (Chapter 4). Moreover, Itk is required for efficient
TH2 responses (Fowell et al., 1999; Miller et al., 2004), whereas HS1 is required for
efficient TH1-associated cytokine production (Chapter 4). These results highlight the
complexity of T cell signaling pathways. Although we can detect a constitutive
interaction between HS1 and Itk in T cell blasts, the phenotypic differences between
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HS1-/- and Itk-/- mice and T cells make it clear that they participate in different aspects of
T cell function.

How does HS1 influence helper T cell differentiation?
We have found that HS1-/- T cells produce reduced amounts of IFNγ, and
subsequently are less likely to become TH1 effector cells, compared to WT T cells
(Chapter 4). Signals that induce potent Ca2+ responses favor differentiation to TH1 cells,
whereas signals associated with weak Ca2+ responses, such as altered peptide ligands or
low peptide dose, tend to favor the development of TH2 cells (Constant et al., 1995;
Pfeiffer et al., 1995). Moreover, prolonged NF-AT activity has been associated with
increased IFN-γ production and a concomitant decrease in IL4 production (Porter and
Clipstone, 2002). Thus, by promoting increased Ca2+ flux responses (Chapter 2 and
Chapter 3) and therefore sustained NF-AT activity, HS1 may influence IFNγ production,
and thus helper T cell differentiation. Thus, in this context, HS1 may function, at least in
part, by modulating signal strength. Although this work has not addressed whether the
effect of HS1 on IFNγ production and helper T cell differentiation involves its role in
regulating actin dynamics, this seems likely to be the case. Disruption of actin dynamics
using cytochalasin D results in decreased IFNγ production. The effect is most
pronounced when the drug is added 10-60 minutes after APC encounter and is
substantially blunted when added later (Valitutti et al., 1995).
Our work with Vav1 (Chapter 2) and PLCγ1 (Chapter 3) shows that HS1 is
important for the organization of signaling molecules at the IS downstream of TCR
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engagement. In Chapter 4, I show that HS1 is required for the efficient development of
IFNγ-producing TH1 cells. Work from the Glimcher group has demonstrated a
correlation between cytokine receptor localization to the IS and helper T cell
differentiation (Maldonado et al., 2004). The IFNγ receptor, but not the IL4 receptor,
localizes to the IS upon TCR engagement. The IFNγ receptor is more likely to
redistribute to the IS in T cells isolated from TH1-prone C57Bl/6 mice than in T cells
from TH2-prone BALB/c mice. Moreover, this process is can be inhibited by the addition
of IL4. More recent work from this group has extended these findings to signaling events
downstream of the IFNγ receptor: STAT1 localization mirrors that of IFNγ receptor and
IL4 signaling impairs this process (Maldonado et al., 2009). The signaling and cell
biological mechanisms that control IFNγ receptor redistribution have not been elucidated.
However, it is conceivable that actin-dependent processes regulate the localization of
cytokine receptors and downstream signaling molecules. Although a decrease in IFNγ
production associated with loss of HS1 is likely to contribute to the observed reduction in
the development of IFNγ producing effector cells, abnormal IFNγ receptor redistribution
may also play a role.
IFNγ is preferentially secreted into the immunological synapse, whereas IL4
secretion appears to be multidirectional (Huse et al., 2006). The mechanisms controlling
cytokine secretion are not well understood. However, actin-dependent processes may
contribute to these events: WASp is required for IFNγ secretion, but not for its production
(Morales-Tirado et al., 2004). This suggests that a defect in secretion of IFNγ by freshly
isolated HS1-/- T cells may underlie the phenotype observed by ELISA (Chapter 4). It
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should be noted that this hypothesis is not mutually exclusive with the idea that HS1
regulates IFNγ at the level of promoter activation.

Is there a role for HS1 in endocytosis?
We have found that HS1 is dispensable for TCR internalization following APC
encounter (Chapter 4). It has been shown that TCRs are internalized via clathrin-coated
vesicles (Boyer et al., 1991; Telerman et al., 1987). This involves the phosphorylation of
clathrin heavy chain (Crotzer et al., 2004), a process implicated in clathrin-mediated
endocytosis (Stoddart et al., 2002; Wilde et al., 1999). T cells lacking CD2ap, a
component of the endocytic machinery, exhibit substantial defects in TCR internalization
(Lee et al., 2003). In contrast, Jurkat cells suppressed for Dynamin 2, another component
of the endocytic machinery, downregulate surface TCR normally (Gomez et al., 2005).
Cortactin has been shown to interact with these components of the endocytic machinery
and to be required for efficient endocytosis (Cao et al., 2003; Lynch et al., 2003;
McNiven et al., 2000; Sauvonnet et al., 2005). Moreover, preliminary data from our lab
has demonstrated a requirement for HS1 in receptor-mediated endocytosis in dendritic
cells (not shown). It is therefore surprising that HS1 is not required for TCR
internalization. It may be that a protein other than HS1 fulfills the role of cortactin in
endocytosis in T cells.
Even if it is dispensable for TCR endocytosis, HS1 may play a role in the
internalization of other surface receptors, e.g., the IL2 receptor. In a system involving
ectopic expression of the β chain of the IL2 receptor (IL2Rβ, CD122) in an epithelial cell
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line, it was found that cortactin, together with dynamin, is required for IL2Rβ
internalization in a clathrin-independent manner (Grassart et al., 2008). The same group
also found that endocytosis of the common gamma chain (γc), a component of the IL2,
IL4, IL7, IL9, IL15, and IL21 receptors, requires cortactin (Sauvonnet et al., 2005).
Because these studies were conducted in a cell line that does not normally express these
receptors, it would be necessary to validate these results in a more physiologically
relevant system, and to determine if HS1 plays a similar role.

Why is CTL function independent of HS1?
Given the role of HS1 in efficient IFNγ production in CD4+ T cells, it is striking
that HS1 is not required for production of IFNγ in CD8+ T cells. Similarly, considering
work showing a requirement for actin in cytotoxicity (Cerottini and Brunner, 1972;
O'Rourke et al., 1991; Plaut et al., 1973; Wulfing et al., 2003), it is surprising that HS1-/CTL kill target cells efficiently (Chapter 4). In CD4+ T cells, IFNγ production and
differentiation to the TH1 lineage, as well as killing by NK cells, depend on the
transcription factor T-bet (Mullen et al., 2001; Szabo et al., 2002). In contrast, IFNγ
production and killing by CD8+ T cells instead relies on the related transcription factor
Eomesodermin (Pearce et al., 2003). Given that I find a defect in IFNγ production only
in CD4+ T cells and no defect in killing by HS1-/- CD8+ T cells, it is possible that HS1
may be required for the induction of T-bet but not Eomesodermin. No role for HS1 in
cytokine production by NK cells has been described.
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Pharmacological studies have demonstrated that the actin cytoskeleton is
important for cytotoxicity (Cerottini and Brunner, 1972; O'Rourke et al., 1991; Plaut et
al., 1973; Wulfing et al., 2003). However, in these studies, inhibition of CTL-mediated
killing required relatively high drug doses. Interestingly, Wülfing et al. showed that
killing by NK cells, but not by CD8+ T cells, is sensitive to low doses of jasplakinolide, a
drug that stabilizes branched actin filaments (Wulfing et al., 2003). Our data show that
HS1 is not absolutely required for actin polymerization in T cells, and instead primarily
functions to stabilize existing F-actin (Chapter 2). HS1 deficiency results in defects in
cytotoxicity in NK cells (Butler et al., 2008). Moreover, while NK cells from WAS
patients exhibit clear defects in cytotoxicity (Orange et al., 2002), no such defect has
been reported for CTL. No clear explanation has arisen for this difference between T
cells and NK cells. While our data suggest that HS1 deficiency results in unstable
immunological synapses, it has been shown that CTL can kill efficiently even in the
absence of a stable IS (Purbhoo et al., 2004). While IS organization may be important for
signaling events, taken together, all these studies point to fundamental differences in the
cell biology of CTL and NK cell killing. This is an area that warrants future study.

Is there a role in T cells for HS1 in integrin or chemokine receptor
function?
In addition to describing a role in NK cell-mediated cytotoxicity, the Cooper lab
study has implicated HS1 in NK cell adhesion and migration processes (Butler et al.,
2008). This study showed that HS1-deficient NK cells exhibit defects in adhesion to
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target cells and in migration to CXCL12 (SDF1α), a CXCR4 ligand. Moreover, several
studies have implicated cortactin in migration of non-hematopoietic cells (Bryce et al.,
2005; Huang et al., 1998; Kowalski et al., 2005; van Rossum et al., 2006). Our
laboratory has also shown that the tyrosine kinase c-Abl, which can interact with HS1 in
T cells, is required for chemokine-induced migration (Huang et al., 2008). In contrast to
these results, data presented in Chapter 4 indicate that HS1 is not required for homing of
T cells to lymphoid organs. Moreover, although we have not conducted a systematic
analysis of adhesion responses in HS1-deficient T cells, we have never detected a
requirement for HS1 in T cell adhesion to APCs (not shown).
Homing of naïve T cells to lymph nodes depends on CD62L (L-selectin), the
chemokine receptors CCR7 and possibly CXCR4, and LFA-1 (αLβ2) and α4β7 integrins
(Bradley et al., 1994; Forster et al., 2008; Marelli-Berg et al., 2008). The signaling
pathways downstream of chemokine receptors are poorly understood, although CXCL12
binding to CXCR4 induces tyrosine phosphorylation of cortactin (Luo et al., 2006).
It is therefore surprising that HS1 does not appear to be required for naïve T cell
migration through lymphoid tissues. In addition to using NK cells, the Cooper lab studies
were conducted in vitro, which contrasts with the in vivo studies presented here.
Differences in cell type and experimental methodology, as well as the developmental
stage of the cells used, may account for some of these discrepancies. Effector T cells use
a different set of chemokine receptors to enter sites of inflammation (Marelli-Berg et al.,
2008), and HS1 may function specifically in this context. It will therefore be important
to test the role of HS1 in migration to sites of inflammation.
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How is HS1 function regulated downstream of TCR engagement?
One of the first identified features of HS1 was its prominent tyrosine
phosphorylation upon antigen receptor engagement (Hata et al., 1994; Takemoto et al.,
1995; Yamanashi et al., 1993). We have shown that HS1 is phosphorylated in Jurkat
cells at Tyr 378 and Tyr 397, most likely by ZAP-70 (Chapter 2 and (Gomez et al.,
2006)). Mutation of these sites prevents Itk-dependent recruitment of HS1 to the IS and
prevents HS1-dependent downstream signaling (Chapters 2 and 3). Because these
tyrosines mediate binding to a host of signaling molecules, it seems unlikely that
defective Itk-dependent IS recruitment is the sole cause of the signaling defects in cells
expressing a variant of HS1 with TyrPhe mutations at these sites.
High-resolution video microscopy studies have demonstrated that signaling
molecules are rapidly recruited to microclusters at sites of TCR engagement (Bunnell et
al., 2002; Bunnell et al., 2006; Yokosuka et al., 2005). The cell spreading process that
accompanies T cell activation, as well assembly of these signaling microclusters, are
actin-dependent processes (Bunnell et al., 2001; Campi et al., 2005). WASp has been
shown to localize initially to signaling microclusters, then to actin-rich sites (Barda-Saad
et al., 2005). It seems likely that HS1 would follow a similar pattern, being initially
recruited to signaling microclusters where it would undergo ZAP-70-dependent tyrosine
phosphorylation. It would then redistribute to the periphery. Although we can detect
some puncta suggestive of signaling microclusters at very early time-points, our data
suggest that HS1 is primarily situated at the cell periphery in a pattern similar to that of
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actin (Chapter 2). It is possible that HS1 is transiently recruited to these clusters before
rapid redistribution, and that we have not detected these events in our experiments.

How does actin binding of HS1 influence its function?
Disease-associated variants provide particularly appealing tools to probe protein
function, in that they are demonstrably physiologically relevant. A striking example is
the discovery of mutations in WASp as the cause of Wiskott-Aldrich syndrome (Derry et
al., 1994). Mutations in HS1, however, appear instead to contribute to a genetically
complex disease, SLE. Although the individual contributions of the disease-associated
variants, HS1HTH2.5 or HS1EP8, to SLE are likely to be small, and HS1 must interact with
other risk factors to cause disease, these variants identify physiologically important
features of these proteins. In this instance, the loss of an actin-binding repeat has
provided us with a tool to assess the importance of actin binding in the regulation and
function of HS1.
In preliminary studies, we have compared the function of a disease-associated
actin-binding mutant, HS1HTH2.5, with the more common variant, HS1EP6. In a B cell
AICD assay, HS1HTH2.5 signals more efficiently than HS1EP6 (Sawabe et al., 2003).
Efficient F-actin binding by HS1 is required for efficient activation Arp2/3 complex and
intact actin responses at the IS (Chapter 2). It is not clear from these studies whether the
primary effect is on Arp2/3 complex activation, on the stability of actin branches, or is a
combination of both. Moreover, the observed defect may reflect changes in the
localization of HS1. We have not examined the effect of the HTH2.5 mutation on HS1
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localization. However, cortactin requires the presence of the fourth HTH repeat for both
actin binding and localization to the cell cortex (Weed et al., 2000), so it is anticipated
that HS1HTH2.5 will exhibit defects in localization to the IS. Proper interpretation of these
data will require analysis of the half-life of branched actin filaments in vitro and kinetic
analyses of actin polymerization and HS1 recruitment to the IS. These studies are
currently underway. As HS1 deficiency also results in defects in Ca2+ flux and IL2
production, it will be interesting to examine the role of HS1 actin binding on TCR
signaling.
Mutations in the HTH repeat region may not only directly affect actin binding, but
may also have larger-scale effects on the structure of HS1. A structure for cortactin has
been proposed in which the SH3 domain lies close to the HTH repeat region (Cowieson
et al., 2008). If this structure also applies to HS1 and represents a closed, inactive form
of the molecule, loss of one HTH repeat may alter the overall structure to a more open
structure. In this model, the C-terminus, including Tyr 378 and 397 as well as the SH3
domain, is more exposed to potential binding partners. HS1HTH2.5 was originally
discovered in a SLE patient (Sawabe et al., 2003). It has not been determined how this
mutant influences disease, or even in which cell type it is relevant. However, if this
mutation alters the structure of HS1 as proposed, then signaling might occur more
efficiently.
An allelic variant of HS1 containing eight glutamic acid-proline repeats, HS1EP8,
(Figure 1.4) instead of the more common six is more common in SLE patients than in
healthy controls; this variant has been shown to have functional consequences for BCR
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signaling that are similar to the HTH2.5 variant (Otsuka et al., 2004). These repeats lie
four amino acids N-terminal to Tyr 378, a known phosphorylation site. Moreover, HS1
can be serine/threonine phosphorylated (Ruzzene et al., 2000) and contains a consensus
MAP kinase recognition site at Thr 352 (Takemoto et al., 1995). MAP kinase-mediated
phosphorylation of cortactin at Ser 405/418 can potentiate its ability to activate Arp2/3
complex, implying that this phosphorylation event induces a conformational change
(Martinez-Quiles et al., 2004). The EP8 insertion may alter the structure of HS1 towards
a more open conformation, due to either the negative charge of the insertion, which may
be phospho-memetic, or to a simple increase in the overall length.

How does HS1 integrate with other components of the T cell actin
regulatory machinery?
HS1 is required for to stabilize F-actin at the immunological synapse (Chapter 2).
This results in the formation of unstable lamellipodial protrusions, and may explain the
defects observed in Vav1 (Chapter 2) localization and PLCγ1 microcluster dynamics in
HS1-deficient cells (Chapter 3). Although HS1 is capable of stimulating Arp2/3
complex-mediated actin branching, its activity in this regard is weaker than that of
cortactin and the WASp VCA fragment (Uruno et al., 2001; Uruno et al., 2003b).
Instead, HS1 extends the half-life of existing branched actin filaments, in agreement with
apparent instability of F-actin structures that we have observed in T cells.
Itk is also required for actin responses in T cells and for Vav1 localization at the
IS (Dombroski et al., 2005; Grasis et al., 2003; Labno et al., 2003). We now find that the
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spreading defects in Itk-deficient cells resemble those of HS1-deficient cells, and that Itk
is required for recruitment of HS1 to the IS (Chapter 3). Because Itk lacks a region that
can directly interact with the actin cytoskeleton, the mechanism by which it regulates
actin dynamics has been unclear. These data now establish HS1 as an effector of Itk in
regulating actin dynamics. Itk is recruited to the plasma membrane via an interaction
between its PH domain and PtIns(3,4,5)P3 (August et al., 1997). In this model (Figure
5.1), TCR engagement leads to HS1 phosphorylation and binding to the SH2 domain of
Itk. Localization at the IS allows HS1 to cross-link existing branched actin filaments, as
well as to participate in the activation of Arp2/3 complex either through its own activity,
or through interaction with other NPFs such as WASp. This also allows for the
stabilization of Vav1 at the IS, where it can activate Cdc42 and Rac. This would in turn
generate localized pools of Cdc42-GTP and Rac-GTP, which can activate WASp (Kim et
al., 2000) or recruit WAVE2 (Steffen et al., 2004), respectively. Our laboratory has
previously shown that Itk and Slp76 are required for the recruitment and localized
activation of Vav1 (Dombroski et al., 2005; Labno et al., 2003; Zeng et al., 2003). Our
data now establish HS1 as an additional player in this complex. Recruitment of Vav1 to
the IS depends on the coordinate activity of these molecules. This is a complex process,
and each protein to some extent probably plays a unique role. HS1 mostly likely
functions to stabilize Vav1 and other signaling molecules such as PLCγ1, discussed
below, at the IS by linking signaling complexes to the actin cytoskeleton. In the absence
of Itk, HS1 is not recruited to the IS and to signaling complexes, and therefore cannot
carry out this function. This would result in a loss of localized WASp activity,
151

potentially leading to more severe defects. Neither HS1 nor WASp is absolutely required
for actin polymerization at the IS (see Chapter 2 and (Gomez et al., 2006) for HS1, and
(Cannon and Burkhardt, 2004; Nolz et al., 2006) for WASp). In this respect, it would be
interesting to test actin responses in cells lacking HS1 and WASp to probe for a
compound phenotype. It is worth noting that WAVE2-deficient cells exhibit actin
defects much more severe than cells lacking HS1, WASp, or Itk (Nolz et al., 2006).
Therefore, it is likely that WAVE2 functions either independently of the pathways
described here, or that other proteins, perhaps other Vav isoforms, can compensate for
perturbations in this pathway.
Coronins are a set of poorly-understood F-actin-binding proteins that appear to
function by inhibiting Arp2/3 complex-dependent nucleation (Humphries et al., 2002).
Coronin1 deficiency results in increased F-actin content in resting as well as activated T
cells (Foger et al., 2006; Mueller et al., 2008; Mugnier et al., 2008). In particular, upon
APC encounter, the duration as well as the amount of F-actin at the IS in Coronindeficient cells is increased. This is almost the opposite phenotype of HS1-deficient cells.
It has been proposed that Coronin1 and cortactin antagonize one another in regulating
lamellipodial actin dynamics (Cai et al., 2008). Loss of both proteins results in
comparatively normal actin dynamics in HEK (human embryonic kidney) 293 cells.
These two proteins localize at the leading edge, although cortactin lies somewhat farther
from the periphery than cortactin. In T cells, HS1 and Coronin1 may exhibit a similar
relationship. Although we have not attempted to colocalize these proteins in spreading T
cells, the same may apply to HS1 and Coronin1. During the spreading process, HS1 is
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responsible for stabilizing existing branched actin filaments at the leading edge.
Coronin1, localized more towards the center, might disassemble branches, recycling actin
monomers and Arp2/3 complex. Working together, these two proteins might regulate
actin dynamics by controlling branch assembly and disassembly at specific locations
within the cell.

What is the role of actin in Ca2+ signaling?
In Chapter 2 and Chapter 3, I show that HS1 is an important component of the
signaling pathway leading to Ca2+ responses downstream of TCR engagement. As of this
writing, no studies have been published on the regulation of Ca2+ signaling by cortactin,
the non-hematopoietic homolog of HS1. Ca2+ flux responses in T cells consist of two
phases. In the initial phase, endoplasmic reticulum stores are depleted, leading to the
second phase, entry of Ca2+ from the extracellular milieu. Store depletion is initiated
through the action of PLCγ isoforms (predominantly PLCγ1 in T cells (Ting et al.,
1992)), which generate Ins(1,4,5)P3 and DAG by hydrolyzing the membrane lipid
PtIns(4,5)P2 (Majerus et al., 1986; Rhee, 2001; Singer et al., 1997).
There is a precedent for phosphorylation-independent regulation of PLCγ1
activity by actin regulatory proteins. T cells lacking Coronin1 have also been shown to
exhibit defects in Ca2+ store release as a consequence of reduced Ins(1,4,5)P3 production,
yet these cells do not have gross defects in PLCγ1 phosphorylation at the activating
tyrosines (Mueller et al., 2008). PLCγ1 microcluster dynamics have not been examined
in Coronin1-deficient cells.
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Figure 5.1: Itk-mediated recruitment of HS1 to the IS activates actin regulatory
pathways.
TCR engagement leads to phosphorylation of HS1 (1). This allows Itk, which
interacts with PtIns(3,4,5)P3 (PIP3, in this figure) at the plasma membrane, to
bind via its SH2 domain, enabling recruitment of HS1 to the IS (2). Once at
the IS, HS1 can bind to and activate Arp2/3 complex, and stabilize branched
actin filaments (3). HS1 also stabilizes Vav1 at the IS, leading to localized
activation of Cdc42 and Rac1 and subsequent actin polymerization by WASp
and WAVE2 (4).
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It has been shown that Coronin1 and cortactin antagonize one another in
regulating actin dynamics (Cai et al., 2008). If the same is true for Coronin1 and HS1,
then the Ca2+ defects in HS1-deficient cells may be rescued by deletion of Coronin1 in
those cells. Several groups have identified links between PLCγ isoforms and the actin
cytoskeleton (Bar-Sagi et al., 1993; Dearden-Badet and Mouchiroud, 2005; Nojiri and
Hoek, 2000; Payrastre et al., 1991; Yang et al., 1994). Together with the work presented
here, these findings suggest that PLCγ1 function depends on intact actin dynamics. I
propose that HS1 functions to stabilize PLCγ1 at the membrane, near its substrate, by
tethering active PLCγ1 molecules to the actin cytoskeleton (Figure 5.2). This may be a
general mechanism by which HS1 facilitates signaling. However, the mechanisms by
which the actin cytoskeleton influences Ca2+ responses in T cells are complex, as
discussed later in this section.
It is possible that PLCγ1 microclusters in HS1-deficient cells exhibit increased,
albeit disordered mobility, due to loss of interactions with actin scaffolds. However, our
experimental system, confocal microscopy imaging of cells expressing conventional
YFP-tagged signaling molecules, does not permit single-molecule tracking, precluding
direct testing of this hypothesis. Increased, disordered PLCγ1 mobility may prevent
sufficiently stable interactions with its membrane-bound substrate to promote efficient
Ins(1,4,5)P3 production.
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Figure 5.2: Model for HS1-mediated facilitation of PLCγ1 signaling
Phosphorylation of HS1 at Tyr 378 and Tyr 397 allows PLCγ1 to bind via its Cterminal SH2 domain. This interaction links PLCγ1 to actin scaffolds, restricting it
near the membrane and facilitating interactions with the substrate, PtIns(4,5)P2 (PIP2
in this figure).
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In addition to acting as an adaptor protein linking PLCγ1 to the actin
cytoskeleton, HS1 is also likely to be a component of larger scale signaling complexes.
This is highlighted by our finding that phosphorylated HS1 can interact with a host of
SH2 domain-containing proteins (Chapter 2). Loss of one component or uncoupling of
the signalosome from the actin cytoskeleton may destabilize these macromolecular
complexes (Bunnell et al., 2006), which may in turn impair PLCγ1 signaling. In support
of this idea, low-dose Latrunculin B treatment of epithelial cells leads to severely reduced
Ins(1,4,5)P3 production (Suzuki et al., 2007). In this study, disruption of the actin
cytoskeleton led to altered cell-surface receptor dynamics. This, in turn, reduced the
specific, localized activation of PLCγ. There is evidence that the TCR, the relevant cellsurface receptor in T cells, interacts with the actin cytoskeleton (Rozdzial et al., 1995).
We have not studied the effect of HS1 deficiency on TCR microcluster dynamics, but it
may be that, in addition to regulating PLCγ1 microcluster dynamics, HS1 may affect
TCR microclusters.
To more fully understand the roles that HS1 and other actin regulatory proteins
play in microcluster dynamics would require a different experimental approach. Our
current assay system, stimulation of cells on glass coverslips coated with anti-CD3,
allows the formation of signaling microclusters, but in many instances they remain
stationary rather than moving to a c-SMAC structure; a notable exception is Slp76
(Bunnell et al., 2002). This is probably because the activating ligand is immobilized on a
glass substrate. The most physiologically relevant system would be to image
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microcluster dynamics in T cells responding to APCs presenting peptides, which requires
imaging over the Z-axis. However, due to the poor spatial and temporal resolution of
three-dimensional images reconstructed from multiple sequentially imaged planes, it is
necessary to employ a system in which the events of interest occur in the X-Y plane
(Bunnell et al., 2003). The planar lipid bilayer system, notably employed by Dustin and
coworkers, in which peptide-MHC complexes are incorporated and are free to diffuse
laterally, is more amenable to the study of microcluster movement. In addition, this
system employs a physiological ligand. However, it remains highly artificial in that it
does not account for contributions from the cytoskeleton of the APC. Cytoskeletal
rearrangements in dendritic cells are important for T cell activation (Al-Alwan et al.,
2001a, b). The use of artificial “molecular mazes” in the lipid bilayer system to restrict
the movement of peptide-MHC complexes (and other embedded molecules) may allow
this system to more closely resemble a dendritic cell (Mossman et al., 2005).
Nonetheless, it would be illuminating to examine the effect of HS1 deficiency on Slp76
microcluster dynamics (movement, lifetime, localization, and size), even with our current
system. However, the lipid bilayer system with or without artificial barriers, particularly
when employed with high-resolution TIRF (total internal reflection microscopy) imaging,
may enable more elaborate and physiologically relevant analysis of the role of HS1 in
microcluster assembly.
Ins(1,4,5)P3 binding to its receptors on ER membranes induces store release. This
is a highly cooperative process requiring the binding of three to four Ins(1,4,5)P3
molecules (Marchant and Taylor, 1997; Meyer et al., 1988). This cooperativity has been
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proposed to be a safeguard against spontaneous activation (Marchant and Taylor, 1997),
but also implies that small, localized changes in PLCγ activity can lead to relatively large
changes in the magnitude of store release.
Although it remains possible that HS1 influences store release independently of
PLCγ1, this seems unlikely. We have shown that HS1 interacts with PLCγ1 in a
phosphorylation-dependent manner (Chapter 2), and that HS1 deficiency results in
abnormal PLCγ1 microcluster dynamics (Chapter 3). To further support the hypothesis
that HS1 influences PLCγ1 activity would require direct measurement of PLCγ1mediated Ins(1,4,5)P3 production. This could be accomplished by measuring Ins(1,4,5)P3
levels in lysates from WT or HS1-/- T cells. These assays are notoriously difficult, and
although we could detect significant defects in Ins(1,4,5)P3 production in HS1-/- T cells,
these findings were not reproducible (not shown). Alternatively, a FRET (Förster
resonance energy transfer)-based Ins(1,4,5)P3 biosensor would permit assessment of
Ins(1,4,5)P3 levels in living cells (Remus et al., 2006). This system exploits the
conformational change induced in the Ins(1,4,5)P3 receptor upon ligand binding. These
assays are appealing in that they enable analysis at the single-cell level over time,
allowing one to gather information about variability within a population. Moreover,
FRET-based assays can be read with flow cytometer, which would enable bulk
measurement of Ins(1,4,5)P3 production in complex populations, as has been done for
protein phosphorylation (Krutzik et al., 2005a; Krutzik et al., 2005b). More relevant to
the questions at hand, using a microscope would enable direct correlation of Ins(1,4,5)P3
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production with other parameters of T cell activation such as microcluster assembly and
movement.
Other actin regulatory proteins also regulate Ca2+ flux responses downstream of
TCR engagement, although they do so through a variety of mechanisms. The large
GTPase Dynamin 2 is required for Ca2+ flux responses at the level of PLCγ1
phosphorylation (Gomez et al., 2005). Although total PLCγ1 phosphorylation is intact in
Vav1-deficient Jurkat line J.Vav1 (Cao et al., 2002), Vav1-/- T cells also exhibit defects in
PLCγ1 Tyr 783 phosphorylation (Reynolds et al., 2002). In contrast, WAVE2 is not
required for PLCγ1 phosphorylation or release of Ca2+ from intracellular stores, but
instead regulates Ca2+ entry from the extracellular environment (Nolz et al., 2006).
WASp-/- T cells fail to sustain elevated levels of cytoplasmic Ca2+ (Zhang et al., 1999)
and consequently have defects in NF-AT nuclear translocation (Cannon and Burkhardt,
2004), although the reason for this is unknown as of this writing. Interestingly, Jurkat
cells suppressed for Arp2/3 complex expression, which respond to TCR engagement by
generating actin-rich filopodia, have normal Ca2+ flux responses (Gomez et al., 2007).
These varied findings indicate that regulation of Ca2+ by actin regulatory proteins such as
HS1 is not merely through the organization of actin dynamics at the IS. Rather, it is
likely that these proteins function as adaptors, linking signaling molecules, such as
PLCγ1, to cytoskeletal scaffolds. Our finding that PLCγ1 localizes poorly to F-actin-rich
fractions in HS1-/- cells supports this hypothesis (Chapter 3). Moreover, HS1-deficient
Jurkat cells exhibit abnormal PLCγ1 microcluster dynamics (Chapter 3).
Pharmacological disruption of actin dynamics has shown that microcluster assembly at
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the p-SMAC, where active signaling is thought to occur, requires an intact actin
cytoskeleton (Campi et al., 2005).
In some instances, disruption of the actin cytoskeleton can lead to increased Ca2+
flux responses or Ins(1,4,5)P3 production (DeBell et al., 1992; Rivas et al., 2004; Valitutti
et al., 1995). I have, under certain conditions, noted increased IL2 production from HS1/-

T cells relative to controls (not shown); even in these conditions, HS1-/- T cells exhibit a

defect in actin polymerization at the IS. It is difficult to reconcile these findings with the
model in which intact cytoskeletal dynamics are important for signaling microcluster
assembly. However, this may reflect the fact that the actin cytoskeleton is also important
for movement of existing microclusters from the p-SMAC to the c-SMAC, where signal
downregulation occurs (Varma et al., 2006).
Using our conjugate assay system, we have shown that HS1 is required for the
stability of F-actin and of two signaling molecules, Vav1 and PLCγ1, at the
immunological synapse (Chapter 2 and Chapter 3). However, gross IS localization of
these molecules is normal at early time points, during which the bulk of TCR-proximal
signaling occurs. TCR-proximal signaling must proceed for hours for productive T cell
activation to occur. Interruption of TCR engagement, even hours after APC encounter,
impairs productive T cell activation (Huppa et al., 2003). Similarly, pharmacological
inhibition of ZAP-70 kinase activity blocks Ca2+ signaling, even when the inhibitor is
introduced after signaling has been initiated (Levin et al., 2008). Based on these findings,
it is likely that the effects of HS1 on long-term Vav1 and PLCγ1 localization to the IS are
physiologically important, even though these signaling molecules are associated with
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very early TCR signaling events. I have discussed above a model whereby HS1
functions to facilitate Ca2+ signaling by tethering PLCγ1 molecules to the actin
cytoskeleton (Figure 5.2). This is likely to be a general mechanism by which HS1
interacts with and regulates other components of the T cell signaling machinery.

Is there a role for HS1 in other signaling events?
PLCγ activity leads to the production of diacylglycerol in addition to Ins(1,4,5)P3.
DAG activates the Erk signaling cascade, which in turn activates the AP-1 transcription
factor, a component of the IL2 promoter (Smith-Garvin et al., 2009; Zhang and Dong,
2005). Although HS1 appears to be required for PLCγ1 activity, we have thus far found
no defects in Erk phosphorylation or in AP-1 transcriptional activity in a luciferase
reporter assay. The reason for this discrepancy is unknown.
HS1, through its proline-rich region, constitutively interacts with the SH3 domain
of Lck (Takemoto et al., 1995). In addition, phosphorylation of HS1 creates binding sites
for the SH2 domain of Lck (Chapter 2 and (Gomez et al., 2006)). As discussed in
Chapter 1, this may represent a mechanism that allows Lck to phosphorylate HS1 at other
sites, such as Tyr 222, a site identified in vitro (Brunati et al., 1999) and in platelets
(Brunati et al., 2005). Using mass spectrometry, we did not detect, but cannot rule out,
phosphorylation at this site. Another implication for this interaction is that HS1 binding
may regulate Lck kinase activity. Proteins that interact in this way with kinases have
been shown to promote tyrosine kinase activity by stabilizing the open, active
conformation of the enzyme. This has been proposed both for the interaction between
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Lck and Unc119, a poorly understood T cell signaling molecule, (Gorska et al., 2004) and
for the interaction between Itk and Slp76 (Bogin et al., 2007). Lck is a crucial signaling
molecule that is positioned at the earliest stage of the TCR signaling cascade and is
required for HS1 tyrosine phosphorylation (Chapter 2 and (Gomez et al., 2006)). HS1deficiency results in much milder signaling defects than Lck deficiency (Palacios and
Weiss, 2004), and many tyrosine phosphorylation events are grossly intact. Therefore,
HS1 cannot be absolutely required for Lck function. Instead, if HS1 binding enhances
Lck kinase activity, it may serve to promote long-term signaling. It would be interesting
to test the ability of HS1 to regulate kinase activity using in vitro kinase assays with
purified proteins as well as with Lck immunoprecipitated from WT or HS1-deficient T
cells. Unc119 has also been shown to be important for Lck trafficking, an actindependent process (Gorska et al., 2009). Disruption of actin dynamics through loss of
HS1 may impair Lck trafficking. However, this would have to be a partial defect,
because signaling is not completely blocked in HS1-deficient cells.

Concluding Comments
This work has demonstrated a role for HS1 in T cell function. We have shown
that HS1 contains two tyrosines that are phosphorylated upon TCR engagement and
mediate interactions with several molecules involved in TCR signaling. We showed that
the interaction via these tyrosines with Itk is required for HS1 recruitment to the IS,
where HS1 can stabilize actin filaments. These sites mediate an interaction with Vav1,
and stabilize it at the IS, which may represent an additional mechanism by which HS1
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regulates cytoskeletal dynamics. We showed that HS1 is required for release of Ca2+
from intracellular stores, likely due to a regulation of PLCγ1 dynamics by HS1. This
study represents one of the first analyses of the regulation of signaling microclusters by a
specific actin regulatory protein. Our studies of the HS1 knockout mouse demonstrated a
role for HS1 in IFNγ production by CD4+ T cells. However, it was surprising to find that
several aspects of T cell function, including CTL-mediated killing and cytokine
production, TCR endocytosis, and migration, were unaffected by the loss of HS1.
Several open questions remain, as described in this chapter.
Studies using actin depolymerizing agents have demonstrated that intact actin
dynamics are required for T cell function. In spite of this, this work has shown that HS1
deficiency does not result in severe signaling or functional defects. It seems likely that at
least part of the reason for this is that other actin regulatory proteins, even nonhomologous ones such as WASp, may play compensatory roles. However, it is also
likely that each of these proteins plays selective roles within the context of T cell
signaling. The challenge now is to probe for functional interactions among these
molecules.
In vivo studies may ultimately provide insight into a potential role for HS1 in
human disease. Many human diseases are genetically complex, involving contributions
from multiple genetic polymorphisms that individually may be benign. A notable
example of this is systemic lupus erythematosus (Moser et al., 2009). Already, two
studies have linked polymorphisms in HS1 with SLE (Otsuka et al., 2004; Sawabe et al.,
2003). Interestingly, a recent study has linked Coronin1 deficiency to SLE resistance in
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mice (Haraldsson et al., 2008). Although the mechanism of action of HS1 in this disease
is unknown, these studies establish a role for HS1 in disease. A more comprehensive
genetic screen of patient samples (SLE and others) is likely to uncover additional
associations. Ultimately, detailed study of disease-associated polymorphisms may
require generation of “knock-in” mouse models expressing the genetic change in
question.
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Chapter 6: Materials and Methods

Reagents and Antibodies
All reagents are from Sigma unless otherwise specified. Antibodies against PLCγ1, Vav1,
Lck and ZAP-70 have been previously described (Billadeau et al., 2000; Karnitz et al.,
1992; Ting et al., 1992; Williams et al., 1998). Anti-human HS1, anti-mouse HS1, and
anti-WIP were obtained by immunization of rabbits with a GST-fusion protein containing
AA330-407 of human HS1, a GST-fusion protein containing AA226-351 of mouse HS1,
or a KLH-conjugated synthetic peptide corresponding to AA468-494 of human WIP
(Cocalico Biologicals). Rabbit anti-PLCγ1 phosphorylated at Y783 was from Cell
Signaling Technologies. Mouse anti-PLCγ1 was from ECM Biosciences. Rabbit antiWASp, mouse anti-Itk (clone 2F12) and anti-phosphotyrosine (4G10) were from
Millipore. Anti-GST, anti-actin (C-2) and anti-Lamin B (M-20) were from Santa Cruz.
Anti-GAPDH was from Calbiochem. Anti-MBP was from Immunology Consultants
Laboratory. The anti-human CD3 (OKT3) was from the Children’s Hospital of
Philadelphia Pharmacy; anti-TCR (C305) was a gift from Dr. G. Koretzky (University of
Pennsylvania). Antibodies against mouse CD3e (2C11) and CD28 (PV-1) were from the
University of Chicago monoclonal facility. Anti-mouse CD3ε (500.A2) and mouse antihuman HS1 were from BD Pharmingen. Antibodies against Thy 1 (AT83.A) and CD24
(J11D) were gifts from Dr. A. Sperling (University of Chicago). Anti-CD3-PE, antiCD4-allophycocyanin, anti-CD8-Pe/Cy7 (CD28.2), anti-CD25-PE, anti-CD69-PE, antiCD44-FITC, anti-CD62L-PE, and anti-FoxP3-AlexaFluor488 were from Biolegend.
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Goat anti-mouse IgG-IRDye800 was from Rockland Immunochemicals and goat antirabbit IgG Alexa Fluor 680 was from Molecular Probes. Goat anti-mouse IgG1 Alexa
Fluor 555 and goat anti-mouse IgG Alexa Fluor 594 were from Molecular Probes and
donkey anti-mouse IgG Cy3 was from Jackson Immunoresearch.

Plasmids
Human HS1 was amplified from a cDNA library and mutated to generate the
Y397F, Y378/397F, and shRNA-resistant mutants using the Quik Change kit from
Stratagene (see Table 7.1). The IL2p.luc, NFκB.luc, and NF-AT.luc reporter constructs
have been described (Cao et al., 2002).
The shRNA vectors pFRT-H1P and pCMS3.eGFP.H1p have been described
(Gomez et al., 2005; Trushin et al., 2003). pCMS4.eGFP.H1p, derived from
pCMS3.eGFP.H1p, contains an additional CMV promoter for driving the expression of
shRNA-resistant proteins for reconstitution studies. shHS1b and shHS1f targeting
sequences are in Table 7.1 along with the control shHS1mut sequence. The shRNA
vector against Vav1 has been described (Zakaria et al., 2004). cDNA for human HS1
was tagged with the bright YFP variant Venus (Nagai et al., 2002) and cloned into the
MSCV2.1 retroviral expression vector.
The Itk-myc expression constructs were gifts of Dr. L. Berg, University of
Massachusetts. The shRNA vectors pFRT.H1p and pCMS3.eGFP.H1p, and the shHS1f
targeting sequence have been described (Gomez et al., 2005; Gomez et al., 2006; Trushin
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et al., 2003). siRNA duplexes against human Itk (Dombroski et al., 2005) were
synthesized by Qiagen. For some studies, Itk suppression sequences were cloned into
pFRT.H1p and pCMS3.eGFP.H1p as previously described (Gomez et al., 2005; Trushin
et al., 2003). The following targeting sequences were used: shItkc:
GAAGAAACGAGGAATAATA and shItke: GCACTATCCGATCCTCATC. All results
were confirmed using both targeting constructs; results with only one construct are shown
for simplicity. Electroporation was done using an ECM 830 square wave electroporator
(BTX) in 500 µl antibiotic-free RPMI using a 310 V, 10ms pulse. Cells were used 24
hours after transfection with 40 µg Itk-myc expression constructs or 1.5 µg siRNA
duplexes, or 72 hours after transfection with 40 µg shRNA vectors. In each case,
suppression efficiency in the bulk population of cells was at least 60%.
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Table 7.1: PCR primers and shRNA targeting sequences
Name

Sequence

Used for

5’ HS1
3’ HS1
shHS1b

5’-CTTGCACAGGTGAAGCTTTGGAAGTCTGTAGTGGGC-3’
5’-TTGCAGTAGACAGCGGCCGCTAGTCACTCCAGGAGCTTGACATAATTTGC-3’
5’-GCAGCTCTGGGATATGAtTAtAAaGGAGAGACGGAGAAA-3’

PCR of HS1 cDNAa
PCR of HS1 cDNAa
Mutagenesis of HS1

resistant mt

cDNA making it resistant
to shHS1b targetingb

shHS1b

5’-GACTACAAGGGAGAGACGGAG-3’

shHS1b targeting
sequence

shHS1f

5'-GAACCAGAGGGGGACTATG-3'

shHS1f targeting
sequence

shHS1bmut

5’-GACTAgAAGGcAcAGAgGGAG-3’

shHS1bmut non-targeting
mutant sequenceb

shItkc
GAAGAAACGAGGAATAATA
shItke
GCACTATCCGATCCTCATC
a
Underlining in these oligos indicates unique restriction sites used for subcloning the amplified HS1 cDNA.
b

shItkc targeting sequence
shItke targeting sequence

Lower case nucleotides indicate point mutations introduced into the primary sequence of HS1 cDNA or shHS1b.
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Cell culture
All tissue culture reagents were from Invitrogen. Jurkat-E6, JCaM-1, P116, and primary
human peripheral blood CD4+ T cells, NALM6 B cells, Raji B cells, and EBV B cells
were grown in RPMI-1640 supplemented with 5% FBS, 5% newborn calf serum, 25 mM
HEPES, and 4mM glutamine. A Jurkat-E6 T cell line stably expressing GFP-actin was
generated using the pEGFP-actin vector (Clontech). These cells express GFP-actin at
~37% of endogenous levels. Jurkat T cells stably expressing PLCγ1-eYFP ((Braiman et
al., 2006), gift of Dr. L. Samelson, NIH) were maintained in RPMI containing 10% FBS,
penicillin/streptomycin, glutamine, and 1 mg/ml G418. P815 mouse mastocytoma cells
and the mouse B cell line CH27 were cultured in Glutamax DMEM (Gibco), with 5%
FBS, non-essential amino acids, β-mercaptoethanol, penicillin and streptomycin, and 25
mM HEPES. DO11.10 T cell blasts were cultured as described (McKean et al., 2001).
Murine CD4+ T cells were isolated from lymph nodes and spleens by negative selection
using a mixture of anti-MHC class II (M5/114.15.2) and anti-CD8 (2.43) followed by
magnetic bead-conjugated goat anti-rat Ig (Qiagen). Where specified, total T cells were
isolated using anti-MHC II alone. T cell blasts from WT or HS1-/- C57Bl/6 mice were
prepared from CD4+ T cells by stimulation on plates coated with anti-CD3 (2c11) and
anti-CD28 (PV1) for 3 days, followed by 3-8 days of resting culture. Cells were
maintained using DMEM supplemented with 10% FBS, non-essential amino acids,
penicillin, streptomycin, HEPES and β-Mercaptoethanol (Sigma), supplemented with 50
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U/ml rhIL2 (obtained through the AIDS Research and Reference Reagent Program,
Division of AIDS, National Institute of Allergy and Infectious Diseases, National
Institutes of Health; human rIL2 from M. Gately, Hoffmann-LaRoche, Nutley, NJ).

Mice
HS1-/- mice on the C57Bl/6J background have been previously described (Taniuchi et al.,
1995) and were a gift of Dr. D. Rawlings (University of Washington). WT C57Bl/6 mice
were from Jackson Laboratories. To generate T cells specific for moth cytochrome C 88103 (MCC88-103) presented on I-Ek, HS1-/- mice were crossed to AND TCR transgenic
mice (Jackson Labs) (Kaye et al., 1989; Kaye et al., 1992; Vasquez et al., 1992), and
maintained as heterozygotes for the AND transgene. C57Bl/6J mice were obtained from
Jackson Laboratories. All mice were housed under pathogen-free conditions in the
Children’s Hospital of Philadelphia animal facility. All studies involving animals were
reviewed and approved by the Children’s Hospital of Philadelphia Institutional Animal
Care and Use Committee.

Isolation of primary T cells and primary APCs
T cells were prepared from spleens and lymph nodes by negative selection using either
complement lysis (Chapter 2) or magnetic beads (Qiagen Biomag Goat anti-Rat)
(Chapter 3 and Chapter 4. Primary APCs were prepared from wild type splenocytes by
complement enrichment using anti-Thy1 (AT83.A), yielding less than 1% CD3+ cells.
Single cell suspensions were depleted of erythrocytes using Ack lysis buffer (150 mM
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NH4Cl, 10 mM KHCO3, 0.1 mM EDTA) and incubated with hybridoma supernatants for
30-60 minutes. Anti-CD24 (clone J11d), a kind gift of Dr. Anne Sperling, was used for
complement lysis, and anti-MHCII (clone M5/114), anti-CD8.2 (2.43), and anti-CD4
(GK1.5) were used for magnetic bead isolation. For complement lysis, cells were
incubated with rabbit complement H2 (Pel-Freez) for 30 minutes at room temperature
with shaking then washed in DMEM. Dead cells were removed by centrifugation at 2000
RPM for 20 minutes over a Histopaque (Sigma) gradient. For magnetic bead isolation,
cells were collected by centrifugation and incubated with Biomag Goat anti-rat IgG beads
for 15 minutes at 4ºC. Bead-bound cells were removed with a Dynal magnet. Typical
purity as assessed by flow cytometry staining was > 85%.

Preparation of T cell blasts
CD4+ T cells from spleens and lymph nodes of WT or HS1-/- mice were activated on 6well plates coated with (clone 145-2c11) and anti-CD28 (clone PV-1) for three days in
the presence of 50 U/ml exogenous rhIL2 (recombinant human IL2). Blasting cells were
transferred to fresh, uncoated 6-well plates and cultured in the presence of exogenous
rhIL2 (100 U/ml) for three to eight additional days.

Transfection of Jurkat cells by electroporation
Jurkat cells growing in log phase were collected by centrifugation and resuspended at
2x107 cells/ml in RPMI-1640 supplemented with 5% FBS, 5% newborn calf serum, 25
mM HEPES, and 4mM glutamine. 500 µl of cells were transferred to a 4 mm gap
172

cuvette, mixed with DNA, and electroporated at 310 V, 1 ms pulse using a BTX ECM
830 electroporator (Harvard Apparatus). For shRNA experiments, cells were allowed to
recover for 48-96 hours prior to use. For overexpression experiments, cells were used
16-24 hours after transfection.

Luciferase reporter assays
Transient expression and/or suppression and luciferase reporter assays in Jurkat were
done as previously described (Cao et al., 2002; Nolz et al., 2006). For cell-cell
stimulation in reporter assays, live NALM6 B cells (1x106) and 0.5µg/ml Staphylococcal
Enterotoxin E (SEE, Toxin Technologies) were added to each well. For cell-cell
stimulation time courses, Jurkat cells were activated with fixed, SEE-pulsed NALM6 or
RAJI B cells as described (Gomez et al., 2005).

Retroviral transduction of primary mouse T cells
CD4+ T cells were stimulated for three days as described under “Preparation of T cell
blasts.” Cells were then transduced by resuspending in 1 ml retroviral supernatant
containing 8 mg/ml polybrene and 50 U/ml rhIL2 and centrifugation at 823 x g in a 24
well plate for 2 hours at room temperature. Transduced cells were cultured in 24 well
plates in media containing 50 U/ml rhIL2 for four to five days. Transduction efficiency
was assessed by flow cytometry at 48 hours after transduction by staining with mouse
anti-NGFR hybridoma supernatant (ME20.4) and PE-anti-mouse IgG (Biolegend) as
described above.
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Magnetic sorting of retrovirally transduced cells
T cells were resuspended in MACS buffer (PBS containing 0.5% BSA, 2mM EDTA)
supplemented with 25% anti-NGFR hybridoma supernatant and incubated at 4ºC for 15
minutes. Cells were then collected, washed twice in MACS buffer, and incubated with
anti mouse IgG MACS beads (Miltenyi Biotec) at 4ºC for 15 minutes. Bead-bound cells
were positively selected using MACS LS columns, and cultured for overnight prior to
use.

Flow cytometry
For cell-surface staining, samples were washed in FACS buffer (5% FBS, 2 mM EDTA,
and 0.02% NaN3 in PBS), resuspended in 100 µl of FACS buffer, and incubated at 4ºC
with appropriate antibodies for 20 minutes. Samples were washed in FACS buffer,
incubated with secondary antibodies as necessary for 15-20 minutes, and washed twice.
Samples were analyzed immediately or fixed in 0.5% paraformaldehyde. For
intracellular cytokine staining, cells were fixed at room temperature for 10 minutes with
3% paraformaldehyde, then washed once in FACS buffer and once in permeabilization
buffer (1% FBS, 0.1% saponin in PBS). Samples were incubated in 100 µl
permeabilization buffer containing anti-IFNγ and anti-IL4 for 30 minutes, followed by
two washes in FACS buffer and immediate analysis. All flow cytometry data acquisition
was conducted on a FACSCalibur (BD Biocsciences) and analyzed using FlowJo 6.0
(TreeStar).
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Helper T cell differentiation
CD4+ T cells (2.5x105/well) from WT or HS1-/- mice were stimulated on 24-well plates
coated with 1 or 0.1 µg/ml anti-CD3 (145-2c11) and 1 µg/ml anti-CD28 (PV-1) for three
days. Cells were then transferred to fresh plates and cultured in the presence of 50 U/ml
rhIL2 for four days. Cells were assayed for cytokine production by stimulating with
PMA (32 nM) and Ionomycin (500 nM) for two to three hours, then exposed to Brefeldin
A (1 µg/ml) for two hours. Cells were washed in FACS buffer, and then stained as
described above.

Generation of Jurkat cells stably expressing VenusHS1
Jurkat cells were transfected with MSCV-Venus-HS1 expression vector and allowed to
recover for two days prior to selection in 1 mg/ml G418. After two weeks, a population
of G418-resistant cells emerged. This culture was expanded and sorted on cells
expressing low, medium, and high levels of Venus using a FACSVantage cell sorter (BD
Biosciences). Sorted cells were then plated at one cell per well of a flat-bottom 96 well
plate by limiting dilution. Two clones, 6c7 and 8g5, expressing approximately a 1:1 ratio
of Venus-HS1:endogenous HS1 were selected for future use.

Cytotoxicity assays
CTL were generated in vitro by stimulating CD8+ T cells from lymph nodes and spleens
of WT or HS1-/- mice on the C57Bl/6 background (H-2b) on plates coated with anti-CD3
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and anti-CD28 for three days in the presence of 50 U/ml exogenous rhIL2. Cells were
then transferred to fresh plates and cultured for two additional days prior to use. For
cytotoxicity assays, effector CTL were plated in plated in 96-well round bottom plates at
3-fold serial dilutions, starting with 5x105 cells per well. Allogeneic target cells (P815
mouse mastocytoma cells, H-2d) were loaded with 51Cr, washed, and plated (1x104
cells/well). Cells were incubated at 37ºC for four to five hours. To control for
spontaneous 51Cr release, some wells received only target cells. To determine maximal
release, some wells received only target cells, which were lysed with 1% NP40 (Sigma).
Supernatants (100 µl) were harvested to 96-well Luma plates (PerkinElmer) and allowed
to evaporate overnight. Plates were read on TopCount scintillation counter
(PerkinElmer).

TCR internalization
TCR internalization studies were conducted according to (Cemerski et al., 2007). All
manipulations were conducted in DMEM containing 1% FBS. CD4+ T cells prepared by
negative selection from WT or HS1-/- AND TCR transgenic mice. For peptide loading,
CH27 B cells were incubated at 37ºC with 0.1-10 µM MCC88-103 peptide for four hours.
CH27 cells without preloaded peptide served as controls. T cells and B cells were each
washed and resuspended at 1x106/ml. T cells and B cells were then mixed at a 1:1 ratio
in V-bottom plates, 1x105 of each cell type, and incubated for the indicated length of
time. Conjugates were then harvested, washed in FACS buffer, and stained with anti-
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CD4, anti-Vα11, and anti-Vβ3 for analysis by flow cytometry. Only CD4+ events were
analyzed to exclude CH27 cells not in conjugates.

Activation-induced cell death
AICD studies were conducted according to a protocol from Dr. Richard Siegel (NIH).
CD4+ T cell blasts (above) were used three days after removal from stimulatory plates.
To induce AICD, cells were resuspended at 2x106/ml in DMEM containing 50 U/ml
rhIL2 and stimulated on flat-bottom 96-well plates coated with the indicated
concentrations of anti-CD3 for eight hours. Cells were harvested and stained for 20
minutes with Annexin-V-AlexaFluor 647 (Molecular Probes) and 7-AAD (Molecular
Probes) in Annexin binding buffer (10 mM HEPES pH 7.4, 140 mM NaCl, 2.5 mM
CaCl2). Data were acquired on a FACSCalibur (BD Biosciences) and analyzed using
FlowJo (TreeStar, Inc.). Percent specific cell death was calculated according to the
1"

following equation:

ELISA

% Livetreated
#100
% Liveuntreated
.

!

For IL2 ELISA, total T cells (2x105 cells per well) were plated in a 96-well round-bottom
TC plate (Costar) with 50,000 T-depleted splenocytes and SEB (Toxin Technologies).
After incubation at 37ºC for 24h, plates were frozen at -80ºC. IL2 ELISAs were
performed using the mouse IL2 Ready-SET-Go! ELISA kit (eBiosciences). For IFNγ
ELISA, CD4+ or CD8+ T cells isolated from spleens and lymph nodes of WT or HS1-/mice were stimulated at 1x106 cells/ml on 96-well flat-bottom plates (2x105 cells per
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well) coated with anti-CD3 (clone 145-2c11, 1.0 or 0.1 µg/ml) and anti-CD28 (clone PV1, 1 µg/ml) for three days, after which plates were frozen at -80ºC. Supernatants were
assayed for IFNγ content using the mouse IFNγ Ready-SET-Go! kit (eBioscience)
according to the manufacturer’s instructions.

Analysis of surface marker upregulation
Total T cells were stimulated as described for IL2 ELISA except that 1 µg/ml anti-CD3
(145-2c11) was used instead of SEB. After 24 hours, samples were stained and analyzed
by flow cytometry as described above.

F-actin binding assay
Recombinant GST-tagged HS1EP6 or HS1HTH2.5 was produced in Escherichia coli and
affinity purified on a glutathione resin (Amersham) and used in an Actin Binding Protein
Spindown Assay Kit for non-muscle actin (Cytoskeleton, Inc.) according to the
manufacturer’s instructions. Briefly, 1 µM GST-HS1 was incubated with the indicated
concentrations of F-actin for 30 minutes at room temperature in . Samples were then
centrifuged at 150,000 x g for 90 minutes at room temperature. Supernatants were
transferred to fresh tubes, and both supernatants and pellets were analyzed by coomassie
staining or by western blotting for GST. BSA was used as a negative control, and αactinin was used as a positive control.

Actin polymerization assay
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In vitro actin polymerization was assessed using an actin polymerization kit
(Cytoskeleton, Inc.), according to the manufacturer’s instructions. Briefly, recombinant
GST-tagged WASp VCA fragment (80 nM) or GST-tagged HS1EP6 or HS1HTH2.5 (100
mM) were incubated with 70 nM Arp2/3 complex in actin polymerization buffer (50 mM
KCl, 2 mM MgCl2, 1 mM ATP) in a 96-well plate. Reactions were initiated by the
addition of actin containing 20% pyrene labeled actin and monitored every 30 seconds
using a fluorescence plate reader.

Immunofluorescence microscopy
Jurkat T cells were conjugated to Raji B cells at 37ºC as described previously (Cannon et
al., 2001) and stained for F-actin using Alexa Fluor 647-phalloidin (Molecular Probes)
and for HS1 followed by anti-mouse IgG Alexa Fluor 594 or anti-mouse IgG Cy3. For
experiments involving CD4+ T cells from AND transgenic mice, CH27 B cells were
labeled with CMAC (Cell tracker blue, Molecular Probes) and incubated with 5 µM moth
cytochrome C peptide (MCC88-103). Equal numbers of T cells and B cells were
centrifuged together, incubated at 37ºC for various times, and plated on poly-L-lysinecoated coverslips followed by fixation in 3% paraformaldehyde. Excess aldehyde groups
were quenched by incubation in 0.5 mg/ml NaBH4. Samples were blocked in TSGxx.
Conjugates were stained for PLCγ1, Itk, or F-actin using Alexa Fluor 647-phalloidin
followed by anti-mouse IgG1 Alexa Fluor 555. Conjugates were analyzed on a Zeiss
Axiovert 200M microscope equipped with a 63x planapo 1.4 NA objective. Images were
collected using a Photometrics Coolsnap FX-HQ (Roper Scientific) camera and
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deconvolution was performed using a constrained iterative algorithm (Slidebook v. 4.2,
Intelligent Imaging Innovations). Alternatively, conjugates were imaged on a Zeiss
Axiovert 200 equipped with a Perkin Elmer Ultraview ERS6 spinning disk confocal
system and a 63x planapo 1.4 NA objective. Images were collected using an Orca ER
camera (Hamamatsu) and analyzed using Volocity v. 5 (Improvision). For analysis,
conjugates were identified at random as a blue B cell in contact with a T cell, and scored
for the presence of a bright band of protein at the cell-cell contact site. All experiments
were analyzed by an individual blinded to the experimental conditions. At least 50
conjugates were scored per condition in each experiment.

Live cell imaging
Eight well Lab-Tek II chambered coverglasses (Nalge Nunc) were cleaned with 70%
ethanol containing 1 M HCl prior to incubation for 15 minutes with 0.1 mg/ml poly-Llysine. Prior to use, coverglasses were coated with 10 µg/ml OKT-3 for 2 hours at 37ºC
or overnight at 4ºC. Coverglasses were rinsed in PBS and covered with 400 µl RPMI
without phenol red immediately prior to imaging and equilibrated to 37°C on the
microscope stage within a Solent environmental chamber. Cultured cells were
resuspended in phenol red-free RPMI at 2x106/ml, and spreading was initiated by adding
5-10 µl of cell suspension to the coverglass chamber. Time-lapse images were collected
at 63X using a Perkin-Elmer ERS6 Ultraview spinning disk confocal system. Stacks of
3-7 images were collected at 0.5 µm spacing every 3-5 seconds for approximately 6
minutes. GFP-actin dynamics were analyzed using Volocity Quantitation for area
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measurements and Slidebook for radial variance as follows: Projections were created
from the 4D datasets, masks created for each cell at each time point and the areas
determined in pixels. For radial variance calculations, 64 radii were struck from the
centroid of each mask, and the standard deviation of the radii was calculated for each cell
at each time point. Video sequences from several cells were aligned based on initial
contact with the coverslip and the average of the cell area and of the radial variance were
calculated for the population of cells, at each time point. At least 40 cells were analyzed
per condition. To assess PLCγ1 microcluster dynamics, maximum intensity projections
were generated, and individual objects were identified based on pixel intensity and
tracked using Volocity. Microcluster area at 90 seconds after contact with the coverslip
for each individual size. At least 20 cells were analyzed per condition. Objects were
pseudocolored based on time of appearance, relative to the total duration of each timelapse sequence.

Ca2+ assays
For single cell Ca2+ measurements, freshly isolated CD4+ T cells were loaded with the
cell-permeant Ca2+ indicator Fura-2 AM (3.0 µM, Molecular Probes) for 15 min in
normal bath solution (155 mM NaCl, 4.5 mM KCl, 2 mM CaCl2, 1 mM MgCl2, 10 mM
glucose, and 10 mM Hepes (pH 7.4)). Cell suspensions were placed into the recording
chamber on an inverted fluorescence microscope (Nikon) and allowed to adhere to PolyL-lysine-treated (100 µg/ml, Sigma) coverslips for 5 minutes. Extracellular Fura-2 AM
was removed by perfusion with additional normal bath solution. Before stimulation, the
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chamber was perfused with Ca2+ free bath solution containing 155 mM NaCl, 4.5 mM
KCl, 1 mM MgCl2 and 0.5 mM EGTA, 10 mM glucose and 10 mM Hepes (pH = 7.4).
Intracellular Ca2+ mobilization was initiated by addition of anti-CD3 (500.A2) in Ca2+free bath solution; consequently, the initial Ca2+ transient observed in Ca2+-free solution
is due to Ca2+ release from stores. The activation state of calcium entry channels was
then examined by replacing the Ca2+-free solution with normal (Ca2+-containing) bath
solution. Where indicated, 1 µM thapsigargin was added to block SERCA pump activity,
thereby depleting intracellular Ca2+ stores. Fura-2 was alternately excited at 340 nm and
380 nm and fluorescence emission (plotted as the 340 nm/380 nm ratio) of individual
cells was measured by digital imaging microscopy using Metafluor software (Molecular
Devices).

Western blotting
Lysates were separated on Tris-Glycine SDS-PAGE gels, transferred to immobilon-FL
(Millipore) or nitrocellulose (Bio-Rad) membranes, blocked in 3% non-fat dry milk in
TBS and probed with primary antibodies in 3% milk in TBST or 3% BSA in TBST for
phospho-specific antibodies. Blots were probed with goat anti-mouse IgG-IRDye800 or
goat anti-rabbit IgG-Alexa Fluor 680 and imaged on a Licor Odyssey infrared
fluorescence scanner.

GST Pulldowns
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Fragments comprised of the SH3-SH2 domains (AA154-352) or the SH2 domain alone
(aa 237-352) of human Itk were cloned into pGEX-KG and mutations to inactivate the
SH3 (W208/209Y) and/or SH2 (R265A) domains were incorporated using standard
molecular biology techniques. The SH3 domain of HS1 (AA415-486) was cloned into
pGEX-KG and inactivating mutations (W455Y, W456Y) were incorporated.
Recombinant GST fusion proteins were generated in bacteria and bound to glutathione
resin (Amersham). Jurkat cells were harvested, resuspended in PBS with Ca2+ and Mg2+,
allowed to rest at 37ºC for 20 minutes, and treated with pervanadate (1:33 dilution) for 35 minutes or left untreated. Pervanadate was prepared by mixing equal parts Na3VO4 and
3% H2O2 and allowed to react at room temperature for 10 minutes. Cells were collected
by centrifugation and lysed in NP40 lysis buffer (50 mM Tris-HCl pH 8, 1% NP40, 100
mM NaCl, 5 mM EDTA, 0.5mM CaCl2, protease inhibitors, 1 mM Na3VO4, and 5 mM
NaF). Lysates were clarified by centrifugation and exposed to glutathione resin-bound
GST fusion proteins for 1-2 hours. Beads were washed three times in NP40 lysis buffer
and analyzed by western blotting and Coomassie staining. Phosphorylated GST-HS1
fusion peptides (AA361-436) were made in the TKB1 E. coli (Stratagene). For in vitro
binding assays, 30µg of p-GST fusion protein was bound to glutathione-agarose, washed,
incubated with 2 µg of maltose binding protein (MBP)-fused Vav1-SH2 proteins, rotated
at 4°C for 20 minutes, and then washed four times with lysis buffer.

Coimmunoprecipitations
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Cultured CD4+ T cell blasts were harvested and resuspended at 1x108/ml in serum-free
DMEM for antibody stimulation or in PBS with Ca2+ and Mg2+ for pervanadate
treatment. Cells were allowed to rest for 30 minutes at 37ºC, then labeled on ice with 10
µg/ml biotinylated anti-CD3 (2c11) for 20 minutes. Signaling was initiated by the
addition of 2.5 µg/ml streptavidin at 37ºC. At the indicated time points, cells were
collected by centrifugation and lysed in NP40 lysis buffer. Postnuclear lysates from
4x107 cells were incubated with anti-mouse HS1 bound to protein A-sepharose for two
hours at 4ºC, washed in lysis buffer, eluted in 2x SDS-PAGE sample buffer, and analyzed
by western blotting for HS1, Itk, and phosphotyrosine.

Preparation and phosphorylation of recombinant HS1
His-Tagged HS1 was expressed in E. coli. Following IPTG induction, bacteria were lysed
with phosphate buffer (20mM NaPO4, 1% NP40, 500mM NaCl, 20mM Imidazole, pH
7.2) with EDTA-free protease inhibitors (Roche). Lysates were clarified by centrifugation
and loaded onto a HiTrap column (Amersham), pre-charged with 100mM NiSO4 on an
AKTA FPLC. The column was washed with phosphate buffer and eluted with a gradient
to 500mM Imidazole. The appropriate fraction was polished over a HiTrap Q HP column
and eluted with a gradient to 1M KCl. 20µg of recombinant HS1 was incubated with or
without 0.5µg recombinant Syk (Upstate) in 50mM Tris pH7.5, 100µM NaVO4, 0.1% βmercaptoethanol, 5mM MgCl2,100µM ATP for 10 min. at 30°C.

Mass Spectrometry
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Recombinant HS1 or HS1 immunoprecipitated from Jurkat cells was resolved by SDSPAGE, stained with Coomassie R-250 (Pierce), excised, and washed extensively with
50:50 (acetonitrile/25 mM ammonium bicarbonate, pH 8.0). Rehydrated gel pieces were
infused with trypsin (Promega; 12.5ng/µl) or Glu-C (Roche; 20 ng/µl), at pH 8.0, and
digested at 37°C for 18-24h. Reactions were stopped by addition of 5% TFA. Nonpeptide impurities were removed using C18 or SCX ziptips (Millipore) and analysis was
carried out in 0.1% phosphoric acid. MALDI-TOF spectra were acquired on a Ciphergen
SELDI mass spectrometer in the linear mode. vMALDI Ion-Trap spectra were acquired
on a Finnegan LTQ mass spectrometer. Following the MS scan, a data-dependent “Top
9” experiment was acquired such that 1 full MS spectrum was first acquired followed by
9 MS2 spectra. For database searching we used Bioworks 3.2 employing the SEQUEST
algorithm, against the SWISSPROT database. To confirm that phosphopeptides were
present, a neutral loss-dependent MS3 experiment was performed, and peaks that showed
loss of 98 Daltons were subjected to further MS/MS.

Analysis of PLCγ1 phosphorylation and cytoskeletal association
Total T cells isolated from the spleen and lymph nodes of wild-type or HS1-/- C57Bl/6
mice were resuspended at 1x108/ml in DMEM and rested at 37ºC for 30 minutes. Cells
were stimulated by the addition of 5 µg/ml anti-CD3 (500.A2). Stimulation was stopped
by transferring an aliquot of cells to a tube containing ice-cold PBS. Cells were collected
by centrifugation, lysed in RIPA buffer (50 mM Tris pH 8, 1% NP40, 0.5% sodium
deoxycholate, 0.1% SDS, 150 mM NaCl, protease inhibitors, 5 mM NaF, 1 mM Na3VO4,
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5 mM EDTA). Lysates were incubated on ice for 20 minutes, then clarified by
centrifugation at 16,000 x g. Samples were analyzed by western blotting. For isolation
of insoluble F-actin-rich fractions, cells were lysed in cytoskeletal stabilizing lysis buffer
(80 mM PIPES pH6.9, 1% Triton X-100, 1 mM EGTA, 1 mM MgCl2, protease
inhibitors, 5 mM NaF, 1 mM Na3VO4), and centrifuged immediately at 5,000 x g for 5
minutes (Gatfield et al., 2005). The F-actin rich pellet was resuspended in high salt
buffer (20 mM HEPES pH 7.9, 0.4 M NaCl, 1 mM EDTA, protease inhibitors, 5 mM
NaF, 1mM Na3VO4) and vortexed for 1 hour at 4ºC to extract proteins. Samples were
centrifuged at 16,000 x g for 10 minutes, and supernatants were used as the insoluble
fraction for western blot analysis. The amount of PLCγ1 or phospho-PLCγ1 in the pellets
was quantified by normalizing to Lamin B intensity within each lane, then to the
normalized value for unstimulated cells. Lamin B was used as a loading control because
the insoluble fractions contain nuclei.
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